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 DANKWOORD 
 
Tijdens mijn studies heb ik altijd beweerd dat doctoreren niet voor mij was weggelegd… Ik 
was zogezegd genetisch voorbestemd om in het onderwijs te gaan en ging prompt na mijn 
studies in Leuven die richting uit. Maar toen ik tijdens een interim in een middelbare school 
in Brugge de vacature voorgeschoteld kreeg voor een assistentschap, en dan nog wel in 
Gent, dichter bij huis dus, lonkte een ambitieuzere academische start waar ik met veel 
leergierigheid ben op ingestapt. De combinatie onderzoek en onderwijs bleek voor mij de 
perfecte combo en al snel raakte ik gebeten (of beter gestoken) door de bijen. Twee jaar 
lang kreeg ik de kans om mee te draaien in lopende bijenonderzoekingen en betrokken te 
worden in een samenwerking met goede mede-ex-studenten uit de KUL. Maar stilaan 
groeide mijn fascinatie voor een kleiner insect die recent zijn intrede had gemaakt in het 
labo: Nasonia vitripennis. Ik kreeg de keuze om een eventuele switch te maken in 
doctoraatsonderwerp en heb resoluut gekozen om voor de sprong in het diepe te gaan: het 
gif van Nasonia vitripennis. Het opzetten van de kweek en naderhand ook van zijn gastheer, 
de welriekende vleesvliegen, verliepen niet altijd zonder slag of stoot. Maar ondertussen 
draaien beide kweken routineus, al moet ik zeggen dat de geur van rottende lever nooit zal 
wennen. Vijf jaar lang heb ik me vastgebeten in de boeiende interactie tussen beide insecten 
en ik moet zeggen, het heeft me geen seconde verveeld. Met heel veel weemoed kijk ik 
terug op 7 jaar werken als assistent aan de UGent, een job die me enorm veel voldoening en 
plezier heeft bezorgd. 
 
De belangrijkste persoon in de mede-realisatie van dit werk is zonder twijfel mijn promotor 
Prof. Dirk de Graaf. Je enthousiasme in het onderzoek en excellente begeleiding, maken van 
jou de beste promotor die je je als startend doctoraatstudent kunt wensen. Door je niet-
aflatende vertrouwen en steun in zowel mijn onderzoeksexperimenten als mijn 
onderwijstaken, ben ik als doctoraatstudente steeds kunnen blijven groeien en verbeteren. 
Naast de dagelijkse werkomgeving hebben we ook veel lief en leed gedeeld. In die 7 jaar 
hebben we van te veel mensen definitief afscheid moeten nemen en ook daarbij had ik het 
gevoel dat ik steeds bij je terecht kon. Maar laat ons vooral ook de plezante momenten niet 
vergeten, zoals de pizza-for-papers, de barbecues en de vele gezellige koffiepauzes. Enorm 
bedankt voor alles! 
Maar oorspronkelijk ben ik begonnen met mijn doctoraat bij DE bijenman van België, Prof. 
Frans Jacobs. Op de momenten dat het op het werk wat minder ging, wist je me er altijd aan 
te herinneren dat het belangrijkste uiteindelijk familie en gezin zijn, en ik geef je volledig 
gelijk! Bedankt voor het vertrouwen en de kansen die je me hebt gegeven.  
 
Twee is altijd beter dan één. De betrekking van een tweede labo met een enorme expertise 
bij de onderzoekingen in het tweede luik van dit proefschrift, is daarom een gigantische 
meerwaarde geweest. Bedankt Prof. Kathleen Van Craenenbroeck voor het gastvrij 
openstellen van je labo en de aangename samenwerking. 
 
Daarnaast zou ik ook alle overige leden van de examencommissie en de 
begeleidingscommissie willen bedanken voor hun terechte opmerkingen en hun inspanning 
om bij dit proefschrift de puntjes op de i te zetten.  
 
Ik heb het geluk gehad dat ik voor het aanleren van de RNAi techniek 4 weken heb kunnen 
vertoeven in het Centre for Ecological and Evolutionary Studies aan de Rijksuniversiteit 
Groningen. De warme gastvrije ontvangst en perfecte ondersteuning stonden haaks 
tegenover de ijzige kille -7°C die er heerste toen ik er verbleef. Bedankt Prof. Leo 
Beukeboom, Prof. Louis van de Zande, Prof. Bregje Wertheim, Eveline Verhulst, Anna 
Rensink, Elzemiek Geuverink, Sylvia Gerritsma en Rogier Houwerzijl voor de fijne periode! 
 
Maar het grootste deel van mijn doctoraat werd ik perfect omringd door een grote groep 
zeer behulpzame collega’s waar ik met onderzoeksproblemen, maar vooral ook met mijn 
eigen verhaal steeds bij terecht kon. Een speciale merci aan Marleen en Lina voor jullie raad 
en daad en onze gezellige babbels over ons kiendjes! Maar ook aan Matthias, Ellen, Jorgen, 
Tine, Sara, Karel, Karen, Bea, Linde, Prof. Sarah Gerlo, Jolien, An, Kamila en Nadia bedankt 
voor de hulp bij de kweken (zowel van insecten als van cellen), het luisterend oor als mijn 
experimenten maar weer eens mislukt waren, maar ook de ontspannende zwempartijtjes 
tussendoor en de vele gezellige koffiepauzes! 
 
Een collega die veel voor me heeft betekend, maar die jammergenoeg dit dankwoord niet 
meer kan nalezen, is Dieter. Ik ben enorm dankbaar dat ik je heb mogen leren kennen en 
 had dit moment ook graag met jou gedeeld. Ik hoop dat je rust mag vinden en we komen 
elkaar nog wel tegen. Clairette, heel erg bedankt voor onze vele babbels waardoor we Dieter 
toch nog een beetje onder ons houden! 
 
Jammergenoeg wat veraf, maar toch ook steeds betrokken en begaan, zijn mijn goeie West-
Vlaamse vrienden, nu weliswaar over heel België verspreid, maar toch houden we nog 
geregeld contact. We zaten allemaal in hetzelfde schuitje en fier mag ik nu ook als laatste in 
de rij jullie uitnodigen op de doctoraatsverdediging.  Jaja, KULAK still rules! 
 
Uiteraard waren ook mijn ouders, ‘kleine’ zus, schoonbroer Stijn en schoonfamilie van groot 
belang bij het welslagen van dit doctoraat. De keuze om biologie te gaan studeren kwam 
misschien niet zo onverwacht, maar de beslissing om uiteindelijk te gaan doctoreren was dat 
wellicht iets meer. De meerdere pogingen om toch nog maar eens te proberen begrijpen wat 
het nu eigenlijk is wat ik hele dagen zit te doen in Gent en de niet-aflatende steun en 
fierheid voor ‘de (schoon)dochter/(schoon)zus aan de universiteit’, heeft me altijd ontroerd. 
Heel erg merci! 
 
Helemaal op het einde komen natuurlijk mijn twee allergrootste schatten. Zonder David was 
ik waarschijnlijk zelfs nooit begonnen met doctoreren. Jouw oneindige geduld en 
onvoorwaardelijke steun hebben me altijd het volle vertrouwen gegeven om de dingen met 
twee handen vast te grijpen. Je hebt me nooit iets in de weg gestaan, in tegendeel, je hebt 
me altijd gepusht om het beste in mezelf naar boven te halen. En daar ben ik je oneindig 
dankbaar voor! Samen hebben we al heel wat opgebouwd en bereikt. Maar het allermooiste 
is toch wel ons kleine poppemie, Emmelien. Hoewel de vele slapeloze nachten me vaak met 
kleine oogjes naar het werk hebben doen vertrekken, als ze je ’s avonds terug in de armen 
komt aangelopen, vergeet je weer volledig alle zorgen. Mijn klein bolleke, je beseft het 
misschien nog niet, maar je overvloed aan energie maakt telkens opnieuw mijn dag weer 
goed. Dantjewel keppemie! 
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LIST OF ABBREVIATIONS 
 
AA  amino acid 
AARE  amino acid deprivation response element 
AMP  antimicrobial peptide 
Blast  basic local alignment search tool 
bp  base pair 
cAMP  cyclic adenosine monophosphate 
cDNA  complementary deoxyribonucleic acid 
C/EBP  CCAAT-enhancer-binding protein 
CHOP  C/EBP homologous protien 
CRE  cAMP response element 
CREB  cAMP response element-binding protein 
Ct  treshold cycle 
Da  dalton 
DEX  dexamethasone 
dH2O  distilled water 
dsRNA  double-stranded RNA 
DTT  dithiothreitol 
EIF  eukaryotic translation initiation factor 
ELISA  enzyme-linked immunosorbent assay 
ER  endoplasmatic reticulum 
EST  expressed sequence tags 
GC  glucocorticoid 
GFP  green fluorescent protein 
GO  gene ontology 
GR  glucocorticoid receptor 
HEK  human embryonal kidney cells 
HPLC  high performance liquid chromatography 
IL  interleukin 
Imd  Immune deficiency 
ISB  insect phosphate saline buffer 
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JNK  c-Jun N-terminal kinase 
LPS  lipopolysaccharide 
KOG  eukaryotic orthologous group 
MAPK  mitogen-activated protein kinase 
MgCl2  magnesium choride 
mM  millimolar 
mRNA  messenger RNA 
MS  mass spectrometry 
MTT  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
MW  molecular weight 
NF-κB  Nuclear factor kappa-light-chain-enhancer of activated B cells 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PDV  polydnavirus 
PEI  polyethilenimine 
PO  phenoloxidase 
RNA  ribonucleic acid 
RNAi  RNA interference 
RT-PCR reverse transcriptase-PCR 
RT-qPCR reverse transcription quantitative (real time) PCR 
SDS-PAGE sodium dodecylsulphate-polyacrylamide gel electrophoresis 
Sf9  Spodoptera frugiperda cell line 9 
TNF  tumor necrosis factor 
TRE  transcriptional response element 
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SUMMARY 
 
Hymenopteran parasitoids develop at the expense of other arthropods, ultimately killing 
their host and are thus important regulators of pest arthropods. The ectoparasitoid wasp 
Nasonia vitripennis preferably parasitizes pupae from flesh flies (Sarcophagidae) and blow 
flies (Calliphoridae). After locating a suitable host, the female wasp injects venom inside the 
fly pupa and lays her eggs in the space between the pupa and the puparium. The injection of 
this complex mixture of venom compounds prepares the host to present the best possible 
environment for the wasp offspring to survive. Host physiology is altered, in which the host 
development is arrested, its immune system is suppressed and host metabolism is modified 
so that it is synchronized with the development of parasitoid larvae.  
 
First part of this work focussed on the early alterations of host physiology after parasitization 
by N. vitripennis. Only effects caused by venom without modifications caused by larval 
feeding were subject of this study. Therefore, Sarcophaga crassipalpis hosts were examined 
by microarray, 3 and 25 hours after parasitization, before wasp eggs hatch. Since we wanted 
to avoid effects caused by manipulation, the expression of Nanos was tested to verify 
successful parasitization instead of opening host puparium and scavenging for parasitoid 
eggs. A set of transcripts was selected from the EST database available for this host and used 
as target for the microarray performed on control and parasitized pupae. Results were 
validated by RT-qPCR on a set of genes. Clustering the differentially expressed genes, 
enlightened alterations of key immune, developmental and metabolic pathways due to 
envenomation. Many of these same pathways have also been implicated in endoparasitoid 
attack of hosts, suggesting some fundamental, conserved aspects of hostparasitoid 
interactions to be further investigated. 
 
Bioinformatic and proteomic studies of N. vitripennis venom revealed the presence of 80 
proteins, of which 23 that show no homology to any known protein. Functionality of this 
intriguing group of compounds was tackled by 2 different approaches: host injection of 
recombinant expressed venom protein or knock down of venom protein in the female wasp, 
both followed by specific bioassays on the host. Since venom proteins appeared to be 
unglycosylated, recombinant expression of venom proteins was performed in a bacterial 
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expression system. Due to significant up-regulation of immune genes by bacterial fragments 
in the solvent of the venom compound, either further purification methods need to be 
applied, or another expression system needs to be used. The second approach to investigate 
functionality that was used, included silencing of the venom compound in the parasitoid 
wasp. Thereby, it became clear that the exact timing of dsRNA injection is crucial to obtain 
successful knockdown of venom genes. By altering the practical setting, silencing venom 
transcripts in N. vitripennis wasps is still one of the possible approaches to unravel 
functionalities of venom compounds. 
 
Endoparasitoid wasps have many virulence factors at their disposal, of which polydnaviruses 
are mostly used to suppress host immunity. Ectoparasitoids, like N. vitripennis, are also able 
to inhibit the host immune reaction, but, in contrast with endoparasitoids, they only contain 
venom compounds to realize this suppression. As second part of this PhD thesis, the 
interesting ability to diminish the defence system was tested in mammalian cells. The major 
central immune pathway in mammals is the NF-ĸB signalling cascade, that shows strong 
homology with the insect Toll and Imd pathways. LPS- and TNF-induced NF-ĸB activation was 
significantly down-regulated by N. vitripennis venom as tested by IL-6 ELISA in Raw264.7 
macrophages and by NF-ĸB luciferase assay in L929sA fibroblasts. Further studies focussed 
on exploring the specific interaction between venom and this cascade, expanding the search 
to effects on MAPK and GR signalling.  
 
Deregulation of NF-ĸB signalling is involved in several diseases like autoimmune conditions, 
inflammatory diseases and cancer. The high need for more safe and/or gene-specific anti-
inflammatory agents reflects the intensive search for NF-ĸB inhibitors. Since N. vitripennis 
venom was proven to have an anti-inflammatory mode of action in the tested cell lines, 
effects of venom on NF-ĸB target genes were investigated by PCR Array on macrophage 
cells. Several interesting targets involved in inflammatory diseases and cancer were altered 
by treatment with N. vitripennis venom, suggesting its putative biomedical application. 
Further unravelling the specific interaction of venom on the NF-ĸB pathway and identifying 
the responsible venom compound, are the next steps in investigating the biomedical 
applications of N. vitripennis venom.   
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SAMENVATTING 
 
Parasitoïde wespen benutten verschillende levensstadia van arthropoden als gastheer, die 
uiteindelijk gedood worden. Ze hebben een enorm economisch belang als regulator van tal 
van pestsoorten van voedingsgewassen en dieren. De ectoparasitoïde wesp Nasonia 
vitripennis parasiteert bij voorkeur vleesvliegen (Sarcophagidae) en bromvliegen 
(Calliphoridae). Hierbij injecteert ze gif in de gastheer om een zo goed mogelijke omgeving te 
garanderen voor haar nakomelingen. Het gif is in staat om de ontwikkeling van de gastheer 
af te remmen en het afweersysteem tegen de parasitoïde larven te onderdrukken. 
Daarnaast wordt het metabolisme op de noden van de parasitoïden afgestemd om van de 
gastheer een nutriëntrijke omgeving te maken.  
 
In een eerste deel van dit werk, worden vroege veranderingen in fysiologie van de gastheer 
na parasitering door N. vitripennis onderzocht door middel van microarray. Enkel effecten 
veroorzaakt door het gif zijn doel van deze studie, waarbij effecten door voedende larven 
worden gemeden. Drie en 25 uren na parasitering werden gekozen als moment van 
staalname, aangezien hierna parasitoïde larven starten te voeden aan de gastheer. Als 
uitgangspunt voor de transcriptoom studie werd een zo natuurlijk mogelijke situatie beoogd, 
wat betekent dat schade door manipulatie van de poppen moest vermeden worden. 
Daarom werd succesvolle parasitering nagegaan door middel van Nanos expressie in plaats 
van het openen van het puparium om Nasonia eitjes te zoeken. Er werd een selectie 
gemaakt van de beschikbare EST databank voor de gastheer Sarcophaga crassipalpis, die als 
target diende voor de microarray. Ter validatie van de data werd RT-qPCR uitgevoerd op een 
reeks genen, voordien getest door microarray. Het groeperen van de differentieel 
geëxpresseerde genen toonde effecten van het gif op verschillende belangrijke pathways 
aan in verband met immuniteit, ontwikkeling en metabolisme.  
 
Via een bioinformatische benadering en proteoomstudie, werd de aanwezigheid van 80 
proteïnen aangetoond in het gif van N. vitripennis. Hiervan vertoonden er 23 geen enkele 
homologie met reeds gekende eiwitten. Om de functionaliteit van deze intrigerende groep 
eiwitten te onderzoeken, werden 2 benaderingen getest: het recombinant aanmaken van 
gifeiwitten, of het onderdrukken van transcripten van gifcomponenten in N. vitripennis, 
6 
beide gevolgd door specifieke bio-assays op hun gastheer. Aangezien de gifproteïnen niet 
geglycosyleerd bleken te zijn, werd voor de recombinante expressie een bacterieel systeem 
gekozen. Na injectie van het opgezuiverde solvent in de vleesvliegpoppen, bleek deze reeds 
een significante opregulatie teweeg te brengen van het immuunsysteem. Een verder 
doorgedreven opzuivering van de recombinant geëxpresseerde gifcomponent of de 
productie ervan in een ander expressiesysteem wordt hierbij aanbevolen. Bij de tweede 
functionaliteitsbenadering worden transcripten van de gifcomponent neergereguleerd door 
middel van dsRNA injectie in de parasitoïde wesp. Hierbij bleek het exacte moment van de 
injectie cruciaal te zijn. Na aanpassingen in de praktische setup van dit experiment, blijft 
deze benadering zinvol om de functionaliteit van gifcomponenten te onderzoeken.  
 
Endoparasitoïde wespen beschikken over verschillende virulentiefactoren om hun gastheer 
naar hun hand te zetten. Zo blijkt dat vooral het injecteren van polydnavirussen 
verantwoordelijk is voor het onderdrukken van het immuunsysteem bij de gastheer. 
Ectoparasitoïden daarentegen gebruiken enkel gif, wat betekent dat een gifcomponent moet 
verantwoordelijk zijn voor de onderdrukking van het afweersysteem. In een tweede luik van 
dit werk wordt deze immuunsuppressie van het gif onderzocht op zoogdiercellen. Centraal in 
het immuunsysteem bij zoogdieren is de NF-ĸB pathway, die sterke homologie vertoont met 
de Toll en Imd pathways bij insecten. Na inductie met LPS en TNF, bleek de activatie van NF-
ĸB onderdrukt te worden door N. vitripennis gif in respectievelijk Raw264.7 macrofagen en 
L929sA fibroblasten. Verdere onderzoekingen trachtten de specifieke interactie van het gif 
met deze signalisatiecascade te achterhalen.  
 
Ontregeling van de NF-ĸB pathway is betrokken in anti-inflammatoire ziekten, 
autoimmuunziekten en kanker. Door de grote vraag naar anti-inflammatoire componenten, 
werd onderzocht of het gif van N. vitripennis een mogelijke biomedische toepassing heeft. 
Door middel van PCR Array werd het effect van het gif op een reeks targetgenen van NF-ĸB 
signalisatie onderzocht. Hieruit bleek dat het gif enkele targets van anti-inflammatoire 
ziekten en kanker significant beïnvloedt, wat een mogelijke biomedische toekomst voor N. 
vitripennis gif biedt. Hiervoor moet echter de specifieke interactie met de NF-ĸB pathway 
uitgeklaard worden en dient de verantwoordelijke component van deze effecten 
geïdentificeerd te worden.  
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CHAPTER 1 
General introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parts of this introduction are redrafted from publication in Toxins in 2010: 
Venom proteins of the parasitoid wasp Nasonia vitripennis: recent discovery of an untapped 
pharmacopee. 
Danneels L. Ellena, Rivers B. Davidb, de Graaf C. Dirka  
aLaboratory of Molecular Entomology and Bee Pathology, Ghent University, B-9000 Ghent, 
Belgium 
bDepartment of Biology, Loyola University Maryland, Baltimore, MD 21210-2699, USA 
General introduction 
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1. Parasitoids: the ‘Trojan insects’ 
 
 “For, from his home beneath Parnassus, Phocian Epeus, aided by 
the craft of Pallas, framed a horse to bear within its womb an armed host, 
and sent it within the battlements, fraught with death; whence in days to 
come men shall tell of 'the wooden horse,' with its hidden load of warriors.”
 
[Euripides’ play ‘Trojan women’, 415 B.C.] 
 
More than 1,000 years BC, the Greek victoriously won a crucial battle against the Trojans by 
constructing a wooden horse that hid warriors inside. From within Troy, they could destroy 
the high-walled city that had been besieged for over 10 years.  
 
Parasitoids are quite similar to the Greek mentioned, in a way that these insects hide their 
future offspring (warriors) inside the host (enemy), that inevitably loses the battle. Instead of 
building a wooden horse to get inside the city-walls alive, the parasitoids survival strategy 
first consists of injecting toxic fluids inside the host in order to present a nutritious 
environment for its offspring to survive. Only then, the true battle begins: the host is being 
paralyzed, its development is arrested, the immune response weakened and its behaviour is 
altered. It is an unfair battle since secondly the host is attacked by larvae that feed on its 
tissues. Ultimately, the host is completely demolished and the new generation of parasitoids 
prevail. 
 
With its 400,000 species, beetles are commonly known as the most diverse group of insects. 
Molecular studies, however, have suggested that the 60,000 species of parasitoid wasps that 
have been described until now (Pennisi, 2010), are only the tip of the iceberg and could be 
even more diverse than beetles. The fact that these wasps are such picky eaters could partly 
explain this high diversity. Some parasitoid wasps only lay eggs in Holometabolous insects 
that have a four-stage life cycle (egg-larva-pupa-adult) and undergo complete 
metamorphosis, while others are selective for certain life stages of the same host species. 
Sometimes, even certain sites on the host are preferred so that specific tissues are available 
for the offspring (Rivers et al., 1993). This specificity makes parasitoids appealing for 
biological pest control, since they are important regulators of agricultural pest insects (see 
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3.3.1. Agronomic applications). Next to this, parasitoids also attack significant vectors of 
human disease, such as house flies, roaches and ticks (Quicke, 1997).  
 
Science-fiction fans may remember the very popular motion picture ‘Alien’ from 1979 that 
describes the fate of the occupants of a spaceship infiltrated by a deadly alien life form. 
Larvae of these creatures entered the bodies of the crew where they developed and grew, 
finally emerging from the infected human which was inevitably killed. The fact that these 
events cannot happen to humans on Earth is at least reassuring. Insects, on the other hand, 
are constantly attacked by parasitoids, resembling the gruesome creature in ‘Alien’. The 
latter can be recognized as an endoparasitoid, which lays its eggs into a mobile and exposed 
host. The offspring develops inside this host, which in the end is completely consumed by 
the parasitoids (figure 1A). Ectoparasitoids on the other hand, lay their eggs outside the host 
(figure 1B). This means that the host needs to be immobilized, which is ensured by the 
injection of a paralytic venom. Once the larvae are hatched, they use their mouthparts to 
attach themselves to the host and continue to feed until almost nothing remains. Therefore, 
parasitoids can be seen as an intermediate between predators and parasites; like predators, 
they always kill the host they attack, and like parasites, they require a host on which to 
mature (Godfray, 2004). 
 
  
Figure 1: A. Larvae of the endoparasitoid wasp Tetrastichus julis inside the Cereal Leaf Beetle, Oulema 
melanopus (©Claude Pilon) B. Larvae of the ectoparasitoid wasp Euplectrus sp. on a Noctuidae caterpillar 
(©Edith Smith). 
 
B. A. 
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2. Tiny but mighty: Nasonia vitripennis 
Nasonia vitripennis can be seen as the Tinkerbell of the animal kingdom: with its size not 
bigger than 2.5 mm, it received wider recognition since its genome was sequenced in 2010. 
The genus Nasonia consists out of 4 related parasitoid species – N. vitripennis, N. giraulti, N. 
longicornis and N. Oneida – of which N. vitripennis is a worldwide distributed ectoparasitoid, 
that can parasitize the pupal stages of several Dipteran families, including Sarcophagidae 
and Calliphoridae. Like other parasitic Hymenoptera, Nasonia is haplodiploid meaning that 
females are diploid and develop from fertilized eggs, whereas males are haploid and develop 
parthenogenetically from unfertilized eggs (The Nasonia Genome Working Group, 2010). 
The availability of the genome together with its ease to work with in the laboratory, makes 
Nasonia a solid model organism in the insect order of Hymenoptera that can keep standing 
next to heavyweights such as Caenorhabditis elegans and Drosophila.  
 
2.1. Life cycle 
Nasonia has a relatively short generation time of approximately 14 days (figure 2), 
depending on environmental temperatures and exposure to light. When a female 
encounters a suitable host, she drills through the puparial wall with her ovipositor. Firstly, 
she will feed on host hemolymph by producing a tube (with fluids from the alkaline gland) 
that connects the interior of the pupa with the exterior of the puparium (Whiting, 1967). The 
wasp feeds on the host fluid drawn up through this feeding tube. Secondly, she injects 
venom by directly inserting her ovipositor inside the host. Thereafter, she retracts her 
ovipositor to lay 20 to 60 eggs on the exterior of the developing host, but still within the 
puparium. N. vitripennis therefore is an ectoparasitoid wasp with no need for a paralyzing 
venom, since the host is already in an immobile state (in contrast to endoparasitoid wasps). 
The eggs hatch around 24 hours later and the larvae start crawling and feeding on the host. 
Around 9 days after laying, the larvae pupate and undergo several pupal stages. The adults 
eclose from pupation in the host and chew their way out through several exit holes. Mating 
occurs immediately after emergence from the host.  
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2.2. Hosts 
N. vitripennis is known in the field as a generalist that parasitizes a diverse set of hosts. In 
laboratory choice experiments however, it shows a preference for the flesh fly species 
Sarcophaga (Diptera: Sarcophagidae) (Desjardins et al., 2010). Flesh flies are larviparous, 
meaning that eggs are not deposited upon full development (figure 2). Instead, the larvae 
hatch inside of their mother's uterus and are held until a proper host is found. First instar 
larvae are deposited on varying types of carrion (in laboratory conditions, beef liver is used) 
where they eat and rapidly develop. Approximately 5 days after larviposition, they leave the 
host and start pupating. About 10 days later, adult flies emerge. To humans, these flies are 
usually nuisance pests and they can be vectors of pathogens and bacteria. In agriculture, 
they are rather beneficial since the larvae of some species can prey on eggs, nymphs or 
larvae of more harmful insects.  
 
 
Figure 2: The life cycle of N. vitripennis is presented on the left. The eggs are laid on the pupal stage of the 
host, S. crassipalpis (centre of the figure, puparium partly removed). The eggs (difficult to see on the small 
picture) develop into larvae and go through several instar stages after which they pupate inside the host 
puparium. The white pupae gradually change in colour starting from the eyes which first become red. 
Subsequently, the thorax darkens followed by the abdomen until the whole pupa is black. After 14 days, 
the adults emerge from the host pupa. The life cycle of S. crassipalpis is presented on the right. Larvae are 
laid on the host, beef liver in this case, and start pupating 5 days later. After 10 days, adults emerge.  
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Sarcophaga crassipalpis is a flesh fly species that is commonly used to study insect pupal 
diapause (Pavlides et al., 2011). Under very specific environmental stimuli, the pupae can 
enter a hibernation-like state where metabolic processes are reduced almost to a complete 
stop until appropriate environmental conditions return (Denlinger, 1972). In 2009, an EST 
database became available which makes this species even more suitable for research (Hahn 
et al., 2009). 
 
3. Parasitism warfare 
 
“You can figure out what the villain fears by his choice of weapons.”  
[The Bridal Season, Connie Brockway] 
 
The extended plethora of parasitoid effector molecules reflects the hostile environment 
these wasps need to survive in during their early development (Burke & Strand, 2014). 
Endoparasitoid eggs come in direct contact with host tissues raising the need for a variety of 
methods to commander the host. The manipulative capabilities of wasp-injected venom, 
often together with polydnaviruses (PDVs), is essential for wasp survival. These PDVs are 
genetic symbionts of the wasp and their genome is integrated into the genomic DNA of their 
wasp carrier (Gundersen-Rindal et al., 2013). They exclusively replicate in the ovaries of the 
female wasp where they co-mingle with parasitoid eggs. Before or during egg-laying, the 
female wasp also injects venom into the host, which is traditionally produced and secreted 
by the acid gland and stored in the venom reservoir until needed (Asgari & Rivers, 2011). 
After eggs are laid, sometimes teratocytes can be found in the hemolymph of parasitized 
hosts. These large cells typically originate from the anterior and posterior serosal cells 
surrounding the developing embryo and are believed to be involved in bypassing immune 
responses, secretion of proteins and larval nutrient uptake (Andrew et al., 2006;Nakamatsu 
et al., 2002;Hotta et al., 2001). Even the wasp larvae may secrete products while developing, 
affecting metamorphosis, development, hemocytes and other immune reactions in the host 
(Richards & Edwards, 2002;Edwards et al., 2006). This large variety of factors introduced by 
parasitoids make up their arsenal, empowering them to cause major mortality in host 
populations.  
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3.1. Shared arsenal in parasitoids: venom 
Venoms that function as defensive secretions, produced for instance by honeybees, tend to 
consist of streamlined and conserved components, while predatory venoms, like from 
parasitoids, are more complex and often highly variable in composition and physiological 
effects (Casewell et al., 2013). Parasitoid venoms typically comprise a complex cocktail of 
proteins and peptides (commonly referred to as toxins), salts and organic components, such 
as amino acids and neurotransmitters (Kapoor, 2010). Most studies have been conducted on 
the proteinaceous components using mass spectrometry (Formesyn et al., 2011), in N. 
vitripennis resulting in a list of 80 venom proteins (de Graaf et al., 2010;Ye et al., 2010). Since 
PDVs and teratocytes only aid the parasitization process in endoparasitoids, the arsenal of 
the ectoparasitoid N. vitripennis only consists out of injected venom and secretions from the 
parasitoid larvae making it an interesting model organism to study venom functionalities.  
 
3.2. Mode of action of the venom 
A common strategy in war is to attack on multiple fronts in order to make the enemy more 
vulnerable. This exact tactic is applied by the parasitoid N. vitripennis, modifying host 
physiology on different levels. The ectoparasitoid wasp needs to create an environment that 
supports and promotes its own development, but in the end leads to the detriment of the 
host insect. In order to succeed, N. vitripennis needs to weaken the enemies first defence 
line which means suppressing its immune system (Rivers et al., 2002b). Insects lack adaptive 
immunity but possess an effective innate immune system that successfully combats 
infections (Vilmos & Kurucz, 1998). Figure 3 gives an overview of the innate immune system 
in insects that is (in short) explained below. First, pathogens are recognized (extracellular), 
after which the humoral and the cellular immune responses become immediately activated 
and respond in concert to clear the pathogen. The former defence process includes 
melanisation, clotting of the hemolymph and the synthesis of antimicrobial peptides (AMPs). 
In cellular reactions, the microorganisms or the apoptotic cells are phagocytised, entrapped 
by nodule formation or encapsulated by hemocytes. Exogenous factors trigger immune 
signalling proteins, which transfer the signal across the plasma membrane (now intracellular) 
and initiate host immune response (Lemaitre & Hoffmann, 2007).  
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Figure 3: Summary of the innate immune system in insects. Pathogen recognition can directly lead to 
humoral or cellular immune defence (represented by the vertical grey bar), but can also transfer 
extracellular signals into intracellular signals via immune signalling pathways. The two major immune 
signalling cascades, Toll and Imd, result in the production of AMPs.  
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Defence against Gram-positive bacteria and fungi is driven by the activation of the Toll 
receptor that leads to a series of intracellular signalling cascades. This leads to the activation 
of the transactivator Nuclear Factor-ĸB (NF-ĸB) proteins Dorsal and Dif by the dissociation 
and degradation of Cactus. Both Dorsal and Dif translocate to the nucleus, resulting in the 
nuclear transcription of Drosomycin and other antimicrobials. Gram-negative bacteria on the 
other hand, trigger the immune deficiency (Imd) pathway, which also activates a series of 
signalling cascades in the cytoplasm, this time leading to cleavage of the transcription factor 
Relish into Rel and ANK domains. After translocation of Rel to the nucleus, transcription of 
Diptericin and other antimicrobials is initiated. Other immune signalling cascades in insects 
are the JAK/STAT pathway triggered by cytokines (Pastor-Pareja et al., 2008), the Growth 
Blocking Peptide (GBP) pathway induced by stress (Tsuzuki et al., 2012) and the integrin 
cascade involved in the initiation of cellular immunity (Irving et al., 2005). Parasitoids have 
found innovative ways to overcome this wide variety of defence mechanisms. They 
circumvent the host’s encapsulation response and suppress the host cellular immune 
response by substances introduced into the host’s body cavity. Such substances may 
adversely affect the ability of hemocytes to recognize nonself, proliferate, differentiate, 
migrate and adhere to foreign surfaces, or prevent the host from synthesizing toxic 
molecules (Vass & Nappi, 2000).  
 
When the parasitoid venom has crumbled away the host defence walls, further growth and 
development of the host is arrested (Rivers et al., 1993;Rivers & Denlinger, 1994a), 
presenting it no choice but to atrophy over time. Contributing to this developmental halt, 
cell death is elicited by N. vitripennis venom injection (Rivers et al., 2011). The loss of 
membrane integrity and subsequent calcium release disrupt the sensitive balance of calcium 
homeostasis, causing cells to die by apoptosis or oncosis (Rivers et al., 2006). As if these life-
threatening attacks are not enough, complete control over the host is gained by the venom 
forcing the host to provide lipids and other nutrients in order to satisfy the wasp offspring 
(Rivers & Denlinger, 1995). Many ecto- and endoparasitoid venoms regulate their host 
nutritional milieu by digesting fat body cells and stimulating host nutrient synthesis, allowing 
nutrients to flow into the hemolymph were they can be consumed by the developing larvae 
(Nakamatsu & Tanaka, 2004).The different fought battles between N. vitripennis venom and 
its host are explained into more detail in the following paragraphs. 
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3.2.1. Venom targets the host defence system 
One major innate defence system in invertebrates is the melanisation of pathogens and 
damaged tissues. This important process is controlled by phenoloxidase (PO), a multicopper 
oxidase, which results in the deposition of melanin around the damaged tissue or intruding 
object. This physical shield prevents or retards its growth and, perhaps even more 
importantly during melanin formation, will produce highly reactive and toxic quinine 
intermediates. These quinones are also involved in the production of cytotoxic molecules, 
such as superoxides and hydroxyl radicals, which could aid in the killing of invading 
microorganisms. When N. vitripennis females parasitize on flesh fly hosts, melanisation 
occurs within a matter of minutes in tissues penetrated by the ovipositor (Rivers et al., 
2002b). Blackening of the tissues remains localized unless the fly is a non-permissive host, in 
which case melanisation and tissue necrosis may spread rapidly from the site of venom 
injection (Rivers et al., 2003). In the endoparasitoid wasp Pimpla hypochondriaca, three PO 
proteins were found to be abundantly present in venom (Parkinson et al., 2001). The authors 
suggested that PO products can bind to the hemocyte plasma membrane and disrupt their 
function, thus contributing to host immune suppression. Interestingly, N. vitripennis venom 
was also found to possess PO activity that, different from P. hypochondriaca, was proven to 
play an important role in cell death (Abt & Rivers, 2007). This implies that the venom protein 
is a tyrosinase (EC 1.14.18.1 mono-phenol monooxygenase; L-DOPA:oxygen oxidoreductase) 
that is known to catalyze synthesis of reactants involved in the biosynthesis of melanin 
(Mason, 1965). However, in the bioinformatic and proteomic study of N. vitripennis venom, 
only 2 laccases (EC 1.10.3.1 ο–diphenol oxidase: 1,2-benzenediol:oxygen oxidoreductase) 
were found that, just like tyrosinases also catalyse oxidation of L-DOPA, but are mostly 
involved in tanning of the soft, newly synthesised cuticle rather than in the melanisation 
pathway (Sugumaran, 1988). The specific venom compound responsible for the PO activity in 
the host therefore needs to be elucidated.  
The PO pathway contributes to the prevention of encapsulation of parasitoid eggs. The 
capsules trapping invading microorganisms and parasites require activation of series of 
serine proteinases. This cascade is targeted by several venom compounds of parasitoid 
wasps as another strategy to suppress the host immune system. These venom compounds 
known so far are listed in table 1, together with homologues that were found in N. 
vitripennis venom. The function of the latter proteins however still needs to be confirmed. 
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Table 1: Venom compounds from different parasitoid wasps with their effect on the host organism (see reference) that have a homologue venom protein in venom 
from N. vitripennis of which its effect in the host is yet unproven.  (Abbreviations: IR = immune response; VP = venom protein; PAP = PO-activating proteinase) 
Venom-host interaction Parasitoid venom compound Parasitoid wasp Reference Homologue N. vitripennis VP 
Immune suppression 
    
inhibition of proPO activation Vn50, serine protease homologue Cotesia rubecula (Zhang et al., 2004) serine protease homolog (SPH21) 
inhibition of proPO activation LbSPNy, serine protease inhibitor Leptopilina boulardi (Colinet et al., 2009) small serine protease inhibitor-like VP 
inhibition of proPO activation serine protease inhibitor Venturia canescens (Beck et al., 2000) small serine protease inhibitor-like VP 
inhibition of proPO activation cvp1, Kunitz type cysteine rich VP Pimpla hypochondriaca (Parkinson et al., 2004) cysteine-rich/KU VP 
inhibition of proPO activation cvp2, pacifastin cysteine rich VP Pimpla hypochondriaca (Parkinson et al., 2004) cysteine-rich/pacifastin VP 1-2 
PAP inhibition Egf1.0, cysteine rich TIL VP Microplitis demolitor (Beck & Strand, 2007) cysteine-rich/TIL VP 1-2 
inhibition of host cellular IR PpCRT, calreticulin Pteromalus puparum (Wang et al., 2013) calreticulin 
inhibition of host cellular IR CrCRT, calreticulin Cotesia rubecula (Zhang et al., 2006) calreticulin 
breaking physical barriers PSP, chitinase Toxoneuron nigriceps (Consoli et al., 2005) chitinase 5 
     
immune stimulation 
    
antibacterial ACE, angiotensin converting enzyme Pimpla hypochondriaca (Dani et al., 2003) angiotensin-converting enzyme 
     
developmental arrest 
    
retardation of growth EpMP1-3, metalloproteases Eulophus pennicornis (Price et al., 2009) metalloprotease 
     
cell death 
    
Ca²
+
 release leading to cell death calreticulin Pimpla hypochondriaca (Rivers et al., 2009) calreticulin 
apoptosis in ovaries Ae-γ-GT, γ-glutamyl transpeptidase Aphidius ervi (Falabella et al., 2007) γ-glutamyl transpeptidase-like VP 1-2 
     
nutritional 
    
catalyze trehalose to provide glucose tre1, trehalase Pimpla hypochondriaca (Parkinson et al., 2003) trehalase 
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Another major innate defence system in invertebrates is the clotting reaction of hemolymph, 
which is based on a combination of soluble and cell-derived factors. Hemocytes proliferate 
and differentiate into lamellocytes that carry out a permanent surveillance in circulation. 
When an invasion occurs, these lamellocytes are massively released to form a multilayered 
capsule around the particle (Lemaitre & Hoffmann, 2007) being part of the humoral immune 
response. Some snake venoms have been found to prevent blood clotting, mainly to spread 
its venom more effectively and to gain a better digestible prey. A similar function can be 
assigned to parasitoid venom. Remarkably, following oviposition by N. vitripennis, no 
evidence of hemolymph clotting occurred at the wound site. David B. Rivers and colleagues 
suggested that the female wasp must inject factors into the fly host that retard or inhibit 
clotting and/or wound healing processes (Rivers et al., 2002b). After the female wasp has 
injected venom into the host and has laid her eggs, she often starts making a feeding tube 
(depending on whether the female has oviposited before (Rivers, 1996)), connecting the 
interior of the pupa with the exterior of the puparium (Whiting, 1967). Inhibition of 
coagulation is of crucial importance in this process, since the wasp feeds on the host fluid 
drawn up through the feeding tube. In addition to this, the young parasitoid larvae also feed 
on the host, grabbing and puncturing the host’s integument with their mandibles and taking 
in the host’s body fluids. Richards and Edwards argued that the ectoparasitoid Eulophus 
pennicornis relies entirely on salivary secretions from larvae to knock out host defences 
(Richards & Edwards, 2000). A similar scenario was reported for the ectoparasitoid 
Euplectrus plathypenae (Coudron et al., 1990). Larval secretions are known to inhibit clotting 
but they can also contribute to the action of maternal venom that is injected into the host.  
Next to preventing clotting to keep the host digestible, venom also serves to inhibit 
accumulation of hemocytes around the parasitoid eggs aiding the suppression of immune 
defence. The protein calreticulin in venoms of two endoparasitoid wasps, PpCRT in 
Pteromalus puparum and CrCRT in Cotesia rubecula, has been demonstrated to inhibit 
hemocyte spreading behaviour and prevent encapsulation (Wang et al., 2013;Zhang et al., 
2006). Calreticulin is also present in N. vitripennis venom (table 1), but its possible 
involvement in host immune suppression still needs to be elucidated.  
 
Both targeted melanisation and coagulation cascades represent direct immune suppression 
towards the parasitoid eggs. However, since suppression of these cascades typically occurs 
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with endoparasitic species to protect the eggs/larvae, the exact significance to an 
ectoparasitoid like N. vitripennis still needs to be determined. Furthermore, venom 
components are also assumed to target the overall defence system of the host next to 
blocking direct encapsulation or clotting around the invading parasitoids. Chitinase for 
instance, from teratocytes of the endoparasitoid Toxoneuron nigriceps was suggested to be 
involved in breaking physical barriers and gaining access to the host to initiate an infection 
process (Consoli et al., 2005;Kramer & Muthukrishnan, 1997). A chitinase 5 protein is also 
present in N. vitripennis venom (table 1), possibly aiding in weakening the host as a whole 
making it unable to start up a sufficient immune response against intruders.  
 
The suppressive potential towards the immune system of the host is relatively well-known 
for parasitoid venom (Fang et al., 2010;Labrosse et al., 2003;Schmidt et al., 2001). However, 
these female wasps face the challenge of conditioning the host to maximize progeny 
production, while avoiding excessive manipulation that leads to rapid deterioration of the 
host. If injected venom evokes suppression of host physiology leading to a completely 
immune-compromised host, unregulated microbial attack may occur. The result is an 
unfavourable host environment in which the parasitoid’s progeny compete directly with 
microorganisms for host nutrients, and in turn, face direct invasion by the microbes. Thus, 
one might expect that the parasitoid’s venom suppresses host immunity only selectively, for 
instance by interfering with host melanisation and coagulation responses (see above), yet 
allowing or even stimulating certain antimicrobial defences. Venom of P. hypochondriaca, 
was found to have antibacterial activity against two Gram-negative bacteria (Dani et al., 
2003). Peptidases present in this venom were speculated to be involved in the processing of 
biologically active peptides, including antibacterial peptides. An angiotensin-converting 
enzyme (ACE) could be involved in the synthesis of the antibacterial peptide, peptide B, from 
the C-terminal region of pro-enkepahlin Tasiemski et al., 2000). This enzyme was also found 
in N. vitripennis venom (table 1), but its possible antibacterial function has not been 
investigated yet.  
 
3.2.2. Venom targets the host development 
Parasitized insects typically undergo developmental arrest and die some time after the 
parasitoid has become independent of its host. In endoparasitoids, the developmental arrest 
General introduction 
22 
is induced by the venom, polydnaviruses or teratocytes (Dahlman et al., 2003;Reed & 
Beckage, 1997). In ectoparasitoids, paralysis is used to immobilize the host and the 
developmental arrest is necessary to prevent elimination of the larvae during host moulting. 
Interestingly, David B. Rivers and colleagues suggested that the venom of N. vitripennis is 
nonparalytic and development of envenomated hosts is either arrested or delayed (Rivers et 
al., 1993). In several parasitized hosts, developmental arrest is due to ecdysteroid deficiency, 
which is often the result of a hormone imbalance, caused by a disruption or deterioration of 
endocrine tissues, or by inhibition of target tissues to respond to hormone signals (Asgari & 
Rivers, 2011). But unlike many host-parasitoid associations, the arrest in hosts parasitized by 
N. vitripennis seems not to be due to ecdysteroid deficiency (Rivers & Denlinger, 1994a). 
Interestingly, brain tissues of Sarcophaga hosts were also found to be affected by the 
venom, resulting in cell death and may be involved in the developmental arrest observed in 
parasitized hosts (Rivers et al., 2011). Recent studies revealed that under this arrest, N. 
vitripennis venom causes incomplete development of bristles and eye pigment deposition 
(Rivers & Brogan, 2008). When recombinant EpMP3, resembling the venom protein 
metalloproteinase from E. pennicornis, was injected into fifth instar larvae of Lacanobia 
oleracae, it was found to retard host development (Price et al., 2009). N. vitripennis venom 
contains a similar metalloprotease of which its function until now is unknown (table 1).  
 
3.2.3. Venom causes host cell death 
Cell death is a common process in living organisms and plays an important role during 
developmental processes, tissue homeostasis, immune reactions and wound repair. Under 
certain pathological conditions, cells can undergo apoptosis, which is often seen in host-
parasitoid relationships and associated with immune suppression of the host (Suzuki & 
Tanaka, 2006;Asgari & Rivers, 2011;Fang et al., 2010). Apoptosis results in DNA 
fragmentation, degradation of cytoskeletal and nuclear proteins, cytoskeletal reorganization 
and formation of apoptotic bodies (Elmore, 2007). Inappropriate regulation of apoptosis 
leads to many human pathologies, for instance too little apoptosis can result in certain 
cancers, while overexcessive apoptosis can lead to certain autoimmune diseases. 
 
Upon venom induction by N. vitripennis, several events are initiated in the host, starting with 
the loss of mitochondrial membrane potential (Rivers et al., 1999). The induced changes in 
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plasma membrane permeability cause an influx of Na+, which results in the release of Ca²+ 
from the mitochondria (Rivers et al., 2002a, 2005). The disruption of the calcium 
homeostasis in cells, may cause them to die by apoptosis. The uncontrolled Ca²+ efflux into 
the cytosol is followed by the increase of cytoplasmic cAMP levels that promote additional 
Ca²+ release from intracellular stores. Excessive Ca²+ release then triggers PLA2 activation 
which may stimulate fatty acid synthesis in the host fat body. This fatty acid accumulation 
can become toxic and again induce cell death (Rivers et al., 2002a). When homeostasis of 
the intracellular environment is disrupted, macromolecules and ions can enter the cell in an 
unregulated way, followed by water. This process results in membrane blebbing, rounding, 
swelling and eventually in lysis of the cells. Venom from N. vitripennis causes this cellular 
injury that ultimately culminates in oncotic cell death (Rivers et al., 2006). Phenoloxidase 
activity has been proposed to be directly linked to cell death, but since only laccases and no 
tyrosinases were found in the venom (see 3.2.1. Venom targets the host defence system), 
maybe other venom compounds are involved in this complex process. The protein 
calreticulin, which was suggested to be involved in the inhibition of hemocyte spreading (see 
above), was found to mobilize intracellular Ca2+ leading to cell death in hosts envenomated 
by P. hypochondriaca (Rivers et al., 2009). The venom compound γ-glutamyl transpeptidase 
in another endoparasitoid wasp was proven to initiate apoptosis, specifically to the ovaries 
causing host castration (Falabella et al., 2007). Both calreticulin and γ-glutamyl 
transpeptidase are also found in N. vitripennis venom (table 1), but their function needs to 
be assigned.  
 
3.2.4. Venom provides host with available nutrients  
Parasitoids regulate host physiology in an attempt to maximize mother’s fecundity and to 
provide optimal conditions for the offspring to feed and develop. Therefore, the nutritional 
and physiological environment of the host is manipulated by venom or other related factors 
injected by the female wasp. Teratocytes of endoparasitoids for example, have a secretory 
and nutritive function to ensure a nutritional milieu for the offspring (Nakamatsu et al., 
2002), while venom of some ectoparasitoids changes the host metabolism to provide 
nutrients (Rivers & Denlinger, 1995; Mrinalini et al., 2014). Early after venom injection by N. 
vitripennis, host trehalose levels drop significantly. Since tre1, a trehalase venom protein in 
P. hypochondriaca was found to catalyze trehalose to provide the wasp offspring with 
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sufficient glucose, a putative role of N. vitripennis venom trehalase in providing host 
nutrients can be proposed (table 1). On the long term, pyruvate levels in the host increase, 
whereas whole body lipid levels rise during the first 4 days, followed by a decrease 8 days 
after envenomation (Rivers & Denlinger, 1994b). These high lipid levels seem to be 
synchronized with the development of the parasitoid larvae. The change in plasma 
membrane permeability that leads to mitochondrial Ca²+ release and finally results in fatty 
acid synthesis in host fat body (see 3.2.3. Venom causes host cell death), is also a proposed 
pathway for lipid elevation (Rivers et al., 2002a). Parasitoid larvae have to share the 
available host lipids with adult N. vitripennis wasps, since the latter have lost the ability to 
synthesize lipids de novo and therefore, are completely dependent on the lipids of the host 
(Rivers et al., 2002a). Next to this, the developing larvae are also competing with host tissues 
for available nutrients. Teratocytes are able to convert lipids into fatty acids which are 
specifically delivered to the parasitoid larvae, giving them the lead in the competition for 
lipids with host tissues (Falabella et al., 2005).  
 
3.3. At war’s end: applications 
The suite of parasitoid products that is delivered to the host insect is so amazingly potent 
and innovative in its manipulative ability that we as scientists can still learn immensely from 
this regulatory warfare. Once these regulatory molecules have been identified and 
characterized, research activities must be lifted to the next level. More specifically, their 
potential application must be investigated, either in the agronomic sector or in the 
biomedical domain.  
 
3.3.1. Agronomic applications 
It is estimated that insect pests destroy approximately 14% of the World’s crop production 
(Oerke & Dehne, 2004). In many cases, natural enemies are not sufficient to control pests 
adequately (Hopper, 2003). Therefore, chemical insecticides are currently the dominant 
approach for combating crop pests (Vais et al., 2001). However, the perceived ecological and 
human health risks in combination with the development of insecticide resistance in many 
pest insect populations, have created an urgent need for improved methods in insect pest 
control that keeps the pest species below the economic-damage threshold, while leaving the 
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other fauna species undisturbed. Mechanical methods are used that include barriers or traps 
to capture pest insects (Hansen et al., 2006), yet biological methods have gained the upper 
hand. Biological pest control contains the reproduction of natural predators of the host 
insects (Nagai & Yano, 2000), the interruption of the reproductive process of the pest 
through the insertion of sterile individuals (Gurr & Kvedaras, 2010), and the use of bio 
pesticides. For the latter, a promising source of novel insecticidal peptides are the venoms of 
arthropod predators. These interesting compounds have been optimized via a prey-predator 
arms race spanning hundreds of millions of years to target specific types of insect ion 
channels and receptors.  
 
Since parasitoids are known to have the ability to control populations of insect pests, 
agronomic industrials have already manifested their interest towards parasitoid venom 
proteins as attested, for example, by the patent application concerning Bracon hebetor 
venom neurotoxins (Quistad & Leisy, 1996). Nonetheless, no parasitoid venom compound 
has yet been used as a pest control agent. This restriction may come from the fact that these 
compounds need to be directly delivered into the host hemolymph and they would be 
degraded after delivery by foliar sprays. Therefore, in order to be effective, the venom 
proteins or peptides would need to be delivered via a vector, such as entomopathogens. 
Baculoviruses or fungi can be engineered in such a way that they express transgenes 
encoding the venomous toxins. This implies that the venom peptides are produced 
systemically in the insect host after viral/fungal infection and the often difficult delivery by 
oral uptake is avoided. Another major advantage is the limitation of off-target effects, since 
the range of affected insects is largely determined by the host range of the entomopathogen 
(Smith et al., 2013). Another possible deployment of the venom toxins to the pest insects is 
through transgenic plants. Genetically modified plants can express the venom toxins with a 
fusion protein so they can be orally delivered to the hemolymph of the insect pests. An 
insecticidal spider venom neurotoxin has been successfully delivered to the hemolymph of 
its lepidopteran host by using the mannose-specific snowdrop lectin as a carrier protein 
(Fitches et al., 2004). The lectin resists gut proteolysis, binds to glycoproteins on the surface 
of the gut epithelium and can be detected in the hemolymph of orally exposed insects. Also 
trait stacking of insecticidal venom peptides with δ–endotoxin from Bacillus thuringiensis 
(Bt) that has already proven to be commercially effective (Kumar et al., 2008), might 
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constitute a promising insect pest control system. Both transgenes have completely different 
mechanisms of action and are likely to be synergized by Bt, which should facilitate 
movement of venom peptides into the insect hemocoel by virtue of its ability to induce lysis 
of midgut epithelial cells (Soberon et al., 2007).  
 
3.3.2. Biomedical applications 
The most innovative and promising potential of parasitoid venom proteins probably 
concerns biomedical applications. Many arthropod venoms are known for their antimicrobial 
and cytolytic peptides (Kuhn-Nentwig, 2003;Ye et al., 2010). Also in the venom of parasitoid 
wasps, antibacterial activity has been detected (Dani et al., 2003), insinuating a possible use 
of these compounds as new antibiotics. However, the broad cytolytic effects of many of 
these venom constituents unfortunately results in difficult discrimination between 
microorganisms and eukaryotic cells, making them not well suited for antibiotic drug use. On 
the other hand, more recently, the potential of parasitoid venom compounds in treatments 
for certain cancers and neurodegenerative and inflammatory diseases seems to be very 
promising. This is explained in more detail in the following paragraphs.  
 
3.3.2.1. NF-ĸB as biomedical target 
The central and evolutionary conserved coordinator in these pathologies is the nuclear 
factor-ĸB (NF-ĸB) pathway. It controls the expression of genes involved in development, cell 
cycle regulation (Ledoux & Perkins, 2014), immune regulation, acute and chronic 
inflammation, cytoskeletal remodelling, cellular adhesion, survival and apoptosis (Baldwin, 
2001;Oeckinghaus et al., 2011). When NF-ĸB is constitutively active, it drives chronic 
inflammation, which is essential to the development, maintenance and progression of 
multiple diseases. These diseases include cancer, arthritis, atherosclerosis, inflammatory 
bowel disease, degenerative disorders and autoimmune processes. A large number of 
external stimuli can lead to activation of NF-ĸB , such as bacterial and viral infections (e.g. 
through recognition of microbial products by receptors like the Toll-like receptors), 
inflammatory cytokines and antigen receptor engagement eventually induced upon physical 
(UV- or γ–irradiation), physiological or oxidative stresses (Hayden & Ghosh, 2004) (figure 6). 
In most unstimulated cells, NF-ĸB dimers are retained in an inactive form in the cytosol 
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through their interaction with the inhibitor of NF-ĸB proteins (IĸBs). The majority of the 
diverse signalling pathways that lead to NF-ĸB activation converge on the IĸB kinase (IKK) 
complex, which is responsible for IĸB phosphorylation that is ubiquinated and degraded by 
the IKK proteasome (Karin & Ben-Neriah, 2000). The degradation of IĸB thus allows NF-ĸB to 
translocate into the nucleus where it can act as a transcription factor. NF-ĸB then binds to 
specific elements (ĸB-sites) within the promoters of responsive genes to activate their 
transcription. An extensive list of target genes is controlled by NF-ĸB, including central 
components of the immune response, inflammatory processes (controlled by cytokines, 
chemokines, cell adhesion molecules, complement cascade factors and acute phase 
proteins), regulators of apoptosis and proliferation, embryonic development and physiology 
of the bone, skin and central nervous system (Pahl, 1999;Xing et al., 2013). Figure 6 gives an 
overview of the most important stimuli and targets of the central NF-ĸB pathway, together 
with a simplified presentation of the canonical NF-ĸB cascade. Parallels can be observed 
when comparing figure 6 that describes the NF-ĸB pathway in mammals with figure 3 that 
overviews the well conserved Toll and Imd pathways in insects.  
 
Because so many key cellular processes such as cell survival, proliferation and immunity are 
regulated through NF-ĸB-dependent transcription, it is not surprising that it is tightly 
regulated at multiple levels. The primary mechanism for NF-ĸB regulation is through IĸB and 
the kinase that phosphorylates IĸBs, namely the IKK complex. A number of post-translational 
modifications also modulate the activity of the IĸB and IKK proteins, as well as the NF-ĸB 
molecules themselves, that generate auto-regulatory feedback loops in the NF-ĸB response 
(Oeckinghaus & Ghosh, 2009). Since the deregulation of the NF-ĸB pathway results in severe 
diseases, there has been (and still is) great pharmacological interest in modulators of NF-ĸB 
activation. Many natural products have appeared to contain therapeutic and preventative 
effects in certain cancers and inflammatory diseases, most likely due to their ability to inhibit 
NF-ĸB (Gilmore & Herscovitch, 2006). In 2006, over 785 inhibitors of the NF-ĸB pathway 
were already identified, but for most inhibitors, neither the molecular target nor the cell-
type specificity was known. Since single molecular components take part in overlapping 
signalling pathways, it is a challenge to find molecules that block specific pathways leading to 
NF-ĸB activation without interfering with other signalling cascades. Therefore, it remains 
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interesting to see whether venom compounds from N. vitripennis are able to meet with 
these conditions and could serve as potent therapeutic NF-ĸB-inhibitory agents. 
 
Figure 6: Summary of the NF-ĸB pathway in mammals with its stimuli in orange and its targets in green. 
NF-ĸB acts as a central mediator of immune and inflammatory responses, and is involved in stress 
responses and regulation of cell proliferation and apoptosis. The respective NF-ĸB target genes allow the 
organism to respond effectively to these environmental changes. Representative examples are given for 
NF-ĸB inducers and ĸB-dependent target genes.  
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3.3.2.2. Insect compounds targeting mammalian immune systems 
The innate immune system confers broad protection against pathogens and its response is 
essentially instantaneous. Interestingly, most multicellular organisms exclusively depend on 
this fundamental immune system (Kimbrell & Beutler, 2001). Many insect proteins that are 
important compounds in this innate immune system, have been tested for potential 
therapeutical use in mammalian pathologies. For instance, several insect hemolymph 
peptides have shown to display specific tumoricidal activity by disrupting the membrane of 
cancer cells. Some AMPs like cecropins and defensins have the ability to form ion-permeable 
channels subsequently resulting in cell depolarization, irreversible cytolysis and finally cell 
death. Interestingly, these antibacterial compounds in insects also exert tumoricidal activity 
by selective cytotoxicity against several mammalian cancer cell lines (Iwasaki et al., 
2009;Lehmann et al., 2006;Hui et al., 2002;Winder et al., 1998). Furthermore, hemolymph 
from Heliothis virescens contains a N-myristoylated peptide, which was found to have 
antitumor activity against 34 human tumour cell lines by inhibiting their cell growth (Ourth, 
2011).  
 
The major mediator of immune signalling in mammals, the NF-ĸB pathway, has a paralogous 
system in insects, defined by two distinct control pathways, the Toll and the Imd pathways 
(see 3.2. Mode of action of the venom) (Lemaitre et al., 1995). Dorsal, Dif and Rel are related 
to NF-ĸB, whereas Cactus is a homologue of IĸB. The high conservation has led to the 
biomedical paradigm in which insect proteins are tested for potential therapeutical use in 
mammalian diseases caused by dysregulation of the NF-ĸB pathway. More specifically, 
venom from several insects has been extensively studied for its biomedical functions in 
human auto inflammatory diseases and oncology (Heinen & da Veiga, 2011;Dkhil et al., 
2010;Son et al., 2007). For instance melittin from honeybees induces cell death in cancer 
cells, using cytotoxicity as its tumoricidal strategy (Orsolic, 2012). More interestingly, instead 
of killing the mammalian tumour cells with toxic compounds, several parasitoids have shown 
to directly inhibit NF-ĸB activation in the host, appointing their virulence factors as perfect 
candidates for NF-ĸB inhibitors in the treatment of inflammatory diseases and cancer. PDVs 
that are symbiotically associated with parasitoid wasps, encode a family of genes with 
homology to IĸB proteins from insects and mammals. Two of these genes expressed by the 
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bracovirus from the endoparasitoid wasp Microplitis demolitor greatly reduced the 
expression of AMPs, which are under NF-ĸB regulation through the Toll and Imd pathways, 
suggesting their involvement in the suppression of the host immune system (Thoetkiattikul 
et al., 2005). Moreover, both bracoviruses and ichnoviruses from parasitoid wasps in the 
Braconidae and Ichneumonidae families respectively, express several genes belonging to the 
viral ankyrin (vankyrin) gene family (Kroemer & Webb, 2005;Gundersen-Rindal & Pedroni, 
2006). Vankyrin proteins are homologous to IĸB proteins, but lack sequences for regulated 
degradation, suggesting that these proteins effectively inhibit NF-ĸB signalling in parasitized 
insects by perturbing the NF-ĸB-IĸB interaction in the host. Later, vankyrins were proven to 
suppress host antiviral response (Bae & Kim, 2009) and aid the parasitic wasp survival by 
selective inhibition of immune NF-ĸB signalling (Gueguen et al., 2013). These genes were 
primarily studied to gain a better understanding of insect immune systems and of the 
counterstrategies pathogens have evolved to circumvent host defences. Interestingly, it 
seems promising to investigate the potential of these polydnaviral genes and other 
parasitoid venom compounds as therapeutic agent by inhibiting NF-ĸB in human diseases. 
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N. vitripennis can quite deserved be called the “lab rat” of the Hymenoptera. Unlike many 
other hymenopteran species, these parasitoid wasps are easy to work with in the laboratory. 
Due to short generation time (2 weeks in 25°C) and large family size (more than 500 
offspring per female), N. vitripennis can be cultivated the whole year around. They can easily 
be sexed in the immobile pupal stage and the adults can be handled without 
anesthetization, resulting in many advantages for laboratory experiments. Next to its 
laboratory tractability, its haplodiploidy and the presence of closely related interfertile 
species makes N. vitripennis the perfect model for complex genetic studies. But maybe the 
most important reasons to study this little wasp, are the many benefits it holds towards 
human health. They are parasitoids of houseflies and other filth flies, that can harbour over 
100 human pathogens and are vectors of many human diseases. N. vitripennis venom is 
known to be highly toxic to several mosquitoes that are vectors of diseases such as malaria, 
encephalitis, yellow fever and West Nile. Its venom contains a wealth of compounds with 
unique chemistries and modes of action, that may serve as leads for developing new classes 
of synthetic chemical insecticides and therapeutic compounds affecting cell physiology.  
 
In 2010, the genome of N. vitripennis became publically available and more research 
facilities started working on this small ectoparasitoid wasp. But already two decades before 
that breakthrough, investigations on the venom advanced quite far. Bioassays revealed the 
many alterations in host physiology caused by the maternally derived venom: arrestment of 
development, alteration in growth and metabolism, suppression of immune responses, 
induction of paralysis, oncosis or apoptosis, and alteration of host behaviour (Quicke, 1997). 
However, only suggestions could be made with regard to specific functions of the large 
number of venom compounds.  
 
This dissertation encloses two major parts. The first part studies the host-parasitoid 
interaction from a fundamental point of view. An in depth investigation of the alterations in 
host physiology caused by the venom from N. vitripennis, creates a better knowledge on the 
processes involved in host development, immunity and metabolism and how the parasitoid 
changes these to its own advantage. This fundamental research soon leads to the more 
applied approach, where more specifically the immune suppressive action of the venom was 
investigated. The availability of a lot more well described techniques and the possibility of 
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discovering a biomedical application for N. vitripennis venom, led us to study this inhibitory 
effect on immunity in mammalian cells, which is included in part 2 of this dissertaion. The 
aims and scope of the several chapters in both parts are described below. 
 
To fully explore the precise modes of action of this complex venom mixture regarding to its 
interactions with the host, we decided to tackle this quest by a large transcriptomic study. 
The aim of the specific experimental setup used, was to closely represent the natural 
parasitation. Two conditions needed to be fulfilled: sampling must be performed before 
Nasonia larvae start to feed on the host and actual venom injection and egg-laying needs to 
be verified without harming the flesh fly pupae. Three and 25 hours, 2 relatively short time 
points after parasitization, were chosen since after that larvae start to develop mouth parts 
and begin to feed on the host. Microarray analysis on whole bodies of flesh flies was chosen 
to investigate possible interactions between venom compounds and all host tissues. The 
results are described in chapter 3 of this dissertation.  
 
Since parasitization involves the injection of a complex venom mixture, the important 
question remains what specific compound is causing the effects. Therefore, functions of 
venom proteins in the host organism were investigated by using two different approaches. 
One is the injection of the venom protein, recombinantly expressed in E. coli, into the host. 
To assess what processes are altered by the recombinant venom protein, bioassays need to 
be performed on the host. The second approach is to silence the venom compound in 
female N. vitripennis. After envenomation in the host, possible caused effects must be 
analysed by bioassays on the host organism. Both approaches were used, but due to several 
practical difficulties, further experiments needed to be postponed. Nonetheless, the 
performed preliminary investigations are described in Addendum to chapter 3.  
 
A collaboration between L-MEB and LEGEST led to the exciting opportunity to investigate 
whether the immune suppressive action of N. vitripennis venom on its host may have 
comparable effects in mammalian cells. The insect immune pathways Toll and Imd are 
known to have high homology to the NF-κB cascade in mammals. First assays with extracted 
venom from N. vitripennis females on murine cells were very promising. Together with the 
high need for NF-κB inhibitors in biomedicine, the clear inhibition of NF-κB activation by the 
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venom intrigued us to dig deeper into its possible interactions with this major immune 
pathway in mammals. Effects of venom on other pathways, that have inhibitory effects on 
NF-κB signalling, and feedback loops were included and the results of this research are 
explained in chapter 4. Probably the most described pathway that shows negative regulation 
of NF-κB signalling is the glucocorticoid receptor (GR) signalling cascade. Since N. vitripennis 
venom was shown to increase two GR regulated target genes, involvement of venom on this 
pathway was further investigated. Latter results are added as an addendum to chapter 4.  
 
Since the slightest alterations in the NF-κB signalling cascade can have large implications 
relating to human pathology, we decided to further investigate the consequences of the 
inhibitory action of the venom on NF-κB activation relating to its targets. Since such an 
extended number of NF-κB target genes have been described, we decided to perform a PCR 
array that already contains a sub-set of these genes. The interesting potential of N. 
vitripennis venom as therapeutic agent in several diseases is discussed in chapter 5. 
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1. Abstract 
We investigated changes in the pupal transcriptome of the flesh fly Sarcophaga crassipalpis, 
3 and 25 hours after parasitization by the ectoparasitoid wasp, Nasonia vitripennis. These 
time points are prior to hatching of the wasp eggs, thus the results document host responses 
to venom injection, rather than feeding by the wasp larvae. Only a single gene appeared to 
be differentially expressed 3 hours after parasitization. However, by 25 hours, 128 genes 
were differentially expressed and expression patterns of a subsample of these genes were 
verified using RT-qPCR. Among the responsive genes were clusters of genes that altered the 
fly’s metabolism, development, induced immune responses, elicited detoxification 
responses, and promoted programmed cell death. Envenomation thus clearly alters the 
metabolic landscape and developmental fate of the fly host prior to subsequent penetration 
of the pupal cuticle by the wasp larva. Overall, this study provides new insights into the 
specific action of ectoparasitoid venoms. 
 
 
Figure 1: A female N. vitripennis wasp injecting venom inside a pupal host (S. crassipalpis). The insertion 
of the stinger through the puparium is visible.  
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2. Introduction 
Endoparasitoids, wasps that deposit their eggs inside the body of their arthropod hosts, have 
developed sophisticated mechanisms to disable the host’s defensive responses. An array of 
virulence factors including polydnaviruses, venoms, virus-like particles, ovarian fluids and 
teratocytes are used to combat the host’s defence system, thus enabling the wasp larvae to 
freely manipulate and devour the host (Glatz et al., 2004;Labrosse et al., 2003;Pennacchio & 
Strand, 2006). Ectoparasitoids, wasps that deposit their eggs on the surface of the host, 
appear to lack many of the virulence factors known from endoparasitoids, yet they too are 
capable of manipulating the host, mainly through the use of the venom that they inject 
(Rivers et al., 1999).  
 
Transcriptomic approaches have pinpointed host pathways that are targeted during 
parasitization, as demonstrated in recent studies that have probed endoparasitoid-host 
relationships including work completed on Drosophila melanogaster-Asobara tabida 
(Wertheim et al., 2005;Wertheim et al., 2011), D. melanogaster-Leptopilina spp. (Schlenke et 
al., 2007), Bemisia tabaci-Eretmocerus mundus (Mahadav et al., 2008), Pieris rapae-
Pteromalus puparum (Fang et al., 2010), Spodoptera frugiperda-Hyposoter didymator, 
Ichnovirus/Microplitis demolitor Bracovirus (Provost et al., 2011), Plutella xylostella-
Diadegma semiclausum (Etebari et al., 2011), and Pseudoplusia includes-M. demolitor (Bitra 
et al., 2011). In spite of this burst of recent work, none of the above analyses have used a 
transcriptomic approach to examine similar responses elicited by an ectoparasitoid. In this 
study we examine the response elicited by an ectoparasitoid, N. vitripennis, on one of its 
favoured hosts (Whiting, 1967), the flesh fly S. crassipalpis. 
 
Although N. vitripennis larvae are capable of developing on late larvae or even pharate 
adults of their hosts, parasitoid survival is highest when parasitizing hosts that are in the 
pupal stage (Rivers et al., 2012). Thus, N. vitripennis is attracted to sites where fly larvae are 
wandering and preparing for pupariation so that it may parasitize freshly pupated hosts. The 
wasp inserts its ovipositor through the puparium, envenomating the fly pupa and then 
depositing its egg on the surface of the pupal body. The eggs are lodged within the space 
between the puparium and the pupal cuticle, thus they are encased within the puparium but 
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remain on the external surface of the fly pupa. The wasp’s venom arrests development in 
the host (Rivers & Denlinger, 1994a), alters host metabolism (Rivers & Denlinger, 1994b), 
and induces paralysis and apoptosis (Rivers et al., 1999), thus ensuring a suitable 
environment for growth and development of the parasitoid. Although N. vitripennis lacks 
some of the virulence factors commonly documented in endoparasitoids, like teratocytes or 
symbiotic polydnaviruses, the venom proteome shows high similarity to the venoms of 
endoparasitoids (Werren et al., 2010;de Graaf et al., 2010). This means that the early steps 
of host manipulation are solely the result of the venomous mixture injected by N. vitripennis, 
clearly differentiating this ectoparasitoid from endoparasitoids that employ teratocytes or 
symbiotic viruses. 
 
The recent EST dataset available for S. crassipalpis (Hahn et al., 2009) has enabled us to 
examine transcriptomic responses of the flesh fly to envenomation by the ectoparasitoid, N. 
vitripennis. Using microarrays we examine transcript expression in the host 3 hours and 25 
hours after envenomation. The sampling points selected are both prior to hatching of the 
wasp larva, thus the response we document here is the response to injection of the venom 
rather than later responses associated with feeding by the wasp larvae. We report little 
response at the transcript level by 3 hours after envenomation, but by 25 hours after 
envenomation expression patterns of key immune, developmental, and metabolic pathways 
have clearly been altered by envenomation. We use these data to build hypotheses for the 
molecular underpinnings of the Sarcophaga host response to envenomation by N. 
vitripennis, and we compare current results from this endoparasitoid with molecular 
patterns observed in other systems involving host attack by endoparasitoids. 
 
3. Materials and methods  
3.1. Preparation of parasitized and non-parasitized flesh fly pupae 
3.1.1. Insect strains 
The laboratory strain N. vitripennis Asym C was kindly provided by Prof. Dr. L. W. 
Beukeboom from Evolutionary Genetics, Centre for Ecological and Evolutionary Studies in 
The Netherlands. This wild-type line collected in The Netherlands was cured from Wolbachia 
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infection and maintained in the laboratory since 1971 (Van den Assem & Jachmann, 1999). 
Wasps were reared at 25°C under a 16:8 light:dark cycle. The flesh flies (S. crassipalpis) were 
provided from a culture maintained at the University of Florida, and cultured in the 
laboratory as described by Denlinger (Denlinger, 1972). Larvae were fed on beef liver at 25°C 
and exposed to a 16:8 light:dark cycle.  
 
3.1.2. Collection of parasitized and control hosts 
Before the start of the experiment, female wasps were exposed to flesh fly puparia for 6 
hours to condition them to oviposit. The next day, new S. crassipalpis puparia (5 days after 
puparium formation) were placed in a culture tube. Holes the size of a flesh fly puparium 
were made in the stopper of the culture tube, so only the posterior region of the puparium 
was accessible to the parasitoids. The experienced N. vitripennis females and the pupae, 5 
days after pupariation, were placed together in a tube in a 3:1 ratio, to promote 
parasitization. After 2 hours, females of N. vitripennis were removed. Flies were sampled 2 
or 24 hours after parasitoids were removed from the tube, snap-frozen in liquid nitrogen, 
and then stored at -80°C until RNA extraction. Because the N. vitripennis females had 2 
hours to parasitize the pupae, the sampling points correspond on average to 3 and 25 hours 
post-parasitization. Control pupae were treated identically except that they were not 
exposed to the parasitoid.  
 
3.2. Sample preparation for the microarray and validation experiment 
3.2.1. RNA isolation and cDNA synthesis 
RNA was extracted using the RNeasy Lipid Tissue Mini Kit (Qiagen). From each treatment (3 
hours control, 3 hours parasitized, 25 hours control, and 25 hours parasitized), 4 replicates 
consisting of a single fly pupa each were analysed. Due to the hard puparium, the Precellys® 
24 Homogenizer (Bertin Technologies, Montigny le Bretonneux, France) was used after 
adding one stainless steel bead (2.3 mm mean diameter) and ¼ of a PCR tube of 
zirconia/silica beads (0.1 mm mean diameter) to an individual pupa. An on-column DNase I 
treatment with the RNase-free DNase set (Qiagen) was performed. RNA was eluted twice, 
first with 30 µl RNase free water, then with 20 µl RNase free water, and then stored at -80°C. 
Five µg of total RNA from each sample was converted to cDNA using Oligo(dT)18 primers (0.5 
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µg/µl) and was carried out according to the RevertAid H Minus First strand cDNA Synthesis 
kit protocol (Fermentas). 
 
3.2.2. Checking parasitized pupae for the nanos gene 
To ensure that the pupae were parasitized, samples were checked for the presence of N. 
vitripennis nanos (nos) (NM_001134922.1) (Olesnicky & Desplan, 2007). This early embryonic 
protein is present in eggs of N. vitripennis but not in pupae of S. crassipalpis, thus enabling 
us to distinguish parasitized from non-parasitized fly pupae. The following primer set was 
used for reverse transcriptase PCR: 5’-TGGCAAGATTCTTTGTCCTAT-3’ and 3’-
AGAAACAGGTTAACTGTCCGC-5’. The obtained amplicon has a length of 264 base pairs and 
was loaded on a 0.8% agarose gel and visualized by ethidium bromide staining. 
 
3.3. Microarray study of S. crassipalpis pupae transcriptional response to 
parasitization by N. vitripennis 
3.3.1. Selection of the EST dataset 
An EST dataset for S. crassipalpis (whole bodies of different life stages including pupae as 
well as protein-fed and protein-starved males and females) became available in 2009. It was 
produced by parallel pyrosequencing on the Roche 454-FLX platform and identified 
approximately 11,000 independent transcripts that are a representative sample of roughly 
75% of the expected transcriptome (Hahn et al., 2009). A sub-set of these sequence data 
was made by blasting the sequences against the protein sequences of D. melanogaster. The 
sequences that showed the best homology to known genes were retained, resulting in a 
dataset of 10,129 EST sequences. Probes were designed and spotted on a custom 8 x 15k 
Agilent array developed with Agilent eArray software.  
 
3.3.2. Microarray experimental procedures 
RNA concentration and purity were determined using a Nanodrop ND-1000 
spectrophotometer (Nanodrop Technologies) and RNA integrity was assessed using a 
Bioanalyser 2100 (Agilent). RNA concentrations varied between 1.9 and 8.6 µg/µl, and the 
RNA Integrity Numbers and the RNA ratios indicated high quality of the RNA samples (table 
S1, p.66). Per sample, 100 ng of total RNA spiked with 10 viral polyA transcript controls 
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(Agilent) was converted to double stranded cDNA in a reverse transcription reaction. 
Subsequently the sample was converted to antisense cRNA, amplified and labeled with 
Cyanine 3-CTP (Cy3) or Cyanine 5-CTP (Cy5) in an in vitro transcription reaction according to 
the manufacturer’s protocol (Agilent). A mixture of purified and labeled cRNA (Cy3 label: 
300ng; Cy5 label: 300ng) was hybridized on the custom Agilent array followed by (manual) 
washing, according to the manufacturer’s procedures. To assess the raw probe signal 
intensities, arrays were scanned using the Agilent DNA MicroArray Scanner with surescan 
High-Resolution Technology, and probe signals were quantified using Agilent’s Feature 
Extraction software (version 10.7.3.1). The microarray data were deposited in the NCBI Gene 
Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/) under accession 
numbers GPL15391 (microarray including detailed annotation) and GSE36996. 
 
3.3.3. Microarray data quality control and statistical analysis  
Statistical data analysis was performed on the processed Cy3 and Cy5 intensities, as 
provided by the Feature Extraction Software version 10.7. Further analysis was performed in 
an R programming environment using a series of Bioconductor packages 
(http://www.bioconductor.org; Gentleman et al., 2004). Differential expression between the 
parasitized and non-parasitized hosts, as well as time comparisons within each group was 
assessed via the moderated t-statistic, described in Smyth (2004) and implemented in the 
limma package of Bioconductor. This moderated t-statistic applies an empirical Bayesian 
strategy to compute the gene-wise residual standard deviations and thereby increases the 
power of the test, which is especially suitable for smaller data sets. To control the false 
discovery rate (FDR), multiple testing correction was performed (Benjamini & Hochberg, 
1995) and probes were called differentially expressed in case of a corrected p-value below 
0.05 and an absolute fold change larger than 1.25. 
 
3.4. Validation experiment 
3.4.1. Reference gene selection and primer design 
Because no reference genes for RT-qPCR were available for S. crassipalpis, candidate 
reference genes were chosen due to their stable expression in other studies that had 
exposed either D. melanogaster or Apis mellifera to a bacterial challenge (Ling & Salvaterra, 
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2011;Scharlaken et al., 2008). Primers with product size-ranges of 80 to 150 bp, were 
designed with Primer3Plus (Untergasser et al., 2007), using the default settings (table S5).  
 
3.4.2. RT-qPCR reaction mixture and cycling program 
RT-qPCR was executed in opaque white 96 well microtiter plates (Hard-Shell 96 Well PCR 
plates, Bio-Rad), sealed with Microseal ‘B’ seals (Bio-Rad), using the CFX96 Real-Time PCR 
Detection System (Bio-Rad). Each 15 µl reaction consisted of 7.5 µl 2x Platinum SYBR Green 
qPCR SuperMix-UDG (Invitrogen), 0.2 µM forward and 0.2 µM reverse primers (Integrated 
DNA Technologies), 6.5 µl Milli-Q and 1 µl cDNA template. 
Each sample was run in triplicate using a PCR program with the following conditions: 50 °C 2 
minutes; 95 °C 2 minutes; and 40 cycles of a combined denaturation (95 °C 20 seconds) and 
annealing (60 °C 40 seconds) step. Fluorescence was measured after each cycle. At the end 
of the program, a melt curve was generated by measuring fluorescence after each 
temperature increase of 0.5 °C for 5 seconds over a range from 65 °C to 95 °C.  
 
3.4.3. Computational selection of reference genes 
Primer efficiencies, R² values and melt curves were calculated with CFX Manager Software 
(Bio-Rad). Reference gene stability was analyzed using the geNormPLUS algorithm within the 
qBasePLUS environment (Biogazelle NV). Default settings were kept, except that target 
specific amplification efficiencies were used. 
 
3.5. Microarray data analysis  
S. crassipalpis genes that were differentially expressed across these treatments were 
functionally annotated with Blast2GO (Conesa et al., 2005). After GO term annotation, an 
enrichment analysis (two-tailed Fisher’s exact test with default settings) within the Blast2GO 
environment was undertaken (table 1). Clusters of Orthologous Groups (COG) functional 
categories were assigned with COGNITOR and stand-alone PSI-BLAST using the Eukaryotic 
Orthologous Groups (KOG) database (Tatusov et al., 2000). Further, genes were manually 
clustered by searching for groups of genes with the same GO-terms, or by putative functions 
of homologue genes in other species. 
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4. Results and Discussion 
4.1. Verifying parasitization 
Before conducting the microarray experiment, we verified whether individual flesh flies were 
parasitized by screening for transcripts of nanos (nos), a developmental patterning gene that 
should be abundant in early embryos of N. vitripennis, but not in pupae of S. crassipalpis. 
Only individual RNA samples that showed a clear band at 264 nucleotides indicating N. 
vitripennis nos expression were used for further experiments (figure 2).  
A.       B. 
Figure 2: Gel electrophoresis analysis for the presence of nos in test samples for microarray and validation 
experiment. A. Samples at 3 hours parasitization. B. Samples at 25 hours parasitization. From left to right: 
1 kb ladder (Fermentas), 4 control samples, 4 parasitized samples, positive control (abdomen from N. 
vitripennis female), negative control 
 
4.2. Overview of differential gene expression  
In current analyses, we considered a transcript to be differentially expressed between 
envenomated and non-parasitized control samples if the FDR-adjusted p-value was < 0.05 
and the fold change was > 1.25. When comparing all four treatments to each other (Control 
3 h, Parasitized 3 h, Control 25 h, and Parasitized 25 h) hundreds of genes were differentially 
expressed between the 3 hours and 25 hours samples in both control and parasitized 
samples (figure 3). The large changes in transcript profiles observed through time do not 
reflect the effects of envenomation on the transcriptome, but rather reflect the dynamic 
nature of development as S. crassipalpis pupae undergo metamorphosis and transition into 
pharate adult development (Denlinger & Zaarek, 1994;Ragland et al., 2010).  
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A 
 
Down-regulated Up-regulated 
 
p-val < 0.05 
and |FC| > 2 
p-val < 0.05 
and |FC| > 1 
p-val < 0.05 
and |FC| > 2 
p-val < 0.05 
and |FC| > 1 
Contr_3h versus Contr_25h 286 978 185 753 
Paras_3h versus Paras_25h 749 1722 199 1428 
Paras_3h versus Contr_3h 0 1 0 0 
Paras_25h versus Contr_25h 6 19 51 109 
B 
 
Figure 3: General statistics on the differentially regulated genes in response to parasitization. A. The 4 
comparisons with their respective amounts of up- and down-regulated genes that were identified by 
microarray hybridization according to the following selection criteria:  p-value < 0.05 and fold change ≥ 2, 
or p-value < 0.05 and fold change ≥ 1. B. Distribution of induced (grey bars) and repressed (dark bars) 
genes based on their fold change for the comparison of control and parasitized pupae after 25 hours. 
 
Reinforcing the effect that envenomation has on host physiology, the numbers of 
differentially expressed transcripts between the 3 and 25 hours parasitized pupae were 
greater than the numbers of differentially expressed transcripts between the 3 and 25 hours 
control pupae. When comparing solely the time-matched parasitized and control samples, 
only 1 transcript was differentially expressed 3 hours after envenomation and 128 
transcripts were differentially expressed 25 hours after envenomation (table S2). The 1 
differentially regulated transcript at 3 hours after envenomation was a leucine rich repeat 
protein that was slightly down-regulated (-0.74 fold change). By 25 hours after 
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envenomation, 19 transcripts were down-regulated and 109 were up-regulated (figure 3). 
We found fewer transcripts differentially regulated than several other studies of parasitic 
wasp-host interactions (Wertheim et al., 2005;Fang et al., 2010;Bitra et al., 2011;Etebari et 
al., 2011;Provost et al., 2011;Wertheim et al., 2011). Unlike the previous studies that 
focused on endoparasitoids, N. vitripennis is an ectoparasitoid and we sampled fairly early 
during the interaction, before the developing parasitoid larvae began to interact with the 
host. Thus, the results represent only the earliest stages of the host response to 
envenomation.  
 
4.3. Validation by RT-qPCR 
Twenty ESTs were selected for validation with RT-qPCR, including the single transcript found 
in the 3 hours group (lrr-pr) (table S4). Ten candidate reference genes were tested for their 
stable expression levels across all conditions (3 and 25 hours, control and parasitized), 
resulting in two selected reference genes (table S5, figure S1). EIF or eukaryotic translation 
initiation factor 1 has 97.15% homology to eIF-1A that has been used as a reference target 
for expression profiles of D. melanogaster. Ubq or ubiquitin-conjugating enzyme displays 
92.8% homology to Ubi from D. melanogaster, which has a function in protein degradation. 
In all except two cases, RT-qPCR revealed the same log ratio trends as found in the 
microarray study. Nine of them gave significant differences in expression pattern including 5 
that were up-regulated and 4 that were down-regulated (figure 4).  
 
4.4. Gene-Ontology analysis of microarray data 
Using Blast2GO, we assigned Gene Ontology (GO) terms to the S. crassipalpis EST sequences 
that were used for the microarray analysis, successfully annotating 8,618 out of the 10,129 
ESTs (85%). We then performed GO term enrichment analyses on 4 sets of data Parasitized 3 
h vs Parasitized 25 h, Control 3 h vs Control 25 h, Control 3 h vs Parasitized 3 h and Control 
25 h vs Parasitized 25 h. GO term enrichment analyses of the two sets that compared 3 
hours versus 25 hours samples showed enrichment of GO terms associated with energy 
metabolism (table 1).  
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Figure 4: Validation of microarray data with RT-qPCR. Log2-transformed expression ratio of Paras_3h 
compared to Contr_3h and of Paras_25h compared to Contr_25h. White bars: RT-qPCR experiment. Black 
bars: microarray experiment. T-tests were used to statistically compare parasitized versus unparasitized 
samples. +: significant differential expression (p < 0.05). -: no significant expression (p ≥ 0.05). 
 
As with the time comparisons in the transcript-by-transcript level analyses above, the 
enrichment in energy metabolism categories likely reflects the metabolic demands that have 
been documented to occur at the pupal-pharate adult metamorphic molt (Denlinger & 
Zaarek, 1994;Ragland et al., 2010). 
 
To further explore the effects of envenomation at levels above single ESTs we performed a 
second set of analyses where we tested for enrichment across categories in the COG 
(Clusters of Orthologous Groups from eukaryotic genomes) functional classification using 
Blast2GO (figure 5). We observed enrichment that suggested differential regulation in 
categories associated with growth (including replication, transcription, and translation), cell 
signalling, intermediary metabolism, and defensive mechanisms. In a complementary 
analysis, we also manually clustered 103 differentially expressed EST’s in control versus 
envenomated pupae at 25 hours into 8 GO clusters (25 ESTs out of 128 could not be 
annotated by Blast2GO) representing genetic information processing, metabolism, 
development, programmed cell death, detoxification, immune system, sensory system and 
transporters (table S3 and figure 6).  
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Table 1: Selected biological process GO-terms which were enriched among the EST’s that were differentially expressed in control and parasitized pupae, 3 hours 
and 25 hours after parasitization. 
  
Control 3 hours versus 25 hours Parasitized 3 hours versus 25 hours 
GO-nr GO biological process term FDR
a
 p-value NS
b
 FE
c
 FDR
a
 p-value NS
b
 FE
c
 
GO:0006119 oxidative phosphorylation 4.32E-05 4.78E-08 14 7.53 5.09E-07 5.54E-10 20 6.87 
GO:0022900 electron transport chain 6.53E-05 8.83E-08 15 6.53 4.79E-05 1.06E-07 19 6.70 
GO:0042773 ATP synthesis coupled electron transport 8.21E-05 1.21E-07 13 7.64 3.46E-06 5.37E-09 18 5.04 
GO:0022904 respiratory electron transport chain 8.71E-05 1.39E-07 14 6.83 4.41E-05 9.20E-08 18 6.71 
GO:0045333 cellular respiration 1.29E-04 2.21E-07 16 5.61 3.46E-06 5.53E-09 23 4.31 
GO:0006091 generation of precursor metabolites and energy 2.24E-04 4.42E-07 19 4.48 5.78E-05 1.38E-07 26 5.39 
GO:0042775 mitochondrial ATP synthesis coupled electron transport 2.24E-04 4.68E-07 12 7.43 7.41E-06 1.37E-08 17 5.04 
GO:0015980 energy derivation by oxidation of organic compounds 4.40E-04 1.30E-06 16 4.84 3.47E-05 6.83E-08 23 3.73 
a
False Discovery Rate 
b
Number of genes associated with GO-term which were differentially expressed 
c
Fold Enrichment 
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Figure 5: Square brackets: Total number of EST’s within the S. crassipalpis EST database. On the left, KOG 
functional category labels are listed. C: cellular processes and signalling. M: metabolism. P: poorly 
characterized. Red bars: down-regulation. Green bars: up-regulation. 
 
One challenge for transcriptomic studies like the current study that use either whole bodies 
or complex tissues (e.g. hemocytes, brain, or fat body) is that patterns of gene expression 
represent the sum of transcriptional profiles across many specialized cell types. Thus, a 
transcriptomics study showing some components of energy metabolism by glycolysis that 
are up-regulated and some pathway members that are down-regulated may reflect the fact 
that glycolysis is up-regulated in some cells and down-regulated in others, rather than 
indicating that some components of the pathway are up-regulated and others down-
regulated within a single cell type. Furthermore, a single gene that may affect multiple 
downstream pathways and functional categories (i.e., GO or COG) can also reflect a diversity 
of biochemical cellular events that indicate multiple different physiological effects on 
organismal phenotypes. The responses of Sarcophaga fly hosts to envenomation by N. 
vitripennis have been studied from organismal and physiological perspectives for two 
decades (Rivers & Denlinger, 1994a;Rivers & Denlinger, 1994b;Rivers & Denlinger, 
1995;Rivers et al., 2002b;Rivers et al., 2010) revealing that even without the developmental 
influence of the parasitoid larva, envenomation alters fly hosts in three major ways: by 
suppressing host immunity, arresting host development, and altering host metabolism to 
A: RNA processing and modification [269] 
D: Cell cycle control, cell division, chromosome partitioning [195] 
J: Translation, ribosomal structure and biogenesis [372] 
K: Transcription [356] 
O: Posttranslational modification, protein turnover, chaperones [603] 
U: Intracellular trafficking, secretion, and vesicular transport [364] 
T: Signal transduction mechanisms [682] 
V: Defense mechanisms [61] 
Z: Cytoskeleton [224] 
C: Energy production and conversion [276] 
E: Amino acid transport and metabolism [289] 
F:  Nucleotide transport and metabolism [96] 
G: Carbohydrate transport and metabolism [251] 
I: Lipid transport and metabolism [279] 
P: Inorganic ion transport and metabolism [176] 
Q: Secondary metabolites biosynthesis, transport and catabolism [135] 
R: General function prediction only [1006] 
S: Function unknown [570] 
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favour parasitoid development. Below, we interpret current transcriptomic results in the 
context of these three host manipulations. Many patterns of transcript abundance are 
products of host manipulation by the parasitoid (e.g., changes in many downstream players 
in genetic information processing), but here we consciously focus the discussion on 
regulatory processes that we believe may be important in modulating host immunity, 
development, and metabolism to benefit parasitoid development. We acknowledge that 
other, more-subtle interactions between parasitoid venom and host physiology, beyond 
those observed in current data or discussed here, are undoubtedly occurring. For example, 
some of the transcriptional responses we observe may be the product of host responses 
attempting to deter parasitoid success. However, we cannot currently disentangle host-
defensive responses from parasitoid manipulation of hosts. Future work comparing 
responses to envenomation across populations of strains of hosts that vary in their 
susceptibility to parasitism by N. vitripennis is needed. Because successful envenomation by 
N. vitripennis always leads to developmental arrest and eventual host death in the strains 
used here, we focus the discussion from the perspective of host molecular responses to 
parasite manipulation. We hope that current data, the first to our knowledge on genome 
wide transcriptomic responses to ectoparasitoid envenomation, will motivate additional 
hypothesis building that leads to careful biochemical and cellular studies of venom modes of 
action in the N. vitripennis-Sarcophaga interaction and other host-parasitoid systems.  
 
Figure 6: Differentially expressed EST’s for comparisons Contr_25h vs Paras_25h, manually clustered 
into 8 different classes. Schematically presented. 
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4.5. Immunity 
From the perspective of host exploitation, venoms should inhibit components of the host 
immune response that target parasitoid larvae while either maintaining or even enhancing 
components of the host immune system that target other invaders, like bacteria or fungi, 
that may promote degrading host quality, compete for parasitoid larvae for host resources, 
or infect the parasitoids themselves (Asgari & Rivers, 2011). Hosts will react to the invasion 
of foreign agents by producing antimicrobial peptides and reactive oxygen species by contact 
epithelia, fat body and hemocytes and more directly by phagocytosis, encapsulation and 
nodule formation in which specialized hemocytes interplay (Danneels et al., 2010). Studies of 
hemocyte dynamics showed that envenomation of Sarcophaga bullata pupae by N. 
vitripennis resulted in the rapid death of plasmatocytes, inhibited proliferation and 
differentiation of pro-hemocytes into plasmatocytes, and diminished granulocyte spreading 
(Rivers & Denlinger, 1995;Rivers et al., 2002b). The transcripts that are described in the 
following sub-sections on immunity, are marked with green asterisk (*) in tables S2 and S3. 
 
4.5.1. Programmed cell death in hemocytes and other tissues 
In vivo studies in Sarcophaga hosts and in vitro work on lepidopteran cells suggests that 
venom-induced hemocyte cell death occurs by apoptosis signaled by phospholipase A2 (PLA2) 
that alters cellular Ca²+ signalling and Na+ homeostasis leading to characteristic changes in 
cell shape, including blebbing caused by membrane separation from the cytoskeleton, 
cellular swelling, DNA fragmentation, phosphatidylserine externalization and activation of 
caspase activity (Rivers & Denlinger, 1994a, 1994b;Rivers et al., 2002a, 2010;Formesyn et al., 
2013b). We show differential regulation of apoptotic transcripts, including up-regulation 
(2.15-fold) of a secretory PLA2 transcript that may activate caspase activity. Consistent with 
the previous observations that PLA2 activity is associated with changes in cellular Na
+ and 
Ca²+ homeostasis that may induce apoptosis, we found a putative small mitochondrial 
calcium-binding protein transcriptionally up-regulated 25 hours after envenomation (1.83-
fold), as well as a putative calcyphosine that was also up-regulated (1.44-fold). Up-regulation 
of a putative cytochrome oxidase III subunit (3.81-fold) may also be related to mitochondrial 
dysfunction induced by PLA2 signalling. Overexpression of cytochrome III may help to induce 
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apoptosis by affecting the redox state of cytochrome C, a known effector of caspase activity 
and apoptosis (Brown & Borutaite, 2008;Wu et al., 2009).  
 
Three transcripts annotated to the Rho family of GTP-binding proteins and a guanine 
nucleotide exchange factor were highly up-regulated 25 hours after envenomation (13.2, 
9.7, 1.38, and 1.3-fold enrichment respectively, table S2). Rho GTPases belong to the Ras 
superfamily and play diverse roles in intracellular signalling (Rossman et al., 2005;Cox & Der, 
2003). We propose that Rho GTP-binding proteins and the observed guanine nucleotide 
exchange factor modulate Rho signalling and promote apoptosis in hemocytes and other 
tissues by activating the RASSF1/Nore1/Mst1 signalling pathway that leads eventually to 
caspase activation. Rho signalling pathway members were also found to be differentially 
regulated in a study of the evolution of resistance of D. melanogaster hosts to the parasitoid 
wasp A. tabida (Wertheim et al., 2011). Thus, further interrogation of the potential roles of 
Rho signalling is needed to understand how N. vitripennis venom affects Sarcophaga hosts 
from the perspectives of both immune modulation by hemocyte cell death and selective 
programmed cell death in other tissues (see 4.6.1. Developmental signalling pathways).  
 
Rho GTPases are also known for their involvement in cytoskeletal actin reorganization 
(Coleman & Olson, 2002;Fiorentini et al., 2003). Blebbing, where the cell membrane 
separates from the cytoskeleton, is one of the phenotypic hallmarks of cell death when 
cultured lepidopteran cells are exposed to N. vitripennis venom in vitro (Rivers et al., 2002a, 
2002b, 2010), and Rho signalling has been shown to promote blebbing by actin cytoskeleton 
reorganization in cultured mammalian cells (Aznar & Lacal, 2001). Consistent with this view, 
several cytoskeleton-related transcripts were up-regulated by envenomation in current 
study (table S2: kinesin-like protein kif1a, actin-related protein 5, map kinase-activated 
protein kinase, annexin b11 isoform a). Cytoskeletal disorganization could also reduce the 
ability of hemocytes to produce pseudopodial projections critical for endocytosis or 
spreading responses, and venom of several endoparasitoids has been shown to reduce the 
efficacy of spreading by disrupting hemocyte cytoskeletal structure (Gillespie et al., 
1997;Strand, 2008;Asgari & Rivers, 2011;Richards et al., 2013).  Differential regulation of 
cytoskeletal transcripts has been observed in other transcriptional studies of parasitism 
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(Wertheim et al., 2005, 2011), suggesting conservation of this mode of action between 
endoparasitoid and ectoparasitoid venoms. 
 
4.5.2. Cellular and humoral immune responses 
Although N. vitripennis venom dramatically suppresses Sarcophaga immunity by rapidly 
killing hemocytes, hosts still do mount an immune response characterized by both cellular 
and humoral mechanisms (Rivers et al., 2002b). The p38K and JNK cascades of the 
multifunctional mitogen-activated protein kinase (MAPK) pathway are promising candidates 
for regulating both the cellular immune response to envenomation and hemocyte apoptosis 
(Concannon et al., 2003;Rane et al., 2003). MAPKs are cytosolic proteins that translocate 
into the nucleus to regulate transcription when activated. The p38K and JNK signalling 
cascades are associated with cellular stress responses including apoptosis, immunity, and 
cell cycle arrest. After envenomation, a putative MAPK 3 or MAPK 4 transcript possibly 
belonging to either the p38 or JNK cascade was down-regulated (-1.46-fold) and transcript 
abundance of a putative MAPK 3 or MAPK 4-phosphatase that suppresses MAPK activity was 
up-regulated (1.86-fold). We currently cannot distinguish whether this transcript functions 
as MAPK 3 by activating the p38K cascade or acting as MAPK 4 by activating the JNK cascade 
because we did not detect other transcripts clearly assigned to either cascade. However, 
both signalling cascades participate in immune system function, and down-regulating this 
arm of MAPK signalling may be an important part of the parasitoid’s strategy for host 
immune suppression. MAPKs are activated post-translationally by phosphorylation, thus 
testing whether any of the arms of MAPK signalling are important in immune modulation at 
envenomation will involve further biochemical work at the level of immune cells and other 
tissues.  
 
Parasitoid detection and immune system activation may also be modulated by the NF-ĸB 
pathway (Strand, 2008). A transcript for a putative tumor necrosis factor (TNF) receptor 
associated factor (TRAF) known to regulate NF-ĸB activity in Drosophila (Zapata et al., 2000) 
was up-regulated 25 hours after envenomation (1.7-fold). A protein tyrosine phosphatase 
involved in intracellular immune signalling pathways that had previously been implicated in 
the immune response of D. melanogaster to the wasp A. tabida (Wertheim et al., 2005) was 
also up-regulated (2.17-fold).  
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The immune response in all organisms, including insects, has been associated with microRNA 
(miRNA) activity (O'Connell et al., 2010;Asgari, 2013). Two different transcripts that 
annotated to the host argonaute-2 protein, a critical mediator of the RNAi response, were 
up-regulated 25 hours after envenomation (1.36 and 1.35-fold respectively). In addition to 
their known roles in antimicrobial immunity in insects (Fullaondo & Lee, 2012;Asgari, 2013), 
microRNAs have also recently been implicated in the response of a lepidopteran host, P. 
xylostella, to the parasitoid wasp D. semiclastrum (Etebari et al., 2013), motivating further 
study of microRNAs in regulating envenomation responses. We also observed up-regulation 
of transcripts for two odorant-binding proteins (OBPs) (6.56 and 7.38-fold). Beyond their 
activities in chemoreception, OBPs have been implicated in diverse cellular responses 
including pathogen recognition and neutralization of invading microorganisms (Levy et al., 
2004). Of further interest, two distinct OBPs were also discovered in N. vitripennis venom (de 
Graaf et al., 2010), but whether and how endogenous host OBPs and venom-derived 
parasitoid OBPs may interact is unknown and merits further study. 
 
Envenomation by N. vitripennis has long been associated with decreased melanisation of 
Sarcophaga host hemolymph (Rivers & Denlinger, 1994a;Rivers et al., 2002). The deposition 
of melanin around the intruding object forms a physical shield and prevents or retards the 
growth of the intruder. Given such a crucial role for melanisation in host immunity, 
alterations of this process in hosts likely represents a strategy for host manipulation. Analysis 
of N. vitripennis venom has revealed both serine protease inhibitors (serpins) and cysteine-
rich protease inhibitors that may impede the activity of pro-phenoloxidase and the 
melanisation response (de Graaf et al., 2010). We found substantial up-regulation of 
transcripts for two serine proteases (2.12 and 3.11-fold) that could compete with venom-
derived protease inhibitors in an effort to disrupt the parasitoid’s immune-suppressive 
strategy, similar to the enhanced expression of melanisation cascade transcripts observed 
when D. melanogaster was parasitized by the virulent parasitoid wasp Leptopilina boulardi 
(Schlenke et al., 2007).  
 
A targeted oxidative burst that is facilitated by both cellular and humoral elements of 
immunity is associated with melanisation (Strand, 2008). For hosts, this targeted burst of 
free radicals and pro-oxidants must be delivered precisely to stress the invader while 
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protecting host tissues. Concomitantly, parasitoids must reduce effects of oxidative damage 
on their own bodies and critical host tissues such as the fat body. Consistent with this 
dynamic interplay of host and parasitoid control of free radical damage, we found 
enrichment of detoxification proteins that could control redox events and may play roles in 
immune oxidative burst reactions, including down-regulation of a putative metallothionein 
family 5 protein (-2.01-fold), cytochrome p450-28a1 (-1.91-fold), copper uptake protein (-
1.65-fold), and up-regulation of transcripts for putative myoinositol oxygenase (1.83-fold) 
and ribonucleoside-diphosphate reductase (1.46-fold). These redox proteins may be 
important in detoxification responses that facilitate immunity. Other detoxification 
transcripts were also differentially regulated, including down-regulation of the glutathione 
metabolism enzyme alanyl aminopeptidase (-2.93-fold), and an apparent ABC transporter 
was up-regulated (2.75-fold).  
 
We detected no change in abundance of antimicrobial peptide transcripts, an important 
component of humoral immunity. Other studies on host-parasitoid responses also showed 
minimal up-regulation of antimicrobial peptides in responses to parasitoids relative to 
exposure to microorganisms (Ross & Dunn, 1989;Nicolas et al., 1996;Masova et al., 
2010;Wertheim et al., 2005).  
 
4.6. Development 
Delaying or arresting host development is a common life history tactic for parasitoids. In 
endoparasitoids, suppressive actions are begun by venom components, and sometimes 
symbiotic viruses, then reinforced by developing parasitoids (Strand, 2008;Asgari & Rivers, 
2011). As ectoparasitoid without obvious viral symbionts, N. vitripennis uses venom to arrest 
host development until external parasitoid eggs can hatch and larvae can affect host 
physiology directly. Even without the influence of a developing wasp larva, Sarcophaga 
pupae envenomated by N. vitripennis enter an irreversible state of developmental arrest 
that can last more than a month before the host dies (Rivers & Denlinger, 1994a). 
Envenomation-induced developmental arrest in Sarcophaga pupae superficially resembles 
the developmental arrest induced at pupal diapause in this species. However, within 24 
hours of envenomation the brain of a Sarcophaga host pupa undergoes substantial 
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programmed cell death and thus will never be able to develop into a functional adult (Rivers 
et al., 2011).  
 
Degeneration of the brain contributes to envenomation-induced developmental arrest 
because the release of ecdysteroids from the prothoracic glands instructed by the brain 
corpora cardiaca is needed to coordinate pupal-adult metamorphosis. However, unlike 
diapausing pupae that will resume development with exogenous ecdysteroid exposure, 
exogenous ecdysteroids cannot restart development in envenomated pupae (Rivers & 
Denlinger, 1994a). This suggests that the developmental arrest in envenomated Sarcophaga 
pupae is regulated differently than pupal diapause. Envenomation-induced developmental 
arrest must somehow disrupt ecdysteroid signalling and may also include coordinated cell 
death in other critical tissues, like partially differentiated imaginal wing or antennal discs. In 
contrast to the programmed cell death that occurs after envenomation in hemocytes and 
brain cells, cells of the host fat body remain healthy (Rivers et al., 2011) and continue 
participating in intermediary metabolism of the pupae, including the accumulation of greater 
fat reserves (Rivers & Denlinger, 1995). This clear contrast in the cellular viability responses 
amongst the three Sarcophaga tissues that have been studied is consistent with venom 
manipulating the host environment to favour parasitoid larvae. Further examination may 
reveal that other host tissues benefiting larval development, like the heart and respiratory 
system, are also selectively maintained. An important question is, what cellular and 
biochemical factors promote survival and viability in some Sarcophaga pupal tissues, like the 
fat body which survives for weeks despite exposure to N. vitripennis venom, when other 
tissues undergo programmed cell death within hours of envenomation? The transcripts that 
are described in the following sub-sections on development, are marked with red asterisk (*) 
in tables S2 and S3. 
 
4.6.1. Developmental signalling pathways 
One third of the differentially expressed genes at 25 hours post-envenomation have putative 
roles in developmental processes, with 70% of these transcripts up-regulated and 30% 
down-regulated (tables S2 and S3). Many genes classified as promoting development by 
cellular proliferation and growth also have functions in apoptosis (discussed above). A 
possible regulator of developmental arrest is down-regulation (-2.87-fold) of a putative 
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alkyldihydroxy-acetonephosphate synthase (ADHAPS) required for normal development in 
humans and C. elegans (Motley et al., 2000). Understanding the molecular basis of selective 
maintenance of some tissues during developmental arrest while others are destroyed will 
require picking apart the activity of candidate genes and signalling pathways in individual 
tissues.  
 
As mentioned above (see 4.5.2. Cellular and humoral immune responses), 25 hours after 
envenomation we observed up-regulation in transcripts of a putative MAPK 3 or MAPK 4-
phosphatase (1.86-fold) that could inhibit MAPK signalling through the p38K or JNK 
cascades, and down-regulation of transcripts for a putative MAPK 3 or MAPK 4 protein that 
would activate p38K or JNK signalling (-1.46-fold) and thus modulate development and 
immunity. Because envenomation initiates a developmental arrest in pupae preventing 
pharate adult metamorphosis, we expected that ERK-signalling, which promotes growth and 
morphogenesis, would be down-regulated after envenomation. Interestingly, Torso, a 
peptide-hormone receptor that activates ERK signalling was up-regulated 25 hours after 
envenomation (2.42-fold). Torso is the prothoracicotropic hormone (PTTH) receptor that 
signals the prothoracic glands to produce ecdysone to precipitate molting and 
morphogenesis via ERK signalling (Rewitz et al., 2009). It may seem counterintuitive for 
transcripts of the PTTH receptor to be in greater abundance in developmentally arrested 
pupae compared to control animals already undergoing pupal-adult metamorphosis after 25 
hours. However, by the time of metamorphosis developing flies have already completed 
PTTH signalling and released ecdysteroids so PTTH reception may not be necessary. In 
contrast, envenomated, developmentally arrested pupae may still express the PTTH receptor 
even though exogenous ecdysteroids cannot trigger the resumption of development (Rivers 
& Denlinger, 1994a), indicating that these pupae are stuck perpetually in molecular stasis. A 
putative Torso/PTTH-receptor transcript was also up-regulated in larvae of P. xylostella that 
failed to successfully pupate when parasitized by D. semiclausm (Etebari et al., 2011), again 
suggesting developmental arrest may occur up-stream of ecdysone reception. A putative 
cytochrome p450-28a1 that is down-regulated (-1.91-fold) could also be involved in 
developmental arrest. This p450 is similar to C. elegans daf-9, an enzyme that regulates the 
dauer developmental arrest by producing the steroid hormone dafchronic acid that acts 
through a nuclear steroid hormone receptor, daf-12 (Gerisch & Antebi, 2004). Further 
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detailed investigations of both steroid hormone production and signalling are needed to 
tease apart potential regulatory roles in developmental arrest in host-parasitoid 
interactions. We expect that investigation of sensitivity to the action of PTTH and 
ecdysteroids through the ERK signalling cascade relative to p38K and JNK signalling holds 
promise for understanding the regulation of envenomation-induced arrest of host 
development.  
 
Rho signalling, mentioned above in the context of immunity (see 4.5.1. Programmed cell 
death in hemocytes and other tissues), may also play a critical role in envenomation-induced 
developmental arrest as suggested by high levels of up-regulation in three Rho-family GTP-
binding proteins and a guanine nucleotide exchange factor (13.2, 9.7, 1.38 and 1.3-fold 
enrichment respectively, table S2). Rho signalling affects cytoskeletal structure in embryonic 
and pupal morphogenesis in Drosophila (Chen et al., 2004). Rho signalling is GTP-mediated 
and mutations or transgenes that enhance Rho signalling increase cellular proliferation and 
yield tissue overgrowth (Clark et al., 2000). Thus, up-regulation of Rho family GTP-binding 
proteins and a guanine nuclear exchange factor that regulates cyclic GMP levels may help 
induce developmental arrest by sequestering and decreasing GTP to inhibit the Rho 
signalling that would normally lead to pupal-adult metamorphosis (Chang et al., 1998). Rho 
signalling can also interact with signalling in another pathway affecting cellular proliferation 
and morphogenesis, the SH2 domain ankyrin repeat kinase (Src) pathway (Chan et al., 
1994;Pedraza et al., 2004). Transcripts for a putative inhibitor protein of Src signalling, a Prl 
protein-tyrosine phosphatase (Pagarigan et al., 2013), are up-regulated 25 hours after 
envenomation (2.17-fold), suggesting inhibition of Src signalling may contribute to the 
envenomation-induced developmental arrest.  
 
4.6.2. Other regulators of development 
The only transcript to be detectably differentially expressed 3 hours after envenomation was 
a down-regulated leucine rich-repeat protein (-1.67-fold). Putative homologues of this 
transcript are highly expressed during the pupal-adult transition in D. melanogaster where 
they regulate programmed cell death of larval-pupal structures as the animal undergoes 
adult morphogenesis (Berry & Baehrecke, 2007). Down-regulation of this protein may 
contribute to an early developmental halt upon envenomation, preventing the pupal host 
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from further morphogenesis that may make it less suitable for parasitoid larvae (Rivers & 
Denlinger, 1995). Besides their possible involvement in immunity (see 4.5.2. Cellular and 
humoral immune responses), miRNAs can be important for regulating development in 
insects because they can modulate major transcriptional programs and RNA processing 
(Asgari, 2013). Up-regulation of transcripts for two putative argonaute-2 proteins (1.35 and 
1.16-fold respectively) in current data combined with similar observations in the interaction 
between the lepidopteran host P. xylostella and the wasp D. semiclasum (Etebari et al., 
2013) suggests that miRNAs may play important roles in regulating host developmental 
arrest.  
 
4.7. Metabolism 
Many parasitoids manipulate host intermediary metabolism to improve the nutritional 
milieu for larval development through venom and symbiotic viruses, followed by the 
developing parasitoid and teratocytes (Dahlman et al., 2003;Nakamatsu & Tanaka, 2004, 
2003;Nurullahoglu et al., 2004;Formesyn et al., 2011). Over the 25 hours timeframe of 
current study the egg is external to the host body and would not have yet hatched (Whiting, 
1967). Thus the effects we observe are due to envenomation. Envenomation causes a 
precipitous drop in the metabolic rates of hosts (decreased O2 consumption) (Rivers & 
Denlinger, 1994b, 1995). Although decreased host metabolism upon envenomation may be 
partly due to arresting host development, N. vitripennis venom clearly manipulates host 
intermediary metabolism because just after envenomation hosts increase levels of alanine 
and pyruvate, but decrease oxaloacetate (Rivers & Denlinger, 1994b). Perhaps most striking 
from a metabolic perspective is that envenomation by N. vitripennis causes flesh fly pupae to 
increase the lipid content of their fat bodies while decreasing circulating blood lipids (Rivers 
& Denlinger, 1995, 1994b). We construct hypotheses for regulation of increased lipid storage 
and metabolic depression based on transcript abundance. Because current data are from 
whole bodies, we interpret these data in the context of intermediary metabolism being 
increased in some tissues and decreased in others. The transcripts that are described in the 
following sub-sections on metabolism, are marked with blue asterisk (*) in tables S2 and S3. 
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4.7.1. Reorganizing metabolism to increase fat body lipids 
Because many insect parasitoids, including N. vitripennis, show limited or no capacity to 
synthesize lipids themselves, they must rely on host lipids for fatty acids necessary for 
juvenile growth and adult reproduction (Visser et al., 2010, 2012). Previous work on several 
systems has shown parasitoid manipulation of host lipid metabolism from physiological 
(Rivers & Denlinger, 1995, 1994b;Dahlman et al., 2003;Nakamatsu & Tanaka, 2004, 
2003;Nurullahoglu et al., 2004), proteomic (Song et al., 2008), and transcriptomic 
perspectives (Fang et al., 2010;Etebari et al., 2011;Provost et al., 2011).  
 
Considering that Sarcophaga host pupae are a nutritionally-sealed system that cannot feed, 
N. vitripennis venom must trigger a tissue-specific starvation response so nutrients are 
mobilized from peripheral tissues destined to degenerate, like the brain and thoracic 
muscles, while maintaining metabolic and synthetic function in the fat body. Autophagy is a 
controlled process wherein cells selectively degrade sub-cellular components, recruiting 
components (e.g., mitochondria) to intracellular lysosomes to break them down into 
trafficable units like amino acids that can be reused elsewhere (Cooper & Mitchell-Foster, 
2011;Kroemer & Levine, 2008). Autophagy is a critical component of both starvation 
responses and responses to mild cellular damage. Mild starvation or cellular damage that 
lead to autophagy will induce cell cycle arrest by p53-dependent pathways to stop growth 
and will trigger lysosomal clearance of some sub-cellular structures, but cells can typically 
rebound function and resume growth when nutrients become available again or the stress 
abates (Lee, 2012). Prolonged starvation or chronic stress will induce a shift from the milder 
autophagy response to trigger apoptotic pathways. Both autophagy and apoptosis allow 
organisms to control the breakdown of cellular components into trafficable units that could 
be recycled and used to produce fat body lipid stores. Because autophagy has been 
associated with both starvation/nutrient recycling and cell cycle arrest, regulation of 
autophagy pathways provides an opportunity for parasitoids to manipulate both host 
development and intermediary metabolism to favor offspring production. We observe 
enrichment in several GO categories that are consistent with the expectation that 
envenomation promotes autophagy and nutrient mobilization in peripheral host tissues to 
support lipid synthesis in the fat body, including: cell cycle control, intracellular 
trafficking/vesicular transport, energy production and conversion, amino acid transport and 
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metabolism, nucleotide transport and metabolism, and lipid transport and metabolism 
(figure 5).  
 
When assessing the gene-by-gene analysis (table S3) several autophagy-related transcripts 
were differentially expressed. Damage-related autophagy modulator (DRAM), shown to 
control autophagy in D. melanogaster (O'Prey et al., 2009), was up-regulated 25 hours after 
envenomation (1.47-fold). Mitochondria play an important role in promoting or inhibiting 
autophagy (Cooper & Mitchell-Foster, 2011;Kroemer & Levine, 2008). Specifically, damaged 
or energy-stressed alterations in the mitochondrial trans-membrane potential regulated by 
mitochondrial Ca²+ signalling can trigger recruitment of mitochondria to autolysosomes (e.g., 
mitophagy). Two possible regulators of mitochondrial Ca²+ homeostasis associated with 
autophagy were up-regulated 25 hours after envenomation (Cardenas & Foskett, 2012;Lin et 
al., 2012), a putative calcyphosine (1.44-fold) and a putative small mitochondrial calcium-
binding protein (1.83-fold). A putative DGP-1, an elongation factor that regulates taking 
damaged cells out of the cell cycle and inducing autophagic repair (Gruenewald et al., 
2009;Blanco et al., 2010) was highly up-regulated after envenomation (13.2-fold). A putative 
lysosomal aspartic protease was also up-regulated (1.74-fold) 25 hours after envenomation. 
This transcript has similarities to cathepsin D, a lysosomal protease activated in cells 
undergoing autophagy, apoptosis, and even necrotic cell death (Benes et al., 2008;Guicciardi 
et al., 2004). Cathepsins specifically, and other pro-autophagic genes more generally have 
been implicated in host responses to parasitism in other transcriptomic (Etebari et al., 
2011;Fang et al., 2010) and proteomic studies (Song et al., 2008). Although we have couched 
most of the autophagy-related responses as important to nutritional manipulation of host 
tissues, there is substantial overlap between autophagic and apoptotic genes such that it is 
difficult to determine from simple snapshots of transcripts or proteins what specific 
pathways are being triggered across studies. Clearly pro-autophagy pathways could be 
playing roles in the apoptotic response of host tissues after envenomation in the 
Sarcophaga-Nasonia interaction (see 4.6. Development) (Rivers et al., 2002b) and other 
parasitoid-host manipulation systems (Song et al., 2008;Fang et al., 2010;Etebari et al., 
2011). We expect apoptotic pathways will be rapidly initiated for parasitoid suppression of 
host immunity, then autophagic responses will be important for longer-term manipulation of 
host development and nutritional state. Careful investigation of time-course patterns of 
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autophagy and apoptotic responses are needed across multiple tissue types to test these 
hypotheses about the relative contributions of autophagy and apoptosis to the three major 
axes of host manipulation: immunity, development, and nutrition.  
 
Amino acids are a major product of cellular autophagy responses, and we expect that these 
amino acids liberated from the peripheral host tissues by envenomation are being 
deaminated to provide carbon skeletons for metabolic fuel as substrates for anabolic lipid 
synthesis. Gene Ontology categories including energy production and conversion, amino acid 
transport and metabolism, nucleotide transport and metabolism, and lipid transport and 
metabolism were all differentially expressed in hosts 25 hours after envenomation (figure 5). 
When considering lipid synthesis from amino acids produced by autophagy, some 
transporters were up-regulated including a cationic amino acid transporter (2.13-fold) and 
an oligopeptide transporter (YIN) (2.87-fold) associated with transport of small peptides 
(especially alanylalanine) in D. melanogaster (Charriere et al., 2010). 2-amino-3-ketobutyrate 
coenzyme a ligase (Edgar and Polak, 2000) plays a critical role in the metabolism of serine, 
threonine, and glycine into acetyl-CoA for use in fatty acid synthesis and was up-regulated 
(1.63-fold). Up-regulation (2.05-fold) of a putative sodium-associated monocarboxylate 
transporter 25 hours after envenomation also suggests amino acid catabolism because 
monocarboxylate transporters may be moving metabolic intermediates of catabolism of 
peripheral tissue protein, like pyruvate, acetate, or proprionate, into the fat body for lipid 
synthesis. A putative hydroxy-acid oxidase was also up-regulated (7.43-fold). Hydroxy-acid 
oxidase plays a critical role in glyoxylate and dicarboxylate metabolism following serine, 
threonine, and glycine metabolism. Envenomation could also trigger glyoxylate and 
dicarboxylate metabolism in host peripheral tissues, where two-carbon precursors could be 
used for gluconeogenesis; simple carbohydrates or Krebs-cycle intermediates could be 
trafficked to the host fat body for fatty-acid synthesis (Voet & Voet, 2011). Current data 
suggest that envenomation of Sarcophaga host pupae by N. vitripennis causes a substantial 
shift in protein and amino-acid metabolism to mobilize nutrients from peripheral tissues to 
the host fat body to support larval parasitoid growth, ensuring that parasitoids can acquire 
enough lipids during larval feeding to compensate for their inability to synthesize lipids de 
novo in adulthood (Visser et al., 2010, 2012). Although several candidate metabolic 
pathways emerge above, particularly serine, threonine, and glycine metabolism coupled to 
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the glyoxylate/dicarboxylate cycle, future work should include testing which pathways of 
intermediary metabolism are most affected by envenomation, using techniques to carefully 
track labeled amino acid substrates through their metabolic intermediates (Zera, 2011;Visser 
et al., 2012).  
 
4.7.2. Metabolic depression  
Upon envenomation by N. vitripennis metabolic rates of Sarcophaga pupae decline 
precipitously (Rivers & Denlinger, 1994b) and within 24 hours pupae increase alanine and 
pyruvate levels, but not the Krebs-cycle intermediate oxaloacetate (Rivers & Denlinger, 
1994b). Although pyruvate levels increase initially they later drop as lipid is accumulated in 
the host fat body, suggesting that early high levels of pyruvate may support envenomation-
induced alterations in host lipid metabolism (Rivers & Denlinger, 1994b). As in other 
parasitoid-host interactions that have been studied from a transcriptomic or proteomic 
perspective (Etebari et al., 2011;Wertheim et al., 2011;Zhu et al., 2009;Song et al., 
2008;Nguyen et al., 2008), genes associated with energy metabolism were differentially 
expressed in the current study (figure 5, table S2). Across a wide range of taxa from turtles 
to insects, metabolic depression is associated with inducing hypoxic-like states that induce 
greater anaerobic metabolism through glycolytic/gluconeogenic pathways and decreased 
reliance on the Krebs cycle (Guppy & Withers, 1999). A shift away from aerobic metabolism 
towards increased glycolysis and gluconeogenesis appears to occur with metabolic 
depression during pupal diapause in Sarcophaga flies despite the fact that diapausing pupae 
remain normoxic (Michaud & Denlinger, 2007;Ragland et al., 2010), and several observations 
suggest envenomation may encourage a shift towards increased anaerobic metabolism. 
Lactate dehydrogenase regenerates NAD+ by converting pyruvate to lactate under anaerobic 
conditions (Voet & Voet, 2011), and a putative lactate dehydrogenase was up-regulated 25 
hours after envenomation (3.83-fold). Elevated pyruvate levels in Sarcophaga pupae just 
after envenomation (Rivers & Denlinger, 1994b) are consistent with envenomation causing 
increased glycolysis relative to aerobic Krebs-cycle activity, and lactate dehydrogenase may 
help maintain NAD+ levels to facilitate glycolysis. Up-regulation of a putative myoinositol 
oxygenase (1.83-fold) also suggests greater glycolysis in envenomated hosts. Myoinositol can 
be used for glycolysis or to produce the lipid-precursor inositol, and myoinositol oxygenases 
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have been implicated in sugar balance and diabetes (Ganapathy et al., 2008;Nayak et al., 
2011).  
 
Envenomated pupae were kept in normal-oxygen atmospheres, so a shift towards anaerobic 
metabolism favouring glycolysis and reducing the activity of the Krebs cycle could be caused 
by components of N. vitripennis venom altering pathways that regulate metabolic responses 
to hypoxia. A putative hypoxia-inducible domain family 1 protein was up-regulated 25 hours 
after envenomation (2.22-fold). This protein is a downstream effector of the HIF signalling 
pathway and may be playing a role in directly reducing mitochondrial activity (Gorr et al., 
2004;Hayashi et al., 2012). Future physiological and biochemical studies will be needed to 
test the hypothesis that envenomated host pupae are in a hypoxia-like state despite being 
normoxic. Although most studies of parasitoid manipulation of hosts focus on modulation of 
the immune response, the mechanisms that parasitoids use to manipulate host metabolism 
may provide new perspectives into states of metabolic depression. 
 
5. Conclusions 
These results support earlier studies demonstrating that N. vitripennis venom influences 
diverse physiological processes in one of its preferred host organism S. crassipalpis. Current 
molecular assay to confirm parasitization post hoc is unique because it keeps the samples 
intact, avoiding adverse effects caused by manipulation. Furthermore, to our knowledge this 
is the first transcriptomic study of the response of a host insect to attack by an 
ectoparasitoid, complementing a substantial body of physiological literature on the N. 
vitripennis-Sarcophaga interaction. Overall, fewer genes were found to be differentially 
expressed after parasitization with N. vitripennis than have been observed in studies with 
endoparasitoids. This observation is at least partly the result of venom injection alone rather 
than feeding by the wasp larvae because current samples were taken prior to hatching of the 
wasp eggs. The patterns of differential expression we observed suggest several clear 
candidate pathways for the molecular regulation of immune suppression, host 
developmental arrest, and alteration of host metabolism in response to ectoparasitoid 
envenomation. Many of these same pathways have also been implicated in endoparasitoid 
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attack of hosts, suggesting some fundamental, conserved aspects of host-parasitoid 
interactions to be further investigated. 
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7. Supplementary materials 
Table S1: Concentration and quality of the RNA samples used for microarray and validation experiment. 
Hybridization-ID Sample ID 260/280
a
 260/230
b
 Conc (ng/µl) RIN
c
 
12802 A1-Contr_3h_1 2.24 2.64 1924.11 ok 
12803 A101-Paras_3h_1 2.17 2.69 5983.9 ok 
12804 A164-Paras_25h_1 2.16 2.59 6271.9 ok 
12805 A50-Contr_25h_1 2.17 2.75 4101.4 ok 
12806 A3-Contr_3h_2 2.19 2.62 4779.1 ok 
12807 A51-Contr_25h_2 2.16 2.74 3580.9 ok 
12808 A165-Paras_25h_2 2.14 2.64 5480.5 ok 
12809 A103-Paras_3h_2 2.20 2.73 8566.4 ok 
12810 A4-Contr_3h_3 2.18 2.45 2968.11 ok 
12811 A114-Paras_3h_3 2.17 2.75 5027.4 ok 
12812 A167-Paras_25h_3 2.18 2.35 4349.7 ok 
12813 A52-Contr_25h_3 2.16 2.72 5295.7 ok 
12814 A5-Contr_3h_4 2.21 2.76 2788.5 ok 
12815 A53-Contr_25h_4 2.16 2.63 3081.3 ok 
12816 A168-Paras_25h_4 2.15 2.39 5053.7 ok 
12817 A115-Paras_3h_4 2.17 2.50 5464.3 ok 
a
RNA ratio 260/280 
b
RNA ratio 260/230 
c
RNA integrity number 
 
Chapter 3 
67 
Table S2: Differentially expressed EST’s for comparisons Contr_3h vs Paras_3h and Contr_25h vs 
Paras_25h. 
EST-ID Name Fold change 
Control_3h vs Paras_3h     
  Down-regulated genes     
 EUA37Q302I4V57 leucine rich repeat protein -1.67 
    
Control_25h vs Paras_25h     
  Down-regulated genes     
 gi|296337397|gb|EZ600582.1| alkaline phosphatase -4.84 
 gi|296344996|gb|EZ608181.1| acyl- reductase -3.76 
 gi|296345268|gb|EZ608453.1| af521649_1aminopeptidase 1 * -2.93 
 EUA37Q301EWMAR alkyldihydroxyacetonephosphate synthase * -2.87 
 gi|296344527|gb|EZ607712.1| GJ21452 [Drosophila virilis] -2.36 
 EUA37Q301A5D33 metallothionein family 5 * -2.01 
 EUA37Q301BGZ4G cytochrome p450-28a1 * * -1.91 
 gi|296334792|gb|EZ597977.1| kda salivary protein -1.88 
 gi|296347786|gb|EZ610971.1| vitelline membrane protein 26aa -1.75 
 EUA37Q301BDW2J high-affinity copper uptake protein * -1.65 
 EUA37Q302HYMJL abdominal a -1.58 
 EUA37Q301BG3HQ GM12685 [Drosophila sechellia] -1.49 
 gi|296336476|gb|EZ599661.1| mitogen-activated protein kinase * * -1.46 
 EUA37Q301DQW90 peptidyl-prolyl cis-trans isomerase 10 -1.38 
 gi|296339670|gb|EZ602855.1| CG15096, isoform b -1.35 
 EUA37Q302J1OWE lethal nc136 -1.31 
    
  Up-regulated genes     
 gi|296334764|gb|EZ597949.1| rna polymerase ii second largest subunit 1.27 
 gi|296341632|gb|EZ604817.1| isoleucyl trna synthetase 1.29 
 EUA37Q302FL5NT guanine nucleotide exchange factor * * 1.30 
 gi|296354272|gb|EZ617457.1| tyrosine-protein phosphatase non-receptor type 23 1.33 
 gi|296334548|gb|EZ597733.1| glutaminyl-trna synthetase 1.34 
 EUA37Q302HO4B9 sin3a-associated protein sap130 1.34 
 gi|296335934|gb|EZ599119.1| tubulin-specific chaperone b (tubulin folding cofactor b) 1.34 
 gi|296338738|gb|EZ601923.1| argonaute-2 * * 1.35 
 EUA37Q301D0M2N argonaute-2 * * 1.36 
 gi|296344550|gb|EZ607735.1| GH15944 [Drosophila grimshawi] 1.38 
 gi|296344797|gb|EZ607982.1| nucleolar gtp-binding protein * * 1.38 
 EUA37Q301BS4VV isoleucyl trna synthetase 1.41 
 EUA37Q302HSGOB CG2658, isoform b 1.41 
 gi|296351762|gb|EZ614947.1| maleless 1.42 
 gi|296347793|gb|EZ610978.1| CG10126, isoform a * * 1.44 
 gi|296339430|gb|EZ602615.1| CG13365, isoform a 1.44 
 gi|296346174|gb|EZ609359.1| ribonucleoside-diphosphate reductase large subunit * 1.46 
 gi|296337498|gb|EZ600683.1| GJ13945 [Drosophila virilis] * 1.47 
 gi|296347148|gb|EZ610333.1| transmembrane protein 77 1.47 
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 EUA37Q302FJ8LE GJ21111 [Drosophila virilis] 1.47 
 EUA37Q301CP166 adenosine isoform a 1.50 
 gi|296335801|gb|EZ598986.1| glycyl-trna synthetase 1.51 
 EUA37Q301B50E4 cg32479 cg32479-pa 1.61 
 gi|296338685|gb|EZ601870.1| atp-binding cassette sub-family f member 1 1.63 
 gi|296347140|gb|EZ610325.1| 2-amino-3-ketobutyrate coenzyme a ligase * 1.63 
 gi|296346691|gb|EZ609876.1| protease inhibitor-like protein 1.64 
 gi|296345742|gb|EZ608927.1| ribosomal protein l7ae 1.65 
 gi|296350384|gb|EZ613569.1| tnf receptor associated factor * 1.70 
 gi|296341534|gb|EZ604719.1| tetraspanin 42ed 1.72 
 gi|296342414|gb|EZ605599.1| CG13315, hypothetical conserved protein 1.72 
 gi|296347908|gb|EZ611093.1| lysosomal aspartic protease * 1.74 
 gi|296336063|gb|EZ599248.1| CG1572, isoform a 1.78 
 gi|296341133|gb|EZ604318.1| CG10721, cdna sequence 1.81 
 gi|296334521|gb|EZ597706.1| nonsense-mediated mrna 3 1.81 
 gi|296341333|gb|EZ604518.1| small calcium-binding mitochondrial * * 1.83 
 EUA37Q301DBPNS myoinositol oxygenase * * 1.83 
 gi|296344999|gb|EZ608184.1| CG31086, isoform b 1.85 
 gi|296336730|gb|EZ599915.1| map kinase phosphatase * * 1.86 
 gi|296343686|gb|EZ606871.1| transport and golgi organization 14 1.86 
 EUA37Q302H71B7 CG32103, unknown 1.88 
 gi|296339539|gb|EZ602724.1| GI18822 [Drosophila mojavensis] 1.89 
 gi|296346814|gb|EZ609999.1| tyrosyl-trna synthetase 1.90 
 EUA37Q302GBMZS tyrosyl-trna synthetase 1.91 
 gi|296340589|gb|EZ603774.1| CG6171, isoform b 1.93 
 gi|296338258|gb|EZ601443.1| rna 3 -terminal phosphate cyclase 1.93 
 gi|296347532|gb|EZ610717.1| annexin b11 isoform a 1.96 
 gi|296341392|gb|EZ604577.1| lethal isoform g 1.99 
 gi|296336711|gb|EZ599896.1| CG17549, isoform b 1.99 
 gi|296343254|gb|EZ606439.1| CG10864, secreted peptide 2.01 
 gi|296338517|gb|EZ601702.1| CG10444, isoform a * 2.05 
 EUA37Q302JKFDV karl isoform a 2.07 
 EUA37Q301AOS36 serine protease * 2.12 
 EUA37Q302GXY23 CG5535, isoform b * 2.13 
 EUA37Q301DRADV secretory phospholipase a2 * 2.15 
 gi|296340914|gb|EZ604099.1| GG21026 [Drosophila erecta] 2.16 
 gi|296336709|gb|EZ599894.1| CG17549, isoform b 2.16 
 gi|296343420|gb|EZ606605.1| protein tyrosine phosphatase prl * * 2.17 
 gi|296334090|gb|EZ597275.1| CG17734, isoform a * 2.22 
 gi|296336076|gb|EZ599261.1| CG11050, isoform a 2.24 
 gi|296338864|gb|EZ602049.1| sodium sialic acid 2.29 
 gi|296343363|gb|EZ606548.1| CG4452, uncharacterized conserved protein 2.36 
 gi|296352558|gb|EZ615743.1| receptor tyrosine kinase torso-like protein * 2.42 
 gi|296339089|gb|EZ602274.1| CG3568 2.45 
 gi|296343036|gb|EZ606221.1| map kinase-activated protein kinase 2.46 
 EUA37Q301E3IFP actin-related protein 5 2.63 
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 gi|296351374|gb|EZ614559.1| kinesin-like protein kif1a 2.66 
 EUA37Q301D7PIT osiris 7 2.68 
 gi|296349459|gb|EZ612644.1| abc transporter * 2.75 
 EUA37Q301CDAR9 oligopeptide transporter * 2.87 
 EUA37Q301AOJ10 serine protease * 3.11 
 gi|296349810|gb|EZ612995.1| GA13886 [Drosophila pseudoobscura pseudoobscura] 3.30 
 EUA37Q301BY6H3 GI23044 [Drosophila mojavensis] 3.37 
 gi|296346947|gb|EZ610132.1| cytochrome oxidase subunit iii * 3.81 
 gi|296336117|gb|EZ599302.1| l-lactate dehydrogenase * 3.83 
 gi|296339954|gb|EZ603139.1| dolichyl pyrophosphate glc1man9 c2 alpha- -glucosyltransferase 4.34 
 EUA37Q301DOITT sulfate transporter 5.47 
 gi|296347980|gb|EZ611165.1| CG15650 5.55 
 EUA37Q301EV8JS protein archease-like 5.90 
 gi|296351277|gb|EZ614462.1| protein archease-like 5.95 
 gi|296346767|gb|EZ609952.1| beta-site app-cleaving enzyme 6.11 
 gi|296333743|gb|EZ596928.1| odorant-binding protein 56a * 6.56 
 EUA37Q302JMW6F odorant-binding protein 56a * 7.38 
 EUA37Q301AHLSE GK15652 [Drosophila willistoni] 7.12 
 gi|296346813|gb|EZ609998.1| CG18003, isoform b * 7.43 
 gi|296344784|gb|EZ607969.1| cuticular protein 76bc 8.39 
 gi|296334791|gb|EZ597976.1| gtp-binding protein 1 * * 9.72 
 EOHUN8206DRP1R dgp isoform b * * * 13.20 
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Table S3: Differentially expressed EST’s for comparisons Contr_25h vs Paras_25h, manually clustered into 8 different classes. Several EST’s are present in more than 
one cluster, since they can perform multiple functionalities.* discussed in 4.5, * discussed in 4.6, * discussed in 4.7. 
Classification EST ID 
Fold 
change 
Name #GOs 
KEGG 
code 
Enzyme Codes Ref function 
Genetic Information Processing 
      
 
Transcription 
      
  
gi|296341392|gb|EZ604577.1| 1.99 lethal isoform g 5 K01104 
 
P:regulation of transcription, DNA-dependent 
  
gi|296338258|gb|EZ601443.1| 1.93 rna 3 -terminal phosphate cyclase 2 K01974 EC:6.5.1.4 K01974 
  
gi|296345742|gb|EZ608927.1| 1.65 ribosomal protein l7ae 8 K12845 
 
K12845 
  
gi|296351762|gb|EZ614947.1| 1.42 maleless 11 K13184 
 
(Kotlikova et al., 2006) 
  
gi|296344550|gb|EZ607735.1| 1.38 GH15944 [Drosophila grimshawi] 2 
  
F:nucleic acid binding 
  
gi|296334764|gb|EZ597949.1| 1.27 rna polymerase ii second largest subunit 5 K03010 EC:2.7.7.6 P:transcription from RNA polymerase II promoter 
  
EUA37Q302J1OWE -1.31 lethal nc136 7 
  
P:transcription, DNA-dependent 
  
EUA37Q302HYMJL -1.58 abdominal a 22 K09311 
 
P:regulation of transcription, DNA-dependent 
         
 
Translation 
      
  
EUA37Q302GBMZS 1.91 tyrosyl-trna synthetase 5 K01866 EC:6.1.1.1 K01866 
  
gi|296346814|gb|EZ609999.1| 1.90 tyrosyl-trna synthetase 5 K01866 EC:6.1.1.1 K01866 
  
gi|296334521|gb|EZ597706.1| 1.81 nonsense-mediated mrna 3 2 K07562 
 
K07562 
  
gi|296338685|gb|EZ601870.1| 1.63 atp-binding cassette sub-family f member 1 4 K06184 
 
K06184 
  
gi|296335801|gb|EZ598986.1| 1.51 glycyl-trna synthetase 8 K01880 EC:6.1.1.14 K01880 
  
EUA37Q302FJ8LE 1.47 GJ21111 [Drosophila virilis] 2 K14573 
 
K14573 
  
EUA37Q301BS4VV 1.41 isoleucyl trna synthetase 5 K01870 EC:6.1.1.5 K01870 
  
gi|296344797|gb|EZ607982.1| 1.38 nucleolar gtp-binding protein * * 2 K06943 
 
K06943 
  
gi|296338738|gb|EZ601923.1| 1.35 argonaute-2 * * 21 
 
EC:4.6.1.1 P:translational initiation 
  
gi|296341632|gb|EZ604817.1| 1.29 isoleucyl trna synthetase 9 K01870 EC:6.1.1.5 K01870 
         
 
Replication and repair 
      
  
EUA37Q301E3IFP 2.63 actin-related protein 5 7 K11672 
 
P:double-strand break repair 
  
EUA37Q302GXY23 2.13 isoform b * 6 
  
P:DNA repair 
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gi|296347532|gb|EZ610717.1| 1.96 annexin b11 isoform a 10 
  
P:regulation of transcription from RNA 
polymerase II promoter 
  
gi|296346174|gb|EZ609359.1| 1.46 ribonucleoside-diphosphate reductase large subunit * 11 K10807 EC:1.17.4.1 P:DNA replication 
  
EUA37Q302HO4B9 1.34 sin3a-associated protein sap130 2 
  
(Silverstein & Ekwall, 2005) 
  
EUA37Q301DQW90 -1.38 peptidyl-prolyl cis-trans isomerase 10 7 K12734 EC:5.2.1.8 K12734 
         
 
Folding, sorting and degradation 
      
  
EUA37Q301B50E4 1.61 cg32479 cg32479-pa 3 K11841 EC:3.1.2.15 K11841 
  
gi|296339430|gb|EZ602615.1| 1.44 isoform a 10 K03798 EC:3.4.24.0; EC:3.6.1.3 K03798 
  
EUA37Q302HSGOB 1.41 isoform b 10 K03798 EC:3.4.24.0; EC:3.6.1.3 K03798 
  
gi|296335934|gb|EZ599119.1| 1.34 tubulin-specific chaperone b (tubulin folding cofactor b) 1 
  
(Lytle et al., 2004) 
         
Metabolism 
       
 
Energy metabolism 
      
  
gi|296336117|gb|EZ599302.1| 3.83 l-lactate dehydrogenase * 5 K00016 EC:1.1.1.27 (Xia et al., 2011) 
  
gi|296346947|gb|EZ610132.1| 3.81 cytochrome oxidase subunit iii * 4 K02262 EC:1.9.3.1 (Voet et al., 2011) 
  
EUA37Q301DBPNS 1.83 myoinositol oxygenase * 7 K00469 EC:1.13.99.1 (Vesala et al., 2012) 
         
 
Lipid metabolism 
      
  
EUA37Q301DRADV 2.15 secretory phospholipase a2 * 4 K01047 EC:3.1.1.4 (Stanley, 2006) 
  
EUA37Q301EWMAR -2.87 alkyldihydroxyacetonephosphate synthase  * 7 K00803 EC:2.5.1.26 (Hajra & Bishop, 1982) 
         
 
Amino acid/nucleotide  metabolism 
      
  
gi|296346767|gb|EZ609952.1| 6.11 beta-site app-cleaving enzyme 2 
 
EC:3.4.23.0 (Kotani et al., 2005) 
  
gi|296339954|gb|EZ603139.1| 4.34 
dolichyl pyrophosphate glc1man9 c2 alpha- -
glucosyltransferase 
5 K03849 EC:2.4.1.265 (Sorte et al., 2012) 
  
gi|296347908|gb|EZ611093.1| 1.74 lysosomal aspartic protease * 6 K01379 EC:3.4.23.0 (Benes et al., 2008) 
  
gi|296350384|gb|EZ613569.1| 1.70 tnf receptor associated factor * 18 K09848 EC:6.3.2.19 (Deng et al., 2000) 
  
gi|296346691|gb|EZ609876.1| 1.64 protease inhibitor-like protein 3 
  
(Niimi et al., 1999) 
  
gi|296347140|gb|EZ610325.1| 1.63 2-amino-3-ketobutyrate coenzyme a ligase * 8 K00639 EC:2.3.1.29 
 
  
EUA37Q301B50E4 1.61 cg32479 cg32479-pa (ubiquitin thiolesterase) 3 K11841 EC:3.1.2.15 (Osaka et al., 2003) 
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EUA37Q301CP166 1.50 adenosine isoform a 2 K01952 EC:6.3.5.3 (Tiong & Nash, 1993) 
  
gi|296346174|gb|EZ609359.1| 1.46 ribonucleoside-diphosphate reductase large subunit * 11 K10807 EC:1.17.4.1 (Nordlund & Reichard, 2006) 
  
gi|296339430|gb|EZ602615.1| 1.44 isoform a 10 K03798 EC:3.4.24.0; EC:3.6.1.3 (Juhola et al., 2000) 
  
EUA37Q302HSGOB 1.41 isoform b 10 K03798 EC:3.4.24.0; EC:3.6.1.3 (Juhola et al., 2000) 
  
EUA37Q301D0M2N 1.36 argonaute-2 * * 1 
  
(Linder & Schultz, 2003) 
  
gi|296338738|gb|EZ601923.1| 1.35 argonaute-2 * * 21 
 
EC:4.6.1.1 (Linder & Schultz, 2003) 
  
gi|296334764|gb|EZ597949.1| 1.27 rna polymerase ii second largest subunit 5 K03010 E.C.2.7.7.6 (Cramer et al., 2001) 
  
EUA37Q301DQW90 -1.38 peptidyl-prolyl cis-trans isomerase 10 7 K12734 EC:5.2.1.8 (Schiene-Fischer & Yu, 2001) 
  
gi|296345268|gb|EZ608453.1| -2.93 af521649_1aminopeptidase 1 (alanyl aminopeptidase) * 4 
 
EC 3.4.11.2 (Nakanishi et al., 2002) 
         
 
Others 
       
  
gi|296346813|gb|EZ609998.1| 7.43 isoform b * 3 K11517 EC:1.1.3.15 
 
  
gi|296336076|gb|EZ599261.1| 2.24 isoform a 3 K07023 EC:3.1.4.0 
 
  
gi|296337498|gb|EZ600683.1| 1.47 GJ13945 [Drosophila virilis] (4-nitrophenyl phosphatase) * 1 K01101 EC:3.1.3.41 (Versaw et al., 1991) 
  
EUA37Q302HO4B9 1.34 sin3a-associated protein sap130 2 
 
E.C:3.5 
 
  
gi|296334792|gb|EZ597977.1| -1.88 kda salivary protein 0 
   
  
gi|296337397|gb|EZ600582.1| -4.84 alkaline phosphatase 5 K01077 EC:3.1.3.1 (Funk, 2001) 
         
Development 
       
  
gi|296346947|gb|EZ610132.1| 3.81 cytochrome oxidase subunit iii * 4 K02262 EC:1.9.3.1 (Singtripop et al., 2007) 
  
EUA37Q301AOJ10 3.11 serine protease * 1 
  
(Robich & Denlinger, 2005) 
  
gi|296349459|gb|EZ612644.1| 2.75 abc transporter * 6 
  
(Yabe et al., 2005) 
  
gi|296351374|gb|EZ614559.1| 2.66 kinesin-like protein kif1a 11 K10392 
 
P:neuromuscular junction development 
  
EUA37Q301E3IFP 2.63 actin-related protein 5 7 K11672 
 
(Meagher et al., 2005) 
  
gi|296352558|gb|EZ615743.1| 2.42 receptor tyrosine kinase torso-like protein * 4 
 
EC:2.7.10.0 (Furriols et al., 1998) 
  
gi|296343420|gb|EZ606605.1| 2.17 protein tyrosine phosphatase prl * * 3 K01104 
 
(Diamond et al., 1994) 
  
EUA37Q301AOS36 2.12 serine protease * 3 
 
EC:3.4.21.0 (Robich & Denlinger, 2005) 
  
gi|296343686|gb|EZ606871.1| 1.86 transport and golgi organization 14 2 
  
P:wing disc development 
  
gi|296336730|gb|EZ599915.1| 1.86 map kinase phosphatase * * 3 K04459 EC:3.1.3.48 (Kim et al., 2004) 
  
gi|296334521|gb|EZ597706.1| 1.81 nonsense-mediated mrna 3 2 K07562 
 
(Metzstein & Krasnow, 2006) 
  
gi|296347908|gb|EZ611093.1| 1.74 lysosomal aspartic protease * 6 K01379 EC:3.4.23.0 (Gui et al., 2006) 
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gi|296350384|gb|EZ613569.1| 1.70 tnf receptor associated factor * 18 K09848 EC:6.3.2.19 P:instar larval development 
  
gi|296345742|gb|EZ608927.1| 1.65 ribosomal protein l7ae 8 K12845 
 
P:peripheral nervous system development 
  
gi|296346691|gb|EZ609876.1| 1.64 protease inhibitor-like protein 3 
  
(Oppert et al., 2003)Oppert et al., 2003 
  
gi|296335801|gb|EZ598986.1| 1.51 glycyl-trna synthetase 8 K01880 EC:6.1.1.14 (Uwer et al., 1998) 
  
gi|296344797|gb|EZ607982.1| 1.38 nucleolar gtp-binding protein * * 2 K06943 
 
(Paridaen et al., 2011) 
  
EUA37Q301D0M2N 1.36 argonaute-2 * * 1 
  
(Deshpande et al., 2005) 
  
gi|296338738|gb|EZ601923.1| 1.35 argonaute-2 * * 21 
 
EC:4.6.1.1 (Deshpande et al., 2005) 
  
gi|296334548|gb|EZ597733.1| 1.34 glutaminyl-trna synthetase 5 
 
EC:6.1.1.18 (Yebra et al., 2006) 
  
EUA37Q302FL5NT 1.30 guanine nucleotide exchange factor *  * 6 
  
(Van & D'Souza-Schorey, 1997) 
  
gi|296334764|gb|EZ597949.1| 1.27 rna polymerase ii second largest subunit 5 K03010 EC:2.7.7.6 (Nowock et al., 1978) 
  
EUA37Q301DQW90 -1.38 peptidyl-prolyl cis-trans isomerase 10 7 K12734 EC:5.2.1.8 (Pemberton & Kay, 2005) 
  
gi|296336476|gb|EZ599661.1| -1.46 mitogen-activated protein kinase * * 8 K04432 
 
(Widmann et al., 1999) 
  EUA37Q302HYMJL -1.58 abdominal a 22 K09311  P:oenocyte development; P:genitalia 
development; 
P:midgut development; P:gonadal mesoderm 
development; P:cardiac muscle tissue 
development; 
P:peripheral nervous system development; 
P:neuroblast development; P:positive regulation 
of muscle organ development; 
  
EUA37Q301BDW2J -1.65 high-affinity copper uptake protein * 3 K14686 
 
name: high-affinity copper uptake protein 
  
gi|296334792|gb|EZ597977.1| -1.88 kda salivary protein 0 
  
name: kda salivary protein 
  
EUA37Q301BGZ4G -1.91 cytochrome p450-28a1 * * 1 K15005 
 
(Gerisch & Antebi, 2004) 
  
EUA37Q301EWMAR -2.87 alkyldihydroxyacetonephosphate synthase  * 7 K00803 EC:2.5.1.26 (Motley et al., 2000) 
  
gi|296337397|gb|EZ600582.1| -4.84 alkaline phosphatase 5 K01077 EC:3.1.3.1 (Yi & Adams, 2001) 
         
Programmed cell death 
      
  
EOHUN8206DRP1R 13.20 dgp- isoform b * * * 3 
  
(Takai et al., 2001) 
  
gi|296334791|gb|EZ597976.1| 9.72 gtp-binding protein 1 * * 3 
  
(Bustelo et al., 2007) 
  
gi|296346947|gb|EZ610132.1| 3.81 cytochrome oxidase subunit iii * 4 K02262 EC:1.9.3.1 (Wu et al., 2009) 
  
gi|296343036|gb|EZ606221.1| 2.46 map kinase-activated protein kinase 5 K04443 EC:2.7.11.17 (Concannon et al., 2003) 
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EUA37Q301DRADV 2.15 secretory phospholipase a2 * 4 K01047 EC:3.1.1.4 (Rivers et al., 2002a) 
  
gi|296336730|gb|EZ599915.1| 1.86 map kinase phosphatase * * 3 K04459 EC:3.1.3.48 (Dickinson & Keyse, 2006) 
  
gi|296347908|gb|EZ611093.1| 1.74 lysosomal aspartic protease * 6 K01379 EC:3.4.23.0 (Benes et al., 2008) 
  
gi|296350384|gb|EZ613569.1| 1.70 tnf receptor associated factor * 18 K09848 EC:6.3.2.19 (Kuranaga et al., 2002) 
  
gi|296347148|gb|EZ610333.1| 1.47 transmembrane protein 77 1 
  
(O'Prey et al., 2009) 
  
gi|296346174|gb|EZ609359.1| 1.46 ribonucleoside-diphosphate reductase large subunit * 11 K10807 EC:1.17.4.1 (Akdemir et al., 2007) 
  
gi|296344797|gb|EZ607982.1| 1.38 nucleolar gtp-binding protein * 2 K06943 
 
(Paridaen et al., 2011) 
  
EUA37Q301D0M2N 1.36 argonaute-2 * * 1 
  
(Parisi et al., 2011) 
  
gi|296338738|gb|EZ601923.1| 1.35 argonaute-2 * * 21 
 
EC:4.6.1.1 (Parisi et al., 2011) 
  
EUA37Q302HO4B9 1.34 sin3a-associated protein sap130 2 
 
E.C:3.5 (Zilfou et al., 2001) 
  
gi|296335934|gb|EZ599119.1| 1.34 tubulin-specific chaperone b (tubulin folding cofactor b) 1 
  
(Rossman et al., 2005) 
  
gi|296336476|gb|EZ599661.1| -1.46 mitogen-activated protein kinase * * 8 K04432 
 
(Cai et al., 2006) 
  
EUA37Q302HYMJL -1.58 abdominal a 22 K09311 
 
(Bello et al., 2003) 
  
EUA37Q301BGZ4G -1.91 cytochrome p450-28a1 * * 1 K15005 
 
(Scott & Wen, 2001) 
  
EUA37Q301A5D33 -2.01 metallothionein family 5 * 2 
  
(Shimoda et al., 2003) 
         
Detoxification 
       
  
gi|296349459|gb|EZ612644.1| 2.75 abc transporter * 6 
  
(Glavinas et al., 2004) 
  
EUA37Q301DBPNS 1.83 myoinositol oxygenase * * 7 K00469 EC:1.13.99.1 (Duan et al., 2012) 
  
gi|296338685|gb|EZ601870.1| 1.63 atp-binding cassette sub-family f member 1 4 K06184 
 
(Sipos & Kuchler, 2006) 
  
gi|296346174|gb|EZ609359.1| 1.46 ribonucleoside-diphosphate reductase large subunit * 11 K10807 EC:1.17.4.1 
 
  
EUA37Q301BDW2J -1.65 high-affinity copper uptake protein * 3 K14686 
 
(Balamurugan & Schaffner, 2006) 
  
EUA37Q301BGZ4G -1.91 cytochrome p450-28a1 * * 1 K15005 
 
(Scott & Wen, 2001) 
  
EUA37Q301A5D33 -2.01 metallothionein family 5 * 2 
  
(Coyle et al., 2002) 
  
gi|296345268|gb|EZ608453.1| -2.93 af521649_1aminopeptidase 1 (alanyl aminopeptidase) * 
  
EC 3.4.11.2 (Cappiello et al., 2004) 
  
gi|296337397|gb|EZ600582.1| -4.84 alkaline phosphatase 5 K01077 EC:3.1.3.1 (Arenas et al., 2010) 
         
Immune system 
      
  
gi|296334791|gb|EZ597976.1| 9.72 gtp-binding protein 1 * * 3 
  
(Traver et al., 2011) 
  
EUA37Q302JMW6F 7.38 odorant-binding protein 56a * 6 
  
(Levy et al., 2004) 
  
gi|296333743|gb|EZ596928.1| 6.56 odorant-binding protein 56a * 5 
  
(Levy et al., 2004) 
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EUA37Q301AOJ10 3.11 serine protease * 1 
  
(Tang et al., 2011) 
  
EUA37Q301CDAR9 2.87 oligopeptide transporter * 3 K14206 
 
(Charrier & Merlin, 2006) 
  
gi|296349459|gb|EZ612644.1| 2.75 abc transporter * 6 
  
(van de Ven et al., 2009) 
  
gi|296351374|gb|EZ614559.1| 2.66 kinesin-like protein kif1a 11 K10392 
 
(Hanada et al., 2000) 
  
EUA37Q301E3IFP 2.63 actin-related protein 5 7 K11672 
 
(Yutin et al., 2009) 
  
gi|296343036|gb|EZ606221.1| 2.46 map kinase-activated protein kinase 5 K04443 EC:2.7.11.17 (Cargnello & Roux, 2011) 
  
gi|296343420|gb|EZ606605.1| 2.17 protein tyrosine phosphatase prl * * 3 K01104 
 
(Pruijssers & Strand, 2007) 
  
EUA37Q301DRADV 2.15 secretory phospholipase a2 * 4 K01047 EC:3.1.1.4 (Shrestha et al., 2010) 
  
EUA37Q301AOS36 2.12 serine protease * 3 
 
EC:3.4.21.0 (Tang et al., 2011) 
  
gi|296341392|gb|EZ604577.1| 1.99 lethal isoform g 5 K01104 
 
P:phagocytosis, engulfment 
  
gi|296347532|gb|EZ610717.1| 1.96 annexin b11 isoform a 10 
  
(Yutin et al., 2009) 
  
gi|296336730|gb|EZ599915.1| 1.86 map kinase phosphatase * * 3 K04459 EC:3.1.3.48 
 
  
gi|296334521|gb|EZ597706.1| 1.81 nonsense-mediated mrna 3 2 K07562 
 
(El-Bchiri et al., 2008) 
  
gi|296347908|gb|EZ611093.1| 1.74 lysosomal aspartic protease * 6 K01379 EC:3.4.23.0 (Colbert et al., 2009) 
  
gi|296341534|gb|EZ604719.1| 1.72 tetraspanin 42ed 1 
  
(Wright et al., 2004) 
  
gi|296350384|gb|EZ613569.1| 1.70 tnf receptor associated factor * 18 K09848 EC:6.3.2.19 (Lund & Delotto, 2011) 
  
gi|296346691|gb|EZ609876.1| 1.64 protease inhibitor-like protein 3 
  
(Clermont et al., 2004) 
  
gi|296347793|gb|EZ610978.1| 1.44 isoform a * 3 
  
P:phagocytosis, engulfment 
  
EUA37Q301BS4VV 1.41 isoleucyl trna synthetase 5 K01870 EC:6.1.1.5 (Park et al., 2008b) 
  
EUA37Q301D0M2N 1.36 argonaute-2 * * 1 
  
(van Rij et al., 2006) 
  
gi|296338738|gb|EZ601923.1| 1.35 argonaute-2 * * 21 
 
EC:4.6.1.1 (van Rij et al., 2006) 
  
EUA37Q302HO4B9 1.34 sin3a-associated protein sap130 2 
  
(Cambi & Figdor, 2009) 
  
EUA37Q302FL5NT 1.30 guanine nucleotide exchange factor * * 6 
  
(Hall et al., 2006) 
  
gi|296341632|gb|EZ604817.1| 1.29 isoleucyl trna synthetase 9 K01870 EC:6.1.1.5 (Park et al., 2008b) 
  
gi|296336476|gb|EZ599661.1| -1.46 mitogen-activated protein kinase * * 8 K04432 
 
(Chen et al., 2010) 
  
EUA37Q301BGZ4G -1.91 cytochrome p450-28a1 * * 1 K15005 
 
(Morfin, 2002) 
Sensory system 
       
  
EUA37Q302JMW6F 7.38 odorant-binding protein 56a * 6 
  
(Wertheim et al., 2005) 
  
gi|296333743|gb|EZ596928.1| 6.56 odorant-binding protein 56a * 5 
  
(Wertheim et al., 2005) 
  
gi|296351762|gb|EZ614947.1| 1.42 maleless 11 K13184 
 
(Peixoto & Hall, 1998) 
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Transporters 
       
  
EUA37Q302JMW6F 7.38 odorant-binding protein 56a * 6 
  
(Gong et al., 2009) 
  
EUA37Q301DOITT 5.47 sulfate transporter 4 K14708 
 
(Mount & Romero, 2004) 
  
EUA37Q301CDAR9 2.87 oligopeptide transporter (YIN) * 3 K14206 
 
(Charriere et al., 2010) 
  
gi|296349459|gb|EZ612644.1| 2.75 abc transporter * 6 
  
(Glavinas et al., 2004) 
  
gi|296338864|gb|EZ602049.1| 2.29 sodium sialic acid 4 K12303 
 
(Havelaar et al., 1998) 
  
EUA37Q302GXY23 2.13 isoform b * 6 
  
GO:0015326 
  
gi|296338517|gb|EZ601702.1| 2.05 isoform a * 4 
  
GO:0006814 
  
gi|296339539|gb|EZ602724.1| 1.89 GI18822 [Drosophila mojavensis] 3 
  
GO:0006810 
  
EUA37Q302H71B7 1.88 Unknown 0 
  
GO:0006810 
  
gi|296343686|gb|EZ606871.1| 1.86 transport and golgi organization 14 2 
   
  
gi|296341333|gb|EZ604518.1| 1.83 small calcium-binding mitochondrial * * 6 K14684 
 
(Satrustegui et al., 2007) 
  
gi|296338685|gb|EZ601870.1| 1.63 atp-binding cassette sub-family f member 1 4 K06184 
 
(Sipos & Kuchler, 2006) 
  
gi|296337498|gb|EZ600683.1| 1.47 GJ13945 [Drosophila virilis] (4-nitrophenyl phosphatase) * 1 K01101 EC:3.1.3.41 (Bramkamp et al., 2004) 
  
gi|296339670|gb|EZ602855.1| -1.35 isoform b 3 
  
GO:0005316 
  
EUA37Q301DQW90 -1.38 peptidyl-prolyl cis-trans isomerase 10 7 K12734 EC:5.2.1.8 GO:0006810 
  
EUA37Q301BDW2J -1.65 high-affinity copper uptake protein * 3 K14686 
 
(Balamurugan & Schaffner, 2006) 
  
gi|296337397|gb|EZ600582.1| -4.84 alkaline phosphatase 5 K01077 EC:3.1.3.1 GO:0042045 
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Table S4: Randomly selected genes used in the RT-qPCR experiment to validate the microarray results. 
Sequence Name Sequence Description Symbol Primer sequence (5' to 3') 
Amlicon 
length (bp) 
E 
(%)
a
 
R²
,b
 
log ratio 
microarray 
log ratio 
RT-qPCR 
EUA37Q302I4V57 leucine rich repeat protein lrr-pr GTGACGATAGTGGGCAGGAT 83 106.5 0.992 -0.744 -0.505 
   GTTTTCGGGTGCCTATACCA      
gi|296336476|gb|EZ599661.1| mitogen-activated protein kinase mapk TCATAAATCGCAACGGTGAA 111 107.9 0.910 -0.515 -0.845 
   CGGGTGCCATATAGGGTTTA      
gi|296334792|gb|EZ597977.1| kda salivary protein sal-pr TGGCCTCTTTGGCTATTTTG 94 97.8 0.996 -0.914 -1.664 
   TGCTTTGGTTCTTGTTGCTG      
EUA37Q301BDW2J high-affinity copper uptake protein cup TTTGGGTGCTGGTATTGGTT 89 100.1 0.998 -0.721 -1.239 
   TTGCACATTGCTAGTGACAGTG      
EUA37Q301BGZ4G cytochrome p450-28a1 cytochr GCAGGCGTATTGTCACACAC 143 106.5 0.988 -0.901 -0.886 
   GCATCCAAATAGGGCAATTC      
gi|296344784|gb|EZ607969.1| cuticular protein 76bc cut-pr TGCCAGAATACGTCAAGTGC 137 97.9 0.999 3.068 2.661 
   AGGCTGGAAATCCTCCTGTT      
gi|296334791|gb|EZ597976.1| gtp-binding protein 1 gtp-bpr GTAGTGTCGGGCACCTGTCT 142 94.1 0.998 3.280 2.948 
   CGCCTCTTACCTCTTTCACG      
EOHUN8206DRP1R dgp- isoform b dgp-isoformb TTCGCCATGAGTTAAAACACC 149 92.7 0.999 3.722 2.946 
   GGCAACGTAAAGTTGAAAAAGG      
gi|296350384|gb|EZ613569.1| tnf receptor associated factor traf GGAATTGGTCTCACCACCAT 82 88.4 0.995 0.763 0.593 
   AGGACCATTGCCATTCAAAA      
gi|296343254|gb|EZ606439.1| secreted peptide sec-pep TCTAAGGACATTCCCCATCG 127 85.8 0.992 1.006 0.703 
   AAGCCCATTTGTGGAACAGA      
gi|296335934|gb|EZ599119.1| 
tubulin-specific chaperone b (tubulin folding 
cofactor b) 
tub-cha CAATTGATCCTGGCATGAGA 149 87.3 0.998 0.426 -0.027 
   ACCCATGCGATTCTTTTTCA      
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gi|296343036|gb|EZ606221.1| map kinase-activated protein kinase mapk-apk TCCACCGTTTTACAGCAACA 100 86.0 0.998 1.296 0.527 
   TCCATTCAGGATTGGGAAAA      
gi|296347908|gb|EZ611093.1| lysosomal aspartic protease la-prot CTACAGCAAAGCCAACACGA 85 91.5 0.999 0.801 -0.129 
   CCTTTGTGGATTTTGGGAGA      
gi|296341632|gb|EZ604817.1| isoleucyl trna synthetase isol-synt AGTCTTTGGGCCAACGTTTA 125 107.4 0.967 0.372 0.118 
   ATACGCTGGCCTTCAACTTC      
gi|296336117|gb|EZ599302.1| l-lactate dehydrogenase l-lact-dehydro CAAACGTGATTCACCCTCCT 127 97.4 0.999 1.937 1.952 
   GCAACACGGTTCCAATTTCT      
EUA37Q302GBMZS tyrosyl-trna synthetase tyr-synth TGTACTTCCAATGCGGATCA 85 90.9 0.997 0.934 0.570 
   CTTCGAAGGCTAAACGGCTA      
gi|296346813|gb|EZ609998.1|  isoform b isoformb ACGGGATGTTTCTCAAGTGG 137 92 0.984 2.894 2.753 
   CACCAGCAGCTTTTGCATTA      
EUA37Q302JMW6F odorant-binding protein 56a odorant CCTTGAAGGATGGCCAAGTA 132 93.9 0.999 1.528 2.409 
   AGCCAGTATCACAGCGTCCT      
EUA37Q301DOITT sulfate transporter sulfatetr CGCTTTAAGTCGTTGGTGCT 147 94.4 0.996 1.293 2.002 
   TAATAGCCGCCAATGTAGCC      
EUA37Q301AHLSE GK15652 [Drosophila willistoni] GK15652 TGACAACGATATTGCCATTG 122 97.8 0.98 2.832 2.790 
   ATCCGGTAACAGTGCCAGTC      
aMeasure of the real-time PCR reaction efficiency (calculated by the standard curve method) 
bReproducibility of the real-time PCR reaction 
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Table S5: Candidate reference genes for S. crassipalpis, of which the stability was analyzed with the geNormPLUS algorithm. 
Seq. Name Seq. Description Symbol Primer sequence (5' to 3') Amlicon length (bp) E (%)a R²,b 
       gi|296333647|gb|EZ596832.1| actin actin(1) GGTATGTGCAAGGCTGGTTT 107 102.6 0.998 
   TTTTGACCCATACCGACCAT    
       gi|296336747|gb|EZ599932.1| tubulin alpha chain tubulin (1) CAATTATGCTCGAGGCCATT 142 102.9 0.992 
   ACCACTTCCAGTTCCACCAC    
       gi|296336001|gb|EZ599186.1| glutathione-s-transferase gst GST TTGAGAAAACGAGCCGAAGT 114 110.4 0.990 
   GGAGCAATCAGTGGAACCAT    
       gi|296334900|gb|EZ598085.1| glyceraldehyde 3 phosphate dehydrogenase 2 GAPDH AGCAGGAGCCTGAGCATTTA 112 107.4 0.995 
   CCATGAGGTGGATTTTGCTT    
       gi|296334383|gb|EZ597568.1| ribosomal protein 49 RP49 CGCACAAATGGAGAAAACCT 104 112.4 0.987 
   GGTACGCTTGTTGGAACCAT    
       gi|296347152|gb|EZ610337.1| ribosomal protein l13 RPl13 GGAATTGAAGGGTGCTGGTA 106 102.1 0.993 
   GATATTGCGTTGACGGGATT    
»» gi|296337299|gb|EZ600484.1| ubiquitin-conjugating enzyme Ubq AAAATGGCGAATCAATCCAC 127 104.0 0.993 
   TGTCGTCGTCATTTTCAAGG    
       gi|296339815|gb|EZ603000.1| elongation factor isoform a EF CTCAAGCTGATTGTGCCGTA 121 94.7 0.993 
   TGTTTGACACCCAAGGTGAA    
»» gi|296334587|gb|EZ597772.1| eukaryotic translation initiation factor 1a EIF CAAGATTCAAAGGCCGATGT 124 99.9 0.984 
   AACCGTCTTCCACAAAGGTG    
       gi|296340585|gb|EZ603770.1| sodium potassium-dependent atpase beta-2 subunit NaK-ATPase(2) GTTTTCGCCCCATTAGTGAA 139 103.5 0.995 
   TTGCCACTGTGAGTGCTTTC    
aMeasure of the real-time PCR reaction efficiency (calculated by the standard curve method) 
bReproducibility of the real-time PCR reaction 
»»Reference genes used to normalize the results of the RT-qPCR experiment for microarray data validation. 
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A 
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Figure S1: A. Average expression stability of remaining reference targets (geNorm M-value < 0.5). The M-
value calculates the average for all pairwise variation values, so a lower value indicates increased gene 
stability across all tested genes. B. Determination of the optimal number of reference targets with 
geNormPLUS (geNorm V-value < 0.15). The V-value refers to the pairwise variation between reference 
targets that is reduced by the inclusion of additional reference genes and thus indicates the number of 
genes required to achieve an arbitrarily selected threshold of reference gene stability. Since every amount 
of reference genes that keep high stability stay below the threshold of 0.15, the minimum amount of 
reference genes can be selected (2 reference genes were chosen). 
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1. Introduction 
Once the complexity of animal venoms gained interest among scientists, venomics or the 
analysis of venom proteomes eventually received its proper attention. First studies on 
parasitoid venoms consisted out of bioassays trying to understand what parasitization was 
triggering in a host organism. Alterations in development, the immune reaction, the nutrient 
levels, in short the complete biochemical and physiological profile was explored. The logic 
next step was to find out what exactly in this venomous mixture was causing these effects, 
bringing research activities to a completely different level. Originally by HPLC fractionation, 
the venom compounds were separated from each other and bioassays were conducted 
(Moore et al., 2006;Rivers et al., 2006;Dani et al., 2003). The production of cDNA libraries 
made it possible to start identifying the structure of these proteins and looking for typical 
functional domains (Asgari et al., 2003;Crawford et al., 2008;Baek & Lee, 2010;Zhu et al., 
2010;Falabella et al., 2007;Price et al., 2009). But it took until mass spectrometry and 
genome characterizations were brought to life, before high-throughput venom compound 
screening really started to kick in.  
 
When conducting functional studies on parasitoid venom compounds, producing this 
compound by recombinant expression is one approach. Since HPLC fractionation mostly 
involve time-consuming dissections, the availability of the recombinant venom protein 
enormously broadens the possibilities in functional research. The mode of action of many 
venom proteins was revealed in this way, partly because they showed homology with other 
venom proteins or because they contained certain structural domains that hint at their 
possible function. If for instance, the venom compound shows sequence similarity with a 
known enzyme, specific assays can be performed with the recombinant protein to assess this 
potential enzyme activity (Falabella et al., 2007;Colinet et al., 2011;Zhu et al., 2008). If the 
venom protein contains similarities with proteins from the serpin family for instance (serine 
protease inhibitors), melanisation assays can be performed using the recombinant 
compound since these proteins are known to tightly regulate the phenoloxidase cascade 
(Zhang et al., 2004;Colinet et al., 2009). When the venom components show sequence 
similarity to known proteins, like the examples above, the proposed function can rather 
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quickly be verified when performing recombinant expression combined with focussed bio-
assays.  
 
Next to the approach of recombinant expression, a method to assess venom protein 
functionalities that is gaining interest the last few years, is RNA interference (RNAi) (Box 1) 
(Scott et al., 2013). This relatively new technique in insects makes use of the RNAi machinery 
that contributes to immunity against viruses with a double stranded RNA (dsRNA) genome or 
dsRNA replicative intermediates in the cytoplasm of infected cells (Blair, 2011). The 
accumulating body of literature on insect RNAi has revealed that the efficiency of RNAi 
varies between different species, the mode of RNAi delivery and the genes being targeted. 
Crucial in effective silencing, is the cellular uptake of the RNAi molecule and the transfer to 
other cells. If RNAi-mediated silencing is transmitted widely throughout the treated 
organism, RNAi is described as systemic, which seemed to be the case for dsRNA 
microinjection into several parasitoid wasps (Colinet et al., 2014;Burke et al., 2013;Bonvin et 
al., 2005). The most widely used routes for administering RNAi to insects are injection into 
the hemolymph and feeding.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Microinjection has been applied to all life stages in hemi- and holometabolous insects. In N. 
vitripennis, RNAi has been proven to be successful via microinjection into the larval and the 
pupal stage (Lynch & Desplan, 2006;Werren et al., 2009). Injecting N. vitripennis pupae with 
BOX 1: RNA interference  
RNAi is a post-transcriptional gene silencing mechanism conserved from plants to humans that relies on 
exogenous dsRNA delivery. When dsRNA enters the cell, it is cleaved by RNase III Dicer into 20-25 bp 
fragments. These fragments are incorporated into the multi-protein RNA-induced silencing complex (RISC), 
where one strand (the “passenger” strand) is eliminated and the other “guide” strand is retained. The 
catalytic component of RISC is an Argonaute protein, which cleaves single-stranded RNA molecules having 
sequence complementary to the guide RNA. Endogenous gene transcripts can be cut by Dicer into 20-25 
bp RNAs called microRNAs (miRNAs), which function in the regulation of gene expression. dsRNA 
molecules can also be cleaved by Dicer into small interfering RNAs (siRNAs), providing defense against 
viruses and transposable elements (Sidahmed et al., 2014). This siRNA pathway in which cells degrade a 
single-stranded RNA (ssRNA) (including mRNA) with sequence identity to the administered dsRNA 
molecules is exploited by the experimental RNA interference technique (Scott et al., 2013). 
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dsRNA and examining their progeny for developmental defects, called parental RNAi 
(pRNAi), was proven to be efficient in aiding the study of gene function during embryonic 
patterning (Zwier et al., 2012). However, when dsRNA is injected in a developmental stage of 
N. vitripennis before the third larval stage, developmental arrest was induced, possibly 
through induction of diapause by the stress of injection (Werren et al., 2009). Silencing the 
abundant venom compound LbGAP in the endoparasitoid wasp L. boulardi remained at least 
for 15 days after female emergence, suggesting that the knock-down of gene expression 
lasts the entire lifetime of the injected parasitoid females (Colinet et al., 2014). In that 
specific study, microinjection of dsRNA into the hemolymph of wasp larvae or pupae was 
shown to produce a long term and highly efficient silencing of gene expression in very 
different tissues. In addition, 2 bracovirus genes could be effectively knocked down by RNAi 
in Chelonus inanitus and M. demolitor (Burke et al., 2013). Coupling the RNAi method with 
functional bio-assays, gave insight into the role of these genes in viral replication. Using RNAi 
in N. vitripennis to elucidate the function of its venom compounds, would imply the knock 
down of this specific component in female wasps followed by specific assays on the host 
after parasitization by this wasp.  
 
When in 2010 the venom composition of N. vitripennis became available (de Graaf et al., 
2010), the major task remained to link these 79 proteins to their respective function. 
Interestingly, 23 of these venom proteins showed no similarities to any known protein, 
constituting an intruiging group of newly discovered venom compounds. Therefore, we 
started the quest of functionality with this challenging group of venom proteins. The two 
separate lines of approaches explained above were explored using the N. vitripennis - S. 
crassipalpis parasitoid – host system. Design of the two experimental procedures is outlined 
in figure 1. The possible employment of recombinant expression of N. vitripennis venom 
proteins in E. coli was first analysed by injecting the bacterial background (still present after 
His-tag purification) into the host. This was done to investigate possible host immune effects 
against these impurities and is described below. Additionaly, before applying the second 
approach that makes use of injecting dsRNA into the host, the exact timing of dsRNA 
injection into N. vitripennis pupae and the verification process of successful silencing was 
investigated, which is described below.  
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Figure 1: Overview of two approaches to investigate functionalities of venom proteins from N. vitripennis.  
 
2. Materials and methods  
2.1. Biological material 
N. vitripennis AsymC wasps were reared on pupae of the flesh fly, Sarcophaga crassipalpis, 
and maintained at 25°C with a daily 16:8 light:dark cycle (van den Assem & Jachmann, 1999). 
For the collection of 8 different developmental stages of N. vitripennis, 20 specimens per life 
stage were pooled, except for the eggs, where 50 specimens were harvested from the host.  
The N. vitripennis venom gland tissue preparation was done by dissecting the venom 
reservoirs and associated venom gland in insect saline solution (ISB) (150 mM NaCl, 10 mM 
KCl, 4 mM CaCl2, 2 mM MgCl2, 10 mM 2-[4-(2-hydroxyethyl) piperazin-1-yl] ethanesulfonic 
acid, pH7) and separating secretions from the tissues by rapid spinning. After removal of the 
supernatant, the pellet was resuspended in RNALater® (Ambion) for temporal storage.  
S. crassipalpis Macquart was maintained in the laboratory and cultured as described by 
Denlinger (Denlinger, 1972). Larvae were fed on beef liver at 25°C and exposed to a 16:8 
light:dark cycle.  
 
2.2. RNA extraction and cDNA conversion 
From the developmental stages of N. vitripennis, total RNA was isolated with TRIzol 
(Invitrogen) according to the manufacturer’s protocol. Isolated RNA was subsequently 
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reverse transcribed with the RevertAidTM H Minus First Strand cDNA Synthesis Kit using the 
oligo(dT)18 primer. In order to investigate possible splice variants of venom compounds, 
RNA from adult female N. vitripennis wasps, was also converted into cDNA using the 3’RACE 
Adapter primer (5'-GCGAGCACAGAATTAATACGACTCACTATAGGT12VN-3') from the 
FirstChoice® RLM Race Kit (Invitrogen, Ambion), synthesizing poly(A)-tailed RNA and adding 
an adapter sequence as anchor for primers used in PCR amplification.  
From venom gland tissues, RNA was extracted from the pellet (see 2.1. Biological material) 
using the RNeasy Mini Kit (Qiagen). First-strand cDNA was synthesized using the RevertAid™ 
H Minus First Strand cDNA synthesis kit (Fermentas) using the oligo(dT)18 primer.  
From the single female wasp abdomens, total RNA was isolated with TRIzol. Due to the hard 
exoskeleton, the Precellys®24 Homogenizer (Bertin Technologies, Montigny le Bretonneux, 
France) was used after adding one stainless steel bead (2,3 mm mean diameter) and ¼ of a 
PCR tube of zirconia/silica beads (0,1 mm mean diameter) to an individual abdomen. Further 
extraction was performed according to the manufacturer’s protocol. First-strand cDNA was 
synthesized with the RevertAid™ H Minus First Strand cDNA synthesis kit (Fermentas) using a 
mix of one part oligo(dT)18 primer and six parts random hexamer primer.  
RNA extraction from flesh fly pupae was performed using the RNeasy Mini Kit (Qiagen). 
Tissues were disrupted and homogenized by adding one stainless steel bead, ¼ of a PCR tube 
of zirconia/silica beads and 1 ml Qiazol Lysis Reagent and using the Precellys®24 
Homogenizer (Bertin Technologies, Montigny le Bretonneux, France). An on-column DNase I 
treatment with the RNase-free DNase set (Qiagen) was performed. RNA was eluted twice, 
first with 30 µl RNase free water, then with 20 µl RNase free water, and stored at -80 °C. Five 
µg of total RNA from each sample was converted to cDNA using oligo(dT)18 primer and was 
carried out according to the RevertAidTM H Minus First strand cDNA Synthesis kit protocol. 
 
2.3. Primer design and PCR 
For amplification of transcripts that correspond with the complete coding sequence (CDS) of 
predicted genes from N. vitripennis, primers were developed at the extreme ends with a 
melting temperature of approximately 60°C. The different primer sets are listed in Table S1. 
For amplification of transcripts from the cDNA with the adapter sequence at the poly(A)tail, 
the 3’RACE outer primer (5'-GCGAGCACAGAATTAATACGACT-3') was used in combination 
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with the CDS forward primer. The 3’RACE outer primer is complementary to the anchored 
adapter and ensures, together with the CDS forward primer, amplification of the possible 
splice variants that have been spliced at the 3’ end.  
PCR reactions were carried out in the Eppendorf Mastercycler®. Following an initial step at 
95°C for 15 minutes, the reaction mixtures were subjected to 35 cycles consisting of 
denaturation at 93°C for 1 minute, primer annealing at 55°C for 30 seconds, and DNA 
extension of 2 minutes at 72°C. The reaction was completed by a final extension step at 72°C 
for 10 minutes. 
 
2.4. Recombinant expression 
Plasmids containing the pET100/D-TOPO vector (without insert) were transformed in E. coli 
BL21 star (DE3). Bacteria were grown in 100 ml Luria Bertani (LB) broth medium at 37°C to 
an optical density of 0.5 at 600 nm. Subsequently, isopropyl-1-thio-β-D-galactopyranoside 
(IPTG) was added to a final concentration of 1 mM, and incubation was continued for 
4 hours. Cells were harvested and resuspended in 8 ml lysis buffer (6 M guanidine HCl, 
20 mM sodium phosphate, 500 mM NaCl, pH 7.8). After 10 minutes incubation at room 
temperature, the cell lysate was sonicated on ice with three five-second pulses at high 
intensity and centrifuged. The supernatant was loaded on Profinity IMAC Ni-Charged Resin 
(Bio-Rad) that was equilibrated with binding buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole, pH 8). The column was washed with washing buffer (50 mM NaH2PO4, 300 mM 
NaCl, 20 mM imidazole, pH 8) and eluted in elution buffer (50 mM NaH2PO4, 300 mM NaCl, 
250 mM imidazole, pH 8) in eight steps of 1 ml each. Fractions with recombinant protein are 
pooled and buffer exchange was performed from elution buffer to ISB by using the 
SnakeSkin™ Pleated Dialysis Tubing (Pierce).  
 
2.5. Injection of S. crassipalpis pupae 
The puparium was removed from the posterior end of the pupa. Several minutes before 
injection, the cuticle was pricked with a sterile insect pin and a small droplet of hemolymph 
was removed with a piece of absorbent filter paper. Otherwise, the turgor of the pupae 
would prevent the injection of more fluid into the body. Injections were performed into the 
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last abdominal segments by using a 10 ml Hamilton microsyringe. The injected volume was 
1.5 µl solution per pupa. 
 
2.6. Reference gene selection, primer design and RT-qPCR 
Candidate reference genes for N. vitripennis were chosen due to their stable expression in 
other studies (Cheng et al., 2013a;Sun et al., 2010). Primer sets for the novel venom proteins 
(table S2) and the candidate reference genes (table S3) were developed to contain at least 
one exon-exon spanning primer and to produce products with size-ranges of 80-120 base 
pairs using PerlPrimer (Marshall, 2004). Similarly, primer sets were also developed for 6 
immune genes in S. crassipalpis (table S4). RT-qPCR was executed as described in chapter 3. 
Each sample was run in triplicate.  
 
2.7. Computational selection of reference and test genes 
Primer efficiencies, R² values and melt curves were calculated with CFX Manager Software 
(Bio-Rad). Reference gene stability was analyzed using the geNormPLUS algorithm within the 
qBasePLUS environment (Biogazelle NV). Default settings were kept, except that target 
specific amplification efficiencies were used. RT-qPCR data was evaluated using analysis of 
variance, ANOVA followed by Dunn’s or Bonferroni posthoc test. P-value 0.05 was 
considered statistically significant. All statistical analyses were performed with Prism 5.0 
(GraphPad Software, Inc., La Jolla, CA). 
 
3. Results and Discussion 
3.1. Injection of recombinant venom compounds into the host 
The first approach to investigate the function of N. vitripennis venom proteins was the 
injection of recombinant expressed protein into the host. Since the large amount of 23 novel 
venom proteins caught our interest, we needed an expression system that is high-
throughput. The bacterial expression in E. coli meets these requirements, but bacteria have 
the disadvantage to lack the enzymatic machinery to perform complex post-translational 
modifications like glycosylations. First characterization of N. vitripennis venom with infrared 
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spectroscopy revealed that proteins are unglycosylated (Rivers et al., 2006). This is a quite 
uncommon feature for parasitoid venoms, but a feature shared with P. turionella (Uckan et 
al., 2004) and many social hymenopterans (Leluk et al., 1989). Next to this, the presence of 
several carbohydrates, including polysaccharides, mucopolysaccharides, glycoproteins and 
glycolipids, was also investigated in the Laboratory of Molecular Entomology and Bee 
Pathology. Periodic acid Schiff (PAS) staining of dissected N. vitripennis venom resulted in 
confirmative evidence that N. vitripennis venom lacks carbohydrates (data not presented).  
 
Once the venom proteins are overexpressed in E. coli, they can be purified over a column 
with Ni-Charged Resin due to the N-terminal His-tag. This purification procedure does not 
completely eliminate all bacterial fragments present in the protein elution solution. Since it 
is our goal to investigate the effect of the (recombinant) venom protein on the 
developmental and immune systems of the host, the effects caused by these background 
fragments must be kept to a minimum. To investigate possible side effects, plasmids cloned 
with the pET100/D-TOPO vector without an inserted fragment were transformed into E. coli 
BL21 bacteria. After induction with IPTG, cell lysates were sonicated and transferred to a Ni-
Charged Resin column. The buffer of the purified E. coli lysates was exchanged to ISB via 
overnight dialysis. S. crassipalpis pupae, 5 days post-pupation, were either injected with ISB 
or with the purified E. coli lysate. Not injected pupae served as control group. Viability was 
measured on 40 pupae per group which resulted in 100% for the control group, 93% for the 
ISB injected group and 75% for the purified E. coli lysate injected group. This decline in 
survival rate already indicated that the pupae suffered more from the injection with the 
purified E. coli lysate than with the ISB solution. RNA was extracted and converted into cDNA 
from 3 individual pupae per group. RT-qPCR was performed on 6 immune genes of 
Sarcophaga that are known to participate in immune processes: sapecin (AMP defensin 
homologue from D. melanogaster), sarcotoxin I, (AMP cecropin homologue), sarcotoxin IIA 
(AMP attacinB homologue), dopa decarboxylase (melanisation pathway), dorsal (Toll 
pathway) and relish (Imd pathway) (Natori, 2010). Ten candidate reference genes (see 
chapter 3) were tested for their stable expression levels across all conditions (not injected, 
ISB injected and purified E.coli lysate injected pupae) with geNorm, resulting in two selected 
reference genes; EIF or eukaryotic translation initiation factor 1 and Ubq or ubiquitin 
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conjugating enzyme. Ct-values from the 6 tested immune genes of ISB injected pupae and 
not injected pupae were normalized and fold changes were calculated (figure 2A).  
 
 
Figure 2: Normalized fold change of 6 immune genes in S. crassipalpis pupae. A. ISB injected pupae versus 
not injected pupae. B. Purified E. coli lysate injected pupae versus ISB injected pupae. White bars 
represent relative mRNA expression levels 3 hours post-injection, black bars 25 hours post-injection. Ubq 
and EIF were used to normalize the data. The data are expressed as the mean ± SD of three biological 
replicates. Statistical analysis on ISB injected compared to not injected (A), and on purified E. coli lysate 
injected compared to ISB injected (B), ** p 0.01, *** p 0.001, **** p 0.0001, ANOVA with Bonferroni 
posthoc test. 
 
The injection of the saline solution showed an 8-fold increase in mRNA expression of the 
antimicrobial peptides sarcotoxin IIA and sarcotoxin I, 3 hours after the injection. These two 
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AMPs target Gram-negative bacteria and play a major role in the innate immunity (Natori, 
2010). Their homologues in D. melanogaster, cecropin and attacin respectively, are very 
effective against Gram-negative bacteria, where attacin also targets fungi and Gram-positive 
bacteria (Lemaitre & Hoffmann, 2007). Sterile wounding and the injection of a saline solution 
in Drosophila cause melanotic spots at the site of the lesion shortly after the injection and 
trigger lamellocyte development as part of the cellular immunity (Markus et al., 2005). Next 
to this, the mRNA level of the antimicrobial peptide drosomycin is up regulated after sterile 
wounding of Drosophila embryo’s (Stramer et al., 2008).  
 
The wounding of the S. crassipalpis pupae in the current experiment by a needle and the 
injection of ISB, without the presence of bacteria, already induces the expression of 
antimicrobial peptides. Twenty-five hours after the ISB injection, dopa decarboxylase (DDC) 
transcripts showed a 16-fold increase compared to not injected pupae. DDC converts dopa 
into dopamine, which is further metabolized to produce melanin and sclerotin in epidermal 
tissues. Needle injury to Drosophila larvae or adults induces a melanisation reaction at the 
wounding site, caused by de novo synthesis of melanin by phenoloxidase (PO) (Binggeli et 
al., 2014). This enzyme catalyses the tyrosine to dopa conversion, that in turn, can be 
converted to dopamine by DDC, eventually leading to melanin production. The elevation of 
DDC in ISB injected S. crassipalpis can therefore be expected as sclerotisation spots were 
detected at the injection site of these pupae. These results indicate that the ISB injected 
pupae must be used as negative control for recombinant protein injections, since wounding 
and the injection of a ‘harmless’ saline solution already is a minimal and sufficient trigger for 
a humoral immune response in S. crassipalpis pupae. 
 
When comparing expression levels of the same 6 genes from pupae injected with the 
purified E. coli lysate with pupae injected with ISB, a stimulation of the immune system can 
be noted 3 hours after injection (figure 2B). These changes cannot be attributed to wounding 
by needle insertion since the ISB injected pupae served as control group. Two AMPs, 
sarcotoxin I and sarcotoxin IIA, were triggered by the purified E. coli lysate. Since both AMPs 
are known to play a role in immunity against Gram-negative bacteria, we can conclude that 
probably still fragments of E. coli are present in the purified sample, resulting in the 
production of these AMPs in the injected pupae. DDC was also strongly up-regulated 3 hours 
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after injection. Because in Drosophila the melanisation cascade cooperates with the Toll 
pathway in promoting host defence, there is a possibility that the DDC expression is linked to 
the up-regulation of sarcotoxin I and IIA, explaining its induction 3 hours post-injection.  
Only by looking at 6 important immune related genes, a significant effect of injecting the E. 
coli background solution into the S. crassipalpis pupae could be noted on the immune 
system. From chapter 3, we know that alterations in host immunity can be quit subtle and 
do not always involve large up or down regulations in mRNA expression levels. This means 
that when the recombinant protein still contains traces of bacterial fragments and in this 
way already causes a boost of immune processes in the flesh fly pupa, the potential changes 
caused by the recombinant protein will be overshadowed. To proceed with this approach, 
other purification steps need to be applied, suggested in the section ‘Conclusions’. Since 
recombinant expression was already successfully performed for 10 out of the 23 novel 
venom proteins (data not presented), extra purification would be the logic next step. Next to 
this method to investigate functionalities of the venom proteins, a different approach was 
explored, described below. 
 
3.2. Silencing of venom compound in N. vitripennis pupae 
Instead of directly looking for effects in the host caused by an injected venom protein, the 
effect of normal parasitization but by a parasitoid lacking one (or more) compounds can also 
be a way to tackle functionality studies. This approach, by silencing a venom component in 
N. vitripennis and letting it parasitize its host, has the advantage that no large needles need 
to be inserted into the host, already causing an immune boost. In this way, the parasitization 
process can be kept as natural as possible, which was also the intention in the microarray 
experiment (see chapter 3). For this reason, silencing a venom protein in N. vitripennis is 
another way to explore its functionality. Of the 80 venom proteins discovered, no less than 
23 venom proteins were found to have no similarity with any other protein. The complete 
lack of knowledge on the functionalities of this group of venom compounds had drawn our 
attention. But investigating the functions of 23 venom proteins seems an enormous task, 
therefore we started by optimizing the experiment with 2 of them. Instead of randomly 
pinning the tail on the donkey, we pinpointed 2 venom compounds purely by practical 
considerations, explained below. 
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3.2.1. Selection of venom compound 
Since the protocol for pupal injection of dsRNA in N. vitripennis is well-documented, we 
decided to perform the silencing of venom compounds in the pupal life stage. In order to be 
successful, the mRNA expression of this specific venom compound may only be initiated 
after this developmental stage, more specifically the yellow pupa-stage. Otherwise, the 
mRNA that is already present before the silencing could give rise to the corresponding 
venom proteins through translation, making the following silencing ineffective. The 
expression profile of the 23 novel venom compounds was determined in 8 different N. 
vitripennis developmental stages via RT-qPCR, more specifically egg, white larva, brown 
larva, white pupa, yellow pupa, red-eyed pupa, black & white pupa, black pupa and adult. 
Ten candidate reference genes were tested for their stable expression level across all 
developmental stages with geNorm, resulting in the mean of 2 stable reference genes, 60S 
ribosomal protein L13a-like and elongation factor 1α, as optimal normalization factor. mRNA 
expression levels were extrapolated into percentages, presenting 12 out of the 23 venom 
compounds that showed nearly complete mRNA expression (> 90%) during the adult stage 
(table 1).  
 
The mRNA sequences of the 12 remaining venom compounds were individually blasted 
against the nucleotide database of N. vitripennis to check for sequence specificity. If the 
sequence of one gene shows overlap with sequences of other genes, the specificity of all 
produced siRNAs cannot be guaranteed. Sequences of venom proteins P, V and Z showed 
coverage with sequences from other genes, making them less suited for RNAi (table 2).  
 
If several splice variants of a venom compound would be present in the venom reservoir, 
possibility exists that not al variants are successfully silenced by RNAi, still giving rise to 
functional venom compounds. Therefore, potential splice variants of the remaining 9 venom 
proteins in N. vitripennis female wasps was investigated. Therefore, extracted RNA from 
adult N. vitripennis females was converted into cDNA using a 3’RACE adapter that anneals to 
poly(A)tails. When using a gene-specific forward primer in combination with the 3’RACE 
adapter reverse primer, possible splice variants that mostly occur at the 3’ region are picked 
up by PCR (figure 3). Next to this, PCR was also performed on cDNA from venom glands with 
CDS primers constructed on the coding sequence of the predicted sequences. 
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Table 1: Percentages of relative mRNA expression levels of 23 novel venom compounds throughout N. 
vitripennis developmental stages (for egg stadium n=50, for other life stages n=20) (sum of percentages 
from all life stages equals 100%). The venom compounds that show more than 90% expression level in the 
adult stage are marked in grey.  
venom 
compound 
Relative mRNA expression level (%) 
egg 
white 
larva 
brown 
larva 
white 
pupa 
yellow 
pupa 
red-eyed 
pupa 
salt & 
pepper 
pupa 
black 
pupa 
adult 
VPD 1,10 0,73 1,38 9,78 13,94 4,76 6,97 5,53 55,81 
VPE 6,91 9,13 27,63 0,12 0,11 0,12 0,24 0,43 55,31 
VPF 1,84 1,86 3,67 16,36 14,69 14,28 29,39 14,35 3,56 
VPG 0,00 0,00 0,00 0,00 0,00 0,00 0,01 0,00 99,98 
VPH 0,00 0,00 0,00 0,01 0,01 0,01 0,02 0,02 99,93 
VPI 0,04 0,32 0,31 0,01 0,04 0,01 0,04 0,01 99,22 
VPJ 1,75 0,16 0,31 3,47 6,23 4,38 3,12 1,39 79,20 
VPK 0,01 0,00 0,02 1,55 1,41 1,27 0,74 0,15 94,84 
VPL 0,01 0,00 0,00 0,11 0,02 0,01 0,01 0,02 99,82 
VPM 0,07 5,55 84,73 2,95 2,65 0,72 0,66 0,26 2,41 
VPN 2,45 0,30 0,49 4,33 3,89 3,34 4,90 1,82 78,47 
VPO 2,68 2,97 8,76 5,01 4,50 2,46 9,00 28,58 36,04 
VPP 0,21 0,43 0,10 0,23 0,20 0,22 0,42 1,64 96,55 
VPQ 0,02 0,07 0,39 0,00 0,00 0,00 0,00 0,01 99,52 
VPR 1,17 7,64 46,23 8,11 2,89 1,56 8,26 18,35 5,78 
VPS 0,68 9,87 86,49 0,07 0,07 0,05 0,04 0,03 2,70 
VPT 0,01 0,01 1,30 0,72 0,41 0,42 0,65 13,11 83,36 
VPU 0,47 0,20 0,38 1,67 0,47 0,41 0,13 0,09 96,18 
VPV 0,00 0,00 0,04 0,00 0,03 0,00 0,00 0,01 99,91 
VPW 2,70 1,25 0,95 8,16 12,02 16,41 7,57 2,80 48,13 
VPX 0,04 0,02 0,04 0,43 0,16 0,17 0,19 0,31 98,64 
VPY 0,01 0,00 0,00 0,01 0,00 0,00 0,00 0,01 99,95 
VPZ 0,00 0,00 0,04 0,01 0,00 0,00 0,00 0,00 99,95 
 
Table 2: Venom compounds that show sequence coverage with other N. vitripennis genes. Percentage 
over sequence coverage is presented, together with the percentage of similarity of the covering sequence 
(Identity). Last column presents the accession number of the gene that shows sequence coverage with the 
venom protein.  
Venom 
compound 
Sequence coverage Identity Description of covering gene 
Accession 
Number 
VPP 14% 100% tubulin alpha-1 chain-like XM_001606820 
VPV 93% 82% venom protein Z NM_001161697.1 
VPV 77% 79% 
polyamine-modulated factor 1-binding  
protein 1-like 
XM_003425717.2 
VPZ 98% 82% venom protein V NM_001161569.1 
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Venom proteins H and U did not show any band when CDS primers were used, meaning that 
the 3’ sequence anchoring the CDS reverse primer is different than what was predicted. 
Therefore, 3’RACE would need to be performed in order to gain their full sequence. Venom 
proteins G, I, L, Q and Y showed several splice variants. Venom protein K also shows one 
band around 700 base pairs, which is exactly double the size of the band around 350 base 
pairs. Sequencing data confirmed that this band represents a dimer of the VPK gene, and 
therefore will not pose a problem for silencing. This drop out race finally resulted in 2 venom 
proteins, VPK and VPX, that present good candidates for functionality research by gene 
silencing.  
 
 
Figure 3: Splice variants of 9 novel venom proteins. ‘CDS’ represents transcripts of PCR performed with 
coding sequence primers of the predicted sequences, ‘SV ‘represents transcripts of PCR performed with 
the coding sequence forward primer combined with the 3’-RACE primer on cDNA with the adapter 
attached to the poly(A)tail. White arrows show splice variants for the respective venom protein.  
 
3.2.2. Experimental setting 
N. vitripennis adults, immediately after host emergence, were placed individually in an egg-
laying chamber (figure 4A). In this system, only the posterior region of the host pupa is 
accessible for the N. vitripennis female to parasitize, since venom injection in this side causes 
the best survival rate for the parasitoid offspring (Rivers & Denlinger, 1995). At specific time 
points (figure 4B) a flesh fly host, 5 days after pupation, is placed in the chamber so that the 
female wasp can inject venom and eggs into the host. In order to correlate the results of this 
experiment with the differentially expressed EST data from the microarray (see chapter 3) 
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the same experimental conditions were chosen. This means that only a 2 hour time frame 
was allowed for parasitization (except the first host, since it had solely feeding purposes). 
Twenty-four hours thereafter, the hosts were snap-frozen and stored in -80°C. The first hosts 
served as training, so that effective parasitization can be guaranteed in the final host during 
this short time frame. Since performing RT-qPCR on the dissected venom reservoir of a 
single N. vitripennis female is too time-consuming for the complete experiment, the 
abdomens of single parasitoids were snap-frozen and used for RNA extraction.  
 
A. 
 
B.         
  
 
NV host 
day 0 morning emergence   
  afternoon     
  night   overnight host feeding 
day 1 morning     
  afternoon   2h parasitization 
 
night 
 
 
day 2 morning    
  afternoon   2h parasitization 
  night     
day 3 morning     
  afternoon   2h parasitization 
  evening freezing   
 
Figure 4: A. Schematic representation of an egg-laying chamber in which only the posterior part of the 
host is accessible for the parasitoid. A filter tip is on the bottom and an eppendorf tube with the bottom 
cut off is placed on top. The flesh fly pupa is placed with its posterior end downwards and a single N. 
vitrpennis female is placed in the filter tip. B. Time schedule of the parasitization experiment. In light grey, 
the life span of the parasitoid is represented, in dark grey the placement of a host in the egg-laying 
chamber. 24 hours after the parasitization process, these hosts are snap-frozen and stored in -80°C.  
 
Before starting the dsRNA injections, the practical setup was first put to the test by the 
control group of parasitoids that were not injected. Twenty N. vitripennis females, directly 
after emergence, were given hosts in the time-frame mentioned above (figure 4B). At the 
end of day 3, their abdomens were cut off and frozen. RNA was extracted and converted into 
cDNA. The expression profile of 5 venom compounds were determined via RT-qPCR: VPK, 
VPX and 3 other venom compounds that are expected to be abundantly present in the 
venom (aminotransferase-like venom protein 1 (aminoVP1), γ-glutamyl transpeptidase-like 
venom protein (glutVP1) and laccase). Again, the 10 candidate reference genes for N. 
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vitripennis (table S3) were tested for their stable expression level with geNorm. This resulted 
in the use of the geometrical mean of 2 reference genes, 60S ribosomal protein L13α-like 
(RPL13a) and eukaryotic translation initiation factor 1α (EF1a), as optimal normalization 
factor. The normalized relative mRNA expression levels of these 5 venom compounds for 18 
single N. vitripennis females are presented in table 3.  
 
Table 3: Normalized mRNA expression levels of 5 venom compounds for 18 not injected female N. 
vitripennis female wasps after several parasitizations on flesh fly hosts. For every venom compound, the 5 
highest mRNA levels are marked in orange, the 5 lowest in green. (NV = Nasonia vitripennis) 
NV female VPK VPX aminoVP1 glutVP1 laccase 
1 0.021 0.043 0.101 0.015 0.113 
2 0.485 0.506 0.772 0.319 0.012 
3 0.009 0.021 0.134 0.016 0.499 
4 0.043 0.097 0.460 0.091 0.169 
5 2.180 1.858 3.298 3.057 2.790 
6 1.610 2.198 3.750 4.258 4.258 
7 3.566 1.841 2.854 2.127 1.461 
8 0.112 0.129 0.648 0.252 0.327 
9 2.056 1.832 2.170 2.010 1.481 
10 0.674 0.785 0.558 0.352 0.627 
11 0.403 0.222 0.852 0.366 0.331 
12 2.949 2.949 1.362 2.033 0.529 
13 0.014 0.055 0.259 0.035 0.093 
14 0.006 0.012 0.085 0.011 0.003 
15 0.016 0.047 0.237 0.037 0.013 
16 0.049 0.153 0.724 0.101 0.298 
17 0.010 0.013 0.120 0.008 0.012 
18 0.005 0.019 0.057 0.014 0.073 
 
Large fluctuations in expression levels can be observed for the different samples for all 5 
venom compounds. When the 5 highest (in orange in table 3) and the 5 lowest (in green in 
table 3) expression levels are marked, it is remarkable that a parasitoid has either low or 
high expression levels for all 5 tested venom compounds. Possibly, the amount of mRNA of 
venom compounds present in the parasitoid is linked with the amount of venom present in 
the venom reservoir. If we assume that a low mRNA level implies low amount of venom 
present in the reservoir, these females have injected their venom and have parasitized a 
host. Accordingly, high mRNA levels either imply that no parasitisation occurred or that new 
transcription of venom compounds has been performed after parasitization. Therefore, 
monitoring the reduction of transcript level after RNAi by RT-qPCR does not guarantee 
successful knock-down, since this N. vitripennis female can simply have an empty venom 
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reservoir due to successful parasitization. Snake venom revealed a clear dynamic in gene 
expression of newly synthesized venom compounds following venom depletion (Currier et 
al., 2012). Since this occurs very rapidly, venomous snakes retain the ability to efficiently 
predate and remain defended from predators. In parasitoids, only the time-related 
expression of the venom protein acid phosphatase has been investigated by RT-PCR for the 
endoparasitoid wasp Pteromalus puparum (Zhu et al., 2008). They showed expression of acid 
phosphatase immediately after emergence, but with low abundance. At 2 to 4 days, the 
transcript level increased and dropped after 4 days, but was still detectable with low 
abundance at 7 days. However, the expression level of parasitoid venom transcripts after 
replenishment of the venom reservoir is not known. Therefore, we investigated whether a 
similar dynamics of venom gene expression as seen in snakes, can be detected for venom 
proteins in N. vitripennis. Female N. vitripennis wasps were fed with sugar water until 6 days 
after emergence from the host. RNA was extracted from the abdomens of single wasps, 
converted into cDNA and RT-qPCR was performed (3 biological replicates and 3 technical 
replicates) for the same 5 venom components used in table 3. Since all 5 venom constituents 
showed a similar expression pattern, only the graph for aminoVP1 is presented (figure 5). 
Black bars show that gene expression peaks at 2 days after emergence and decrease after 
day 4, similarly as in P. puparum. A group of wasps that had been feeding on sugar water for 
2 days, received a host (1 host per wasp in egg-laying chamber) at day 3 for the duration of 8 
hours to parasitize. The following 3 days, they only received sugar water. The presence of 
wasp eggs was verified in the hosts in order to guarantee successful parasitization. The 
dotted line in figure 5 represents the moment of parasitization on the host. After that, the 
white bars show the expression of aminoVP1 in the following days (at day 3, sampling 
occurred immediately after the removal of the host), while the black bars represent pupae 
that were only fed with sugar. The instantaneous decrease in gene expression and the 
duration until at least 3 days after parasitization, shows that replenishment of the venom 
reservoir during parasitization enforces new transcription and translation of venom proteins.  
 
Due to the relatively short parasitization periods used (figure 4), successful venom injection 
cannot be guaranteed at the end of this specific setup. The host that was presented to the 
wasps at day 1 hardly could have been successfully parasitized, since the venom compounds 
are only maximally transcribed 2 days after emergence. Female wasps with numbers 5, 6, 7, 
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9 and 12 that show high gene expression levels for at least 4 out of 5 tested venom 
compounds (see table 3), probably did not inject their entire venom stock into the hosts or 
did not parasitize the host at all and only ate on it. Wasps with the numbers 3, 14, 17 and 18 
that show the lowest gene expression levels successfully parasitized at least one of the 
offered hosts, assuming that the low transcript levels correlate with low protein levels. The 
latter should, however, be verified by SDS-PAGE. 
 
 
Figure 5: Expression of aminoVP1 tested by RT-qPCR, normalized with ETIF and RPL13a. The average of 3 
biological replicates and 3 technical replicates is presented ± SD. Dotted line marks the moment of host 
feeding. This graph is representative for transcription of VPK, VPX, glutVP1 and laccase.  
 
Large fluctuations in expression levels of venom compounds in the control group implies 
that the experimental setting for silencing needs to be altered. Unless gene transcription of 
venom compounds elevates again after parasitization (at least later than 6 days post 
emergence), successful silencing of venom compounds cannot be verified by RT-qPCR, since 
the control group will also show low expression levels due to emptying the venom reservoir 
during parasitization. When however, 100% successful silencing of venom compounds can 
be obtained, the control group of not injected wasps can be omitted. Unfortunately, due to 
shortness of time, the optimization of the RNAi experiment could not be performed before 
submitting the thesis.  
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4. Conclusion 
The discovery of 23 completely novel venom proteins impelled us to explore the 
functionalities of this large group of components. Two different approaches were handled. 
First, recombinant expression of venom proteins in E. coli bacteria followed by host injection 
was assessed. The standard on-column purification with Profinity IMAC Ni-Charged Resin 
and subsequent buffer exchange was suggested. As a control, the empty vector was 
expressed in E. coli and purification was performed on the bacteria lysate. This sample was 
injected in S. crassipalpis pupae and RT-qPCR was performed on several immune genes in 
order to test the effect of this E. coli background sample on the host immunity. This resulted 
in significant up-regulation of half of the tested immune genes, which can overshadow 
possible effects of recombinant expressed venom proteins on the host immune system. 
Therefore, other or extra purification steps could be included to remove all bacterial rest 
fragments and obtain a sample with recombinant protein of extreme purity. A commonly 
used protocol for purification of novel protein samples is the combination of ion exchange 
chromatography to capture the protein, hydrophobic interaction chromatography as an 
intermediate purification, followed by gel filtration to polish the purified product 
(Recombinant Protein Purification Handbook, GE Healthcare).  
Another practical adjustment to this experiment would be the use of automated injection 
equipment instead of Hamilton syringes. The Femtojet (Eppendorf), that is used for the 
injection of dsRNA in order to silence venom compounds in female N. vitripennis wasps, are 
used in combination with Femtotips that have a 0.7 μm outer diameter. The Hamilton 
needles, recommended for animal injections, are 0.16 mm in outer diameter, meaning that 
they can harm the delicate pupae much easier than the Femtotips. The use of the 
automated injection equipment could result in less melanisation spots appearing at the 
injection site, reducing the highly up-regulated expression of DDC after the injection of saline 
solution.  
On the other hand, another expression system also belongs to the possibilities. For instance, 
other insect venom proteins have been successfully expressed by recombinant baculovirus 
infection in insect cells (e.g. Sf9 cells) (Seismann et al., 2010;Van Vaerenbergh et al., 2013). 
Even though venom proteins in N. vitripennis have been shown to be unglycosylated, insect 
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cells can perform other post-translational modifications, which is lacking in the bacterial 
expression system.  
 
The second approach used to explore the functionalities of N. vitripennis venom proteins, 
consisted out of silencing the compound in the female wasp by RNAi followed by bioassays 
on parasitized hosts. By performing the preliminary experiments described in Results and 
Discussion, several focus points still need to be addressed. Apparently, the developmental 
stage of N. vitripennis for injection of the dsRNA is crucial for successful silencing of the 
targeted gene. When injecting dsRNA in the yellow pupal stage of N. vitripennis for a target 
component that is only expressed 2 days after emergence, the gap of 5 to 6 days may cause 
the injected dsRNA to be broken down until transcripts of the target gene appear. Therefore, 
for each venom compound individually, the exact timing of dsRNA injection needs to be 
defined, since their expression differs among each other. Larval RNAi in N. vitripennis has 
already been described (Werren et al., 2009) and in the Centre for Ecological and 
Evolutionary Genetics in Groningen, embryonic injections are in trial. In an attempt to assess 
the amount of venom transcripts in the female wasp after parasitization, it became clear 
that replenishment of the venom reservoir also involves new transcription of the venom 
compounds next to translation in order to refill the reservoir. When 100% successful 
silencing can be guaranteed, there is no longer need to control the effectiveness of the 
injected dsRNA. Then, successful parasitization by the silenced wasp, however, needs to be 
verified which can be done by opening the puparium of the host and scavenging for N. 
vitripennis eggs. Preliminary experiments for silencing venom compounds have now been 
performed and the adjusted practical setting can be put to the test. The technique of 
injecting dsRNA into the pupal stage of N. vitripennis was acquired during a 4-week 
internship at the Centre for Ecological and Evolutionary Genetics in Groningen and can 
therefore, readily be applied at the Laboratory of Molecular Entomology and Bee Pathology 
in Ghent.  
 
Both approaches had some road blocks along the way and due to shortness of time, they 
could not be solved by the end of this dissertation. Several solutions have been suggested 
and both recombinant expression as well as silencing of N. vitripennis venom compounds 
still belong to the possibilities of investigating their functionalities.  
Exploring functionalities of novel venom compounds 
102 
5. Supplementary materials 
Table S1: Primer sets developed to amplify transcripts by PCR that contain the coding sequence of the 
corresponding venom proteins in N. vitripennis. (VP = venom protein) 
Gene Primer sequence Amplicon length 
VPG_CDS 5'-GAATTGACCGAGGAAGACGG-3' 243 
 
5'-TTAATTCTTCTGGTTCTCGGC-3' 
 VPH_CDS 5'-GAACCTTCGCTTGAATCGCA-3' 252 
 
5'-TTAAGTTAATTTAACTCCTTGAGT-3' 
 VPI_CDS 5'-ATGTACCTAACTCCTCTGTGT-3' 189 
 
5'-TTAGCCAACAGCATTGTAAAAAG-3' 
 VPK_CDS 5'-CAAGAGATTAAATTTACAGATGAG-3' 282 
 
5'-TTATTGATCATCGTTCGAATCG-3' 
 VPL_CDS 5'-CAAGACATAGAAGATGACGAC-3' 288 
 
5'-TTAAGCTGCGGAACCGTGTT-3' 
 VPQ_CDS 5'-AAACCAACGGCAGATGTTGAG-3' 441 
 
5'-TCACAGCTGCTTCTGTTGTTC-3' 
 VPU_CDS 5'-ATGAAACTAATATTCACAACTCTA-3' 621 
 
5'-TTAAGCTTCCAAACAAGCCTTT-3' 
 VPX_CDS 5'-CAAGTTTATAATTTTTTGCG-3' 334 
 
5'-TTAATTCTCGGAGGACTTGATG-3' 
 VPY_CDS 5'-ATGAAAGCCTTTACCGTGCTA-3' 312 
 
5'-TTACTGGCTGTGATATATATTCC-3' 
  
Table S2: Primer sets developed to amplify transcripts by RT-qPCR (80 to 120 base pairs long) of venom 
proteins in N. vitripennis. (VP = venom protein) 
Primer name Primer sequence Accession 
number 
Gene name 
VPD_qPCR 5'-GATGTCGATATTGCATTGTCAG-3' NM_001161699.1 venom protein D 
 
5'-GTTCTTGTCCGTGACTTCAG-3' 
  VPE_qPCR 5'-AGTAACACCAATCGACTTCTACAG-3' XM_001603388.2 venom protein E 
 
5'-CGTTCAGTTCAATTCTTCCGT-3' 
  VPF_qPCR 5'-GGCAATGATGGACAGAAGGA-3' NM_001161688.1 venom protein F 
 
5'-AGGTATCTCAGTAACTAACGACAG-3' 
  VPG_qPCR 5'-AATTGACCGAGGAAGACGGA-3' XM_008205495.1 venom protein G 
 
5'-CGCTGTTAACGTTGTCACAC-3' 
  VPH_qPCR 5'-CAACACAGCAAACATGAAGG-3' NM_001161555.1 venom protein H 
 
5'-TATGCGATTCAAGCGAAGGT-3' 
  VPI_qPCR 5'-CCTGCTCTATAGTTTGATTGAAGC-3' NM_001170875.1 venom protein I 
 
5'-TGTCTGCTCTTGATTTGTAACG-3' 
  VPJ_qPCR 5'-CTCATTTCTTGTTTCAGTCGCC-3' NM_001170876.1 venom protein J 
 
5'-CACTGGATTTGGCTTCTTCGT-3' 
  VPK_qPCR 5'-GAAATCGACAAATTAGTCGCTGAG-3' NM_001161556.1 venom protein K 
 
5'-GAAGATCATCTCGCAAAGTTTGC-3' 
  VPL_qPCR 5'-GAAGAACAAGTCCAGAAGAACC-3' NM_001161557.1 venom protein L 
 
5'-TCATAATTAACAGGCAGACGG-3' 
  VPM_qPCR 5'-GTACTCATCGTCTGCCTCCT-3' NM_001161558.1 venom protein M 
 
5'-GCCATCCTTGCAGTAGTAACC-3' 
  VPN_qPCR 5'-ATCAACGATGCCCTCAAGGA-3' NM_001170878.1 venom protein N 
 
5'-GTACAATTGGTTCTCACAGGTGG-3' 
  VPO_qPCR 5'-CTCATCAGCAAGAGAATCCAG-3' NM_001161559.1 venom protein O 
 
5'-CTAAGGTCTAGTCCAGTTTGGTC-3' 
  VPP_qPCR 5'-TGGTTCACGATATCTTAAAGGCAG-3' XM_001606115.2 venom protein P 
 
5'-TAGTTTCCCGTCATCATCTGGT-3' 
  VPQ_qPCR 5'-GTACTCTGATACTGGCCAAACC-3' NM_001161689.1 venom protein Q 
 
5'-GAGCTCCACCAGTTCATTACC-3' 
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VPR_qPCR 5'-CTACCTCATCACTCAGATCCGT-3' NM_001161692.1 venom protein R 
 
5'-GACATTGCTGTAGCCCACTC-3' 
  VPS_qPCR 5'-TGCTCGAGAATTAGACGACTG-3' XM_001606782.2 venom protein S 
 
5'-CGAGAAAGCTTCCTCACAAGAC-3' 
  VPT_qPCR 5'-CGAATACAAGACCCACATCG-3' NM_001161694.1 venom protein T 
 
5'-TTTCGACCAGATCTTGCAGG-3' 
  VPU_qPCR 5'-GCCTAGGAATGTCTAATTTGGA-3' NM_001161698.1 venom protein U 
 
5'-TATTCCACATCTCGTTGAACAC-3' 
  VPV_qPCR 5'-GAAATTCAACGAGTTCGTCGTG-3' NM_001161569.1 venom protein V 
 
5'-TTTGTTCTTAACGTTCTGGCC-3' 
  VPW_qPCR 5'-AGAATCCAGTGACGAAGTAGTCC-3' XM_001602674.2 venom protein W 
 
5'-TGGTGATTCGCCGATTTCTG-3' 
  VPX_qPCR 5'-CGGTGAAGCTTTCGATCAAT-3' NM_001161695.1 venom protein X 
 
5'-TTGATGGGTGGTTCATCAGA-3' 
  VPY_qPCR 5'-TTATGTTCAATGGCGGTTCA-3' NM_001161696.1 venom protein Y 
 
5'-CATAAAATGGCGGCAACTCT-3' 
  VPZ_qPCR 5'-CAATCCAAATTACGGGTTCGC-3' NM_001161697.1 venom protein Z 
 
5'-GGATACTTTGTCTTCAAGGTTGTG-3' 
  aminoVP1_qPCR 5’-CTATGAAATTGACGAAGACTAGCG-3’ XP_001607226 aminotransferase-like VP1 
 
5’-TCTTGTTGTTAAAGAGGCTCCT-3’ 
  
glutVP1_qPCR 5’-ATTAACCATATTCTTGGCGCAC-3’ XP_001607488 γ-glutamyl transpeptidase-like VP1 
 
5’-CTCAGAAGGTTCAACCAGGA-3’ 
  
laccase_qPCR 5’-CGAATTATATCCAGTACATCGCAC-3’ XP_001600917 laccase 
 
5’-TCCTTATTGTATCCGCTCTCAC-3’ 
  
 
Table S3:  Primer sets developed to amplify transcripts by RT-qPCR of the candidate reference genes for 
N. vitripennis (transcripts of 80 to 120 basepairs long).  
Primer name Primer sequence Accession number Gene name 
actin_qPCR 5'-GCATCACACCTTCTACAACGA-3' XM_001601454.3 actin-3-like 
 
5'-ATCTGGGTCATCTTCTCACGG-3' 
  
tubulin_qPCR 5'-GCTATCGCAACCATCAAGACC-3' XM_001607649.3 tubulin alpha-1 chain 
 
5'-GTAGTTGATACCGACCTTGAAACC-3' 
  
RPL13a_qPCR 5'-CTATCATCGCCAAGACCATCC-3' XM_008215505.1 60S ribosomal protein L13a 
 
5'-AGCTTGTTCCTGAAGAAGTTACC-3' 
  
nanos_qPCR 5'-ATTTGCGACTGATGACGTCTG-3' NM_001134922.1 nanos 
 
5'-CCGGTACGATCACTTCATCTG-3' 
  
RPS18l_qPCR 5'-AAATACTCACAGCTTACGAGTTCC-3' XM_008215790.1 40S ribosomal protein S18 
 
5'-TAGTGTCGGAGACCTCTGTG-3' 
  
GAPDH_qPCR 5'-GCTTATATCGCCGCTTTGTG-3' XM_001607424.3 glyceraldehyde 3-phosphate 
dehydrogenase 
 
5'-GTTTGTTTGTTAGACGGAGACGA-3' 
  
SDHA_qPCR 5'-TGCTGGATCTGGTTGTATTTGG-3' NM_001172330 succinate dehydrogenase 
complex, subunit A 
 
5'-CTTCTCCAGCGTTAGTTCGG-3' 
  
EF1a_qPCR 5'-CACTTGATCTACAAATGCGG-3' NM_001172756 elongation factor 1-alpha 
 
5'-GAAGTCTCGAATTTCCACAG-3' 
  
ETIF1a_qPCR 5'-CGAAGAATAAGGGAAAGGGAG-3' XM_008206136.1 eukaryotic translation 
initiation factor 1A 
 
5'-GCCATCCTCTTTGAAGACCA-3' 
  
Med8_qPCR 5'-CATCTCATAAACAGGTAGCACAG-3' XM_003427117 mediator of RNA polymerase 
II transcription subunit 8 
 
5'-TTTCACTTTCCCACTCTTCAC-3' 
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Table S4: Primer sets developed to amplify transcripts by RT-qPCR of immune proteins in S. crassipalpis.  
Gene name  
S. crassipalpis 
Accession  
number 
Gene name  
D. melanogaster 
Accession  
number 
%  
identity 
e-value Primer sequences 
sapecin EZ598683.1 defensin NP_523672.1 67.39 1.00E-15 5'-CCTGTTGAAGCTGCTGAGGA-3' 
      
5'-TACGCAGACACCTTTGCCAT-3' 
sarcotoxin IIA EZ599257.1 attacin B NP_523746.1 65.71 8.00E-66 5'-CAGCAGCAAAAACTTGTCCA-3' 
      
5'-TCCTCCACCCACTAGACCAC-3' 
sarcotoxin I EZ603663.1 cecropin A1 NP_524588.1 78.00 2.00E-18 5'-CAACCAACCAGCCTGACTTT-3' 
      
5'-GCGGGGAGCATCATTTACT-3' 
DDC EZ600971.1 DDC AAC67582.1 85.57 4.00E-143 5'-ATCCATTTGTGGGGATTGAA-3' 
      
5'-GTCAGTGCCTGCTGATGAAA-3' 
Dorsal EZ615368.1 Dorsal P15330.2 83.87 2.00E-37 5'-CCACCTCTTCGGGTGTTAAA-3' 
      
5'-ATGTTGATTTGACCGAAGCC-3' 
Relish EZ604192.1 Relish NP_996187.1 48.39 2.00E-35 5'-GCTCACAAACAGCATTGCAT-3' 
      
5'-ATATGTAGCGCGGTATTGCC-3' 
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1. Abstract 
With more than 150,000 species, parasitoids are a large group of hymenopteran insects that 
inject venom into and then lay their eggs in or on other insects, eventually killing the hosts. 
Their venoms have evolved into different mechanisms for manipulating host immunity, 
physiology and behavior in such a way that enhance development of the parasitoid young. 
The venom from the ectoparasitoid N. vitripennis inhibits the immune system in its host 
organism in order to protect their offspring from elimination. Since the major innate 
immune pathways in insects, the Toll and Imd pathways, are homologous to the NF-κB 
pathway in mammals, we were interested in whether a similar immune suppression seen in 
insects could be elicited in a mammalian cell system. A well characterized NF-κB reporter 
gene assay in fibrosarcoma cells showed a dose-dependent inhibition of NF-κB signalling 
caused by the venom. In line with this NF-κB inhibitory action, N. vitripennis venom 
dampened the expression of IL-6, a prototypical proinflammatory cytokine, from LPS-treated 
macrophages. The venom also inhibited the expression of two NF-κB target genes, IκBα and 
A20, that act in a negative feedback loop to prevent excessive NF-κB activity. Surprisingly, 
we did not detect any effect of the venom on the early events in the canonical NF-κB 
activation pathway, leading to NF-κB nuclear translocation, which was unaltered in venom-
treated cells. The MAP kinases ERK, p38 and JNK are other crucial regulators of immune 
responses. We observed that venom treatment did not affect p38 and ERK activation, but 
induced a prolonged JNK activation. In summary, current data indicate that venom from N. 
vitripennis inhibits NF-κB signalling in mammalian cells. We identify venom-induced up 
regulation of the glucocorticoid receptor-regulated GILZ as a most likely molecular mediator 
for this inhibition. 
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2. Introduction 
Animal venoms have long been known for their inflammatory effects, for instance stings 
from honeybees, snakes and scorpions can induce ongoing pain and even hyperalgesia (Chen 
et al., 2006;Liu et al., 2007;Teixeira et al., 2009). But the last few decades, there has been 
growing interest in the anti-inflammatory effects of these venoms. Since Billingham and 
colleagues have discovered the anti-inflammatory effects of honeybee venom, it has been 
used for the treatment of various inflammatory diseases in the oriental medicine (Billingham 
et al., 1973). With the aim of finding treatments for several chronic inflammatory diseases 
(as rheumatoid arthritis and atherosclerosis) and cancer, venom components in diverse 
animal groups have been screened for possible anti-inflammatory characteristics (Park et al., 
2008a;Tsai et al., 2007;Dkhil et al., 2010).  
 
In the search for animal venom-derived immune suppressive agents, the parasitoid-host 
interaction is a highly intriguing system. When parasitoid wasps lay their eggs in or on a host 
organism (endo- or ecto-parasitoid respectively), they also inject a mixture of virulence 
factors that consist of ovarian and venom fluids (Asgari & Rivers, 2011). These parasitoid 
fluids comprise of different active substances, exerting a large range of activities in 
diversified biological functions (Moreau & Guillot, 2005). This complexity could allow for 
adaptation for new or widened host ranges and could increase the difficulty for a resistance 
to emerge considering that a multimodal tolerance might be set up by the host to ensure its 
survival. The diverse mode of action of venom proteins from parasitoid wasps is dependent 
largely on their life strategy (Asgari & Rivers, 2011). In ectoparasitoids, like for instance N. 
vitripennis, the host generally undergoes a developmental arrest and immune suppression in 
order to present a good environment for the development of the parasitoid offspring 
(Danneels et al., 2010;Small et al., 2012). The precise working mechanism of this immune 
suppression is not yet exactly characterized. But the polydnaviruses (PDVs) present in the 
venom of several endoparasitoid wasp species interfere with the Toll signalling pathway, 
which is crucial for maintaining the host immune response (Gueguen et al., 2013). 
 
Toll/Imd receptors are essential for embryonic development and immunity of insects 
(Valanne et al., 2011). The induction of the Toll/Imd pathway by Gram-positive bacteria and 
How the venom from N. vitripennis exhibits anti-inflammatory properties 
110 
fungi or Gram-negative bacteria, respectively, leads to the activation of cellular immunity as 
well as the systemic release of certain antimicrobial peptides. Studies in fruit flies and in 
mammals have revealed that the defensive strategies of invertebrates and vertebrates are 
highly conserved at the molecular level (Kimbrell & Beutler, 2001). Infectious micro-
organisms trigger activation of Toll/Imd receptors in insects or Toll-like receptors in 
mammals, which induces a signalling cascade culminating in the activation of NF-κB 
transcription factors (Silverman & Maniatis, 2001). NF-κB is the generic term for members of 
a family of transcription factors, that act as homo- or heterodimers and regulate 
transcription of multiple genes involved in immunity and inflammation. The NF-κB family in 
insects contains three members (Dif, Dorsal and Relish) and has expanded in mammals, 
which have seven NF-κB family members (p50, p105, p52, p100, p65/RelA, RelB and c-Rel). 
Different insults trigger the activation of different NF-κB dimers, which allows fine-tuning of 
the immune response (Hayden & Ghosh, 2012). Importantly, the NF-κB pathway is subject to 
tight feedback regulation, which ensures termination of NF-κB responses once the infectious 
danger has been eliminated (Ruland, 2011). NF-κB is kept inactive in resting cells by the 
inhibitor protein Cactus in insects and by IκB family members in mammals. When cells sense 
infectious danger, kinase cascades are activated that promote phosphorylation and 
degradation of the NF-ĸB inhibitor proteins, leading to NF-κB release and translocation to 
the nucleus, eventually activating the transcription of target genes involved in inflammation 
(Brasier, 2006;Hayden & Ghosh, 2011).  
 
Whole genome microarrays on parasitized D. melanogaster by Leptopilina species revealed 
gene activation of Toll/NF-κB and JAK/STAT pathway components, involved in regulating 
immune responses toward microbes and macroparasites. The up-regulation of genes 
involved in these particular immune pathways suggests these hosts are better protected 
against microorganisms at parasitoid oviposition (Schlenke et al., 2007). In endoparasitoid 
venoms, the PDVs encode proteins with ankyrin repeats that are also found in Cactus, the 
inhibitor protein of NF-κB signalling in Drosophila, and in mammalian IκB family members. 
These viral ankyrin repeats (vankyrins) however, lack the amino acid sequences necessary 
for their degradation/turnover. Therefore, they act as antagonists of NF-κB nuclear 
translocation, hence supporting parasite success. During the last decade, several PDVs in 
endoparasitoids have been found to express IκB-related vankyrin genes that suppress NF-κB 
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activity during immune responses in parasitized hosts (Kroemer & Webb, 2005;Bae & Kim, 
2009).  
 
In mammalian organisms, the nuclear factor kappa B (NF-κB) transcription factors regulate 
important physiological processes, including inflammation and immune responses 
(Yamamoto & Gaynor, 2001). Maintenance of appropriate levels of NF-κB activity is a critical 
factor in immune system development and normal cell proliferation. Aberrant activation of 
the NF-κB pathway is involved in the pathogenesis of a number of human diseases including 
those related to inflammation, enhanced cellular proliferation, viral infection and genetic 
diseases (DiDonato et al., 2012;Kumar et al., 2004). Asthma for instance is a chronic 
inflammation of the bronchial tubes, of which the activation of NF-κB is stimulated by agents 
such as allergens, ozone and viral infections (Christman et al., 2000). NF-κB also participates 
in many aspects of oncogenesis, since it can suppress apoptosis and induce expression of 
proto-oncogenes. The constitutive NF-κB activity has been observed in a number of human 
cancers and the inhibition of NF-κB abrogates tumour cell proliferation (Bharti & Aggarwal, 
2002). Regulation and control of NF-ĸB activation can be a powerful therapeutic strategy for 
inhibiting tumour growth and viral infections and for reducing the tissue damage that 
follows the release of inflammatory mediators.  
 
Various stimuli give rise to the phosphorylation and degradation of the inhibitor of NF-ĸB 
(IκB) via the IκB kinase (IKK) complex, leading to NF-κB release and translocation to the 
nucleus, eventually activating the transcription of target genes involved in inflammation 
(Brasier, 2006). On the other hand, activation of mitogen-activated protein kinases (MAPKs), 
including extracellular signal-regulated kinase 1/2 (ERK1/2), p38 and c-Jun N-terminal kinase 
(JNK), is another major signal transduction pathway involved in inflammation and is closely 
linked to the activation of the NF-κB pathway (Guha & Mackman, 2001). It is clear that 
deregulation of the transcription factor NF-κB can mediate several inflammatory diseases. 
Therefore several proteins tightly control its activation (Wong & Tergaonkar, 2009). Among 
these proteins are the NF-κB inhibitory proteins, IκBα and A20, the expression of which leads 
to a negative-feedback response that terminates activation of NF-κB (Lee et al., 2000). 
Moreover, the NF-κB inflammatory response is also modulated by endogenous 
glucocorticoids (GCs) that are released following a challenge with various cytokines, with the 
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aim to restore homeostasis. These GCs are steroid hormones that can diffuse freely across 
the plasma membrane and bind to their intracellular receptor, the glucocorticoid receptor 
(GR). Because of their strong anti-inflammatory characteristics, GCs have been used since 
the late 1940s to treat inflammatory and autoimmune disease conditions (Schacke et al., 
2007). 
 
N. vitripennis is an ectoparasitoid wasp that prefers Sarcophaga flesh flies as host organism. 
Bioassays uncovered that the venom of this wasp causes developmental arrest, increase of 
lipid levels, induction of apoptosis in certain tissues and suppression of the host immune 
system (Rivers & Denlinger, 1994a;Rivers et al., 2002b). In contrast with several 
endoparasitoid wasps, N. vitripennis only injects venom and no PDVs into the host and 
therefore cannot express IκB-related vankyrin genes. Interestingly, microarray analysis on 
parasitized S. crassipalpis pupae by N. vitripennis suggested that the venom also targets the 
NF-κB and MAPK pathways in the host in order to regulate the immune response (Danneels 
et al., 2013). Since conserved parallels have been noted between the inflammatory Toll/Imd 
pathways of Drosophila, and immune signalling pathways that activate NF-κB in mammals, 
we have investigated whether venom from N. vitripennis modulates NF-ĸB activation in 
mammalian cells.  
 
Using a well characterized NF-κB reporter gene assay in fibrosarcoma cells (Plaisance et al., 
1997), we found that N. vitripennis venom, at subcytotoxic doses, inhibits NF-κB activity. In 
addition, we found that  N. vitripennis venom, in murine macrophage-like Raw264.7 cells, 
inhibited LPS-induced expression of the pro-inflammatory NF-κB target Interleukin-6 (IL-6). 
The findings suggest that the venom-induced up-regulation of GILZ, a GR-regulated gene, is 
most likely the molecular mediator for this inhibition. One has to keep in mind, however, 
that this venom presents a highly complex mixture that, besides the 79 proteins identified 
(de Graaf et al., 2010), consists of organic molecules, amines, salts, minerals and alkaloids 
(Wong & Belov, 2012). The unique find that the venom of an ectoparasitic wasp is able to 
inhibit one of the most important immune pathways in mammals, focused further research 
activities in unravelling the effect of the venom on this pathway in depth. This innovative 
study therefore, explored not only the effect of N. vitripennis venom on the canonical NF-κB 
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pathway, but also the effect on the MAPK signalling pathways and negative regulatory 
mechanisms of NF-κB activation. 
3. Materials and methods 
3.1. Isolation of crude wasp venom 
N. vitripennis wasps were reared on pupae of the flesh fly, S. crassipalpis, and maintained at 
25°C with a daily 16:8 light : dark cycle. Female wasps were allowed to host feed on flesh fly 
pupae for 24 hours. Venom gland reservoirs were dissected into insect saline buffer (ISB) 
[150 mM NaCl, 10 mM KCl, 4 mM CaCl2, 2 mM MgCl2, 10 mM Hepes] (Formesyn et al., 
2013a) and centrifuged at 12,000 x g for 10 minutes at 4°C. The supernatant containing the 
venom was transferred to a clean microcentrifuge tube and stored frozen at -70°C. Total 
protein in crude venom was determined colorimetrically at 595 nm using a Coomassie 
Protein Assay Reagent (no 23200, Thermo Scientific).  
 
3.2. Chemicals 
The origin and activity of TNF, as well as the preparation of luciferase (luc) reagent, were 
described previously (Vanden Berghe et al., 1998). Dexamethasone (DEX), LPS from 
Escherichia coli, mouse anti-tubulin-α and the specific GR antagonist RU38486 were 
purchased from Sigma Chemical Co. (St. Louis, MO). Antibodies to rabbit IκBα (C-21), mouse 
A20 (A-12), rabbit PARP-1/2 (H-250 and rabbit NF-κB p65 (C-20) were obtained from Santa 
Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies to rabbit phospho-IKKα 
(ser180)/(ser181)β, rabbit phospho-NF-κB p65(ser536), rabbit phospho-ERK MAPK and 
rabbit phospho-p38 MAPK were purchased from Cell Signalling Technology (Danvers, MA, 
USA). Corresponding fluorescent-coupled secondary antibodies were purchased from 
Rockland, Gilbertsville, PA. 
 
3.3. Cell culture 
Raw264.7 cells, a mouse macrophage-like cell line, were maintained in RPMI 1640 medium, 
murine fibrosarcoma L929sA cells and human embryonic kidney (HEK) 293T cells were 
maintained in DMEM at 37°C in 5% CO2 humidified air. Both media were supplemented with 
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10% fetal bovine serum, 100 units/ml penicillin and 0.1 mg/ml streptomycin. Twenty-four 
hours before induction, cells were seeded in multiwell dishes such that they were confluent 
at the time of the experiment.  
 
3.4. Plasmids and transfection procedure 
pGal4, pGal4-p65 and p(Gal)2-50hu.IL6P-luc+ were previously described (Schmitz & Baeuerle, 
1991). pPGKβgeobpA was a gift from P. Soriano (Fred Hutchinson Cancer Research Center, 
Seattle). p(IL6κB)350hu.IL6P-luc+ (Plaisance et al., 1997) and p(GRE)2-50-luc (De Bosscher et 
al., 2005) were described previously. Transient transfections were performed using 
polyethylenimine (PEI) (Longo et al., 2013). Stable transfection was performed by the 
calcium phosphate precipitation procedure according to standard protocols (Vanden Berghe 
et al., 1998).  
 
3.5. Reporter gene analysis 
Luciferase (luc) and galactosidase reporter assays were carried out according to the 
manufacturer’s instructions (Promega) and have been described previously (Vanden Berghe 
et al., 1998). Luc activity, expressed in arbitrary light units, was corrected for differences in 
protein concentration and transfection efficiency in the sample by normalization to 
constitutive β-gal levels. Β-gal levels were quantified with a chemiluminescent reporter assay 
Galacto-Light kit (TROPIX). 
 
3.6. Enzyme-linked immunosorbent assay of IL-6 
Murine IL-6 ELISA was performed using the Mouse IL-6 CytoSet from Invitrogen. 
 
3.7. Western blot analysis 
After inductions (indicated in the figure’s legends) or solvent controls where appropriate, 
cells were washed with ice-cold phosphate-buffered saline (PBS), harvested with a rubber 
policeman and collected in 1 ml of PBS by centrifugation for 10 minutes at 500 g (4°C). 
Preparation of cytoplasmic or nuclear cell extracts have been described previously (Plaisance 
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et al., 1997). If total cell lysates were used, cells were lysed in SDS sample buffer [62.5 mM 
Tris-HCl, pH 7.5, 2% (w/v) SDS, 10% glycerol, 50 mM dithiothreitol (DTT) and 0.01% (w/v) 
bromophenol blue]. To shear DNA and reduce sample viscosity, lysates were sonicated for 1 
minute in a water bath sonicator and then heated to 95°C for 5 minutes after which they 
were immediately cooled in ice and microcentrifuged for 5 minutes. The lysates were 
separated by 10% SDS-PAGE and electrotransferred onto a nitrocellulose membrane. Blots 
were probed using the appropriate antibodies (1:1,000), and their corresponding 
immunoreactive protein (1:10,000) was detected on an Odyssey imaging system (LI-COR 
Biosciences, Lincoln, USA). 
 
3.8. RNA analysis 
RNA was isolated by using TRIzol Reagent (Invitrogen) as described previously (De Bosscher 
et al., 2005). Total RNA was reverse-transcribed into cDNA using the Revert Aid H Minus First 
Strand cDNA Synthesis Kit (Fermentas) following the manufacturer’s instructions. The 
expression of the genes was determined by RT-qPCR in a CFX96 Real-Time PCR Detection 
System (BioRad, Hercules, CA, USA) using the SYBR Green mastermix (Invitrogen). The 
mouse-specific primers that were used, are mentioned in table S1, together with the primers 
of the household genes, used for normalization. The thermal cycling conditions were as 
follows: 5 minutes at 50°C, 2 minutes at 95°C and then 40 cycles of 20 seconds at 95°C and 
40 seconds at 60°C. Melting curve analysis was used to determine primer specificity. 
 
3.9. Immunofluorescence staining 
Cells were seeded on coverslips and grown for 24 hours. Fixation, permeabilization, and 
staining were performed as described previously (De Bosscher et al., 2005). Presence of p65 
was visualized with a 1:200 dilution of anti-p65 antibody, followed by probing with a 1:800 
dilution of Alexa Fluor 488–conjugated goat anti-rabbit IgG. Staining with 4,6-diamidino-2-
phenylindole (DAPI) was used for visualization of the cell nuclei. A Zeiss Axiovert 200M 
microscope was used for visualization of the images, and data were analyzed using Carl Zeiss 
Axiovision software (Carl Zeiss Instruments, Jena, Germany). 
 
How the venom from N. vitripennis exhibits anti-inflammatory properties 
116 
3.10. Statistical analysis 
All assays were carried out in triplicate from three biological repeats and results were 
expressed as the mean ± SDs. Prior to statistical tests, normality of the data was confirmed 
by Shapiro-Wilk tests. With this assumption met, data was evaluated using analysis of 
variance, ANOVA followed by Dunn’s or Bonferroni posthoc test. P-value < 0.05 was 
considered statistically significant. All statistical analyses were performed with Prism 5.0 
(GraphPad Software, Inc., La Jolla, CA).  
 
4. Results 
4.1. Effect of venom on NF-κB signalling 
4.1.1. Venom inhibits NF-κB activation in TNF-stimulated L929sA fibrosarcoma cells. 
To assess the effects of N. vitripennis venom on NF-κB activity, we used a well characterized 
NF-κB reporter gene assay (Plaisance et al., 1997). Briefly, the system makes use of L929sA 
cells stably transfected with a recombinant promoter with an NF-κB-responsive element 
derived from the IL-6 gene promoter (p(IL6κB)350hu.IL6P-luc+), and a constitutively 
expressed reporter gene construct (pPGKbGeobpA), expressing β-galactosidase (Vanden 
Berghe et al., 1998). L929sA cells respond to TNF, followed by an induction of the NF-κB-
reporter gene. Only subcytotoxic concentrations of venom were used on the cells (see figure 
S1 for MTT cell viability assay). As shown in figure 1, enhanced luciferase expression levels 
were measured in response to TNF, whereas pre-treatment with venom was found to 
potently inhibit reporter gene expression in a dose-dependent manner (see figure S2 for the 
separate luciferase and β–galactosidase read-outs of the NF-ĸB-reporter assay). Similar 
assays were performed on L929sA cells stably transfected with a recombinant promoter with 
either the CRE (cyclic AMP response element) responsive element or the AP-1 responsive 
element, which confirmed the specificity of the venom towards NF-ĸB (see figure S3). 
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Figure 1: Venom from N. vitripennis inhibits TNF-induced expression of a NF-κB-dependent reporter gene. 
L929sA cells stably transfected with a NF-κB-dependent reporter gene were pre-treated with indicated 
concentrations of venom for 15 minutes followed by stimulation for 6 hours with TNF (2000 IU/ml). 
Luciferase activity was normalized for β-galactosidase expression. The data are expressed as the mean ± 
SDs of three biological replicates. Normality was confirmed by a Shapiro-Wilk test (W=0.9689). * p<0.05, 
** p<0.01 versus TNF alone; ANOVA with Bonferroni posthoc test. 
 
4.1.2. Venom inhibits IL-6 mRNA and protein expression in LPS-stimulated 
Raw264.7 macrophages. 
Interleukin (IL)-6 is a pleiotropic cytokine involved in acute phase and immune reactions and 
inflammatory responses, the expression of which in response to inflammatory stimuli, 
strongly depends on NF-κB (Libermann & Baltimore, 1990). Macrophages are key players in 
the inflammatory response, and they secrete high levels of IL-6 upon ligation of Toll-like 
receptors (TLRs) by pathogen-associated molecular patterns (PAMPs). We therefore 
explored the effect of N. vitripennis venom on TLR4-dependent, LPS-induced IL-6 production 
in Raw264.7 mouse macrophages. As shown in figure 2A, the elevated levels of IL-6 protein 
detected after 6 hours LPS treatment were strongly repressed in the presence of the venom 
in a concentration-dependent manner.  
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Figure 2: Effect of N. vitripennis venom on IL-6 production in LPS-stimulated Raw264.7 cells. A. Cells were 
stimulated with LPS (1 µg/ml) for 6 hours, alone or after 15 minutes pre-incubation with various 
concentrations of venom. IL-6 produced and released into the culture medium was assayed by ELISA. B. 
Cells were stimulated with LPS (1 µg/ml) alone or with indicated amount of venom for 6 hours. Total RNA 
was isolated and mRNA expression level of IL-6 was determined by RT-qPCR. hPRT1 and cyclophilin were 
used to normalize the data. The data are expressed as the mean ± S.D. of three biological replicates. 
Normality was confirmed by a Shapiro-Wilk test (W=0.7617 for A, W=0.8673 for B). * p<0.05, ** p<0.01, 
*** p<0.001, **** p<0.0001 venom and LPS treated versus LPS alone, ANOVA with Bonferroni posthoc 
test. 
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N. vitripennis venom pre-treatment also inhibited LPS-induced IL-6 mRNA levels, yet this 
effect was less prominent and required ten-fold higher doses of venom (figure 2B).  
 
4.1.3. Venom does not interfere with canonical NF-κB signalling in the cytoplasm. 
One of the major mechanisms involved in the transcriptional activation of NF-κB is the 
activation of the IKK kinase complex and the concomitant phosphorylation and degradation 
of the IκBα protein, which allows the release of free NF-κB and its subsequent translocation 
to the nucleus. Furthermore, post-translational modifications of p65 have been 
demonstrated to be critical for p65-driven gene expression of many target genes (Naumann 
& Scheidereit, 1994). The IKK complex is known to phosphorylate p65 at serine 536 (Sakurai 
et al., 1999), in this way regulating p65 nuclear localization. We assessed whether N. 
vitripennis venom affects these early LPS-induced events in Raw264.7 cells (figure 3). We 
found that LPS promoted phosphorylation of IKK in its activation loop that was apparent 
after 5 minutes and lasted up to 15 minutes of LPS treatment. Venom pre-treatment did not 
affect IKK phosphorylation. Next, it was investigated whether the venom alters LPS-induced 
phosphorylation of p65. As the Western blot analysis in figure 3 shows, p65 phosphorylation 
in Raw264.7 cells is highly increased after 15 minutes LPS induction. However, no difference 
in LPS-induced p65 phosphorylation was apparent after venom co-treatment (figure S4). 
 
4.1.4. Venom does not interfere with nuclear translocation of the p65 subunit. 
LPS induction in Raw264.7 macrophage cells leads to canonical NF-κB activation, that is 
followed by nuclear translocation of the NF-κB p65 subunit prior to NF-κB/DNA binding. 
Therefore, the level of p65 was measured in nuclear extracts of Raw264.7 cells either 
untreated or venom-treated for 10, 30 or 60 minutes LPS induction. Antibody against Poly 
ADP-Ribose polymerase (PARP) was used as a loading control for the nuclear fractions. When 
analyzed by Western blotting, LPS-induced p65 nuclear translocation was not affected by N. 
vitripennis venom (figure 4A). These results were confirmed in figure 4B by 
immunofluorescence staining to visualize the trafficking of the p65 subunit. LPS induction 
after 30 and 60 minutes caused an accumulation of green fluorescent signal in the nucleus, 
conform the translocation of p65 from the cytoplasm to the nucleus. Co-incubation of these 
cells with venom, however, did not alter this translocation. 
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Figure 3: Effect of venom on cytosolic protein activity. Raw264.7 cells were left untreated or were 
pretreated with 5 µg/ml venom for 15 minutes and then stimulated with 1 µg/ml LPS for the indicated 
times. Total cell extracts were assayed by Western blot analysis using antibodies against indicated 
proteins. The unphosphorylated protein and Tubulin-α were used as loading controls. A representative 
result from three separate experiments is shown. 
 
Figure 4: Effect of venom on nuclear translocation of p65. A. Western blot analysis of nuclear extracts 
from Raw264.7. After pre-incubation with N. vitripennis venom (5 µg/ml) for 15 minutes, cells were 
induced for the indicated times with LPS (1 µg/ml). Subsequently, nuclear extracts were subjected to 
Western blot analysis to determine p65 levels. Separation of nuclear and cytoplasmic fractions was 
verified using PARP as control for the nuclear fractions. B. After 15 minutes pre-incubation with N. 
vitripennis venom, cells were induced for the indicated times with LPS (1 µg/ml). Immunofluorescence 
staining was performed to visualize the trafficking of the p65 subunit. Representative results from three 
separate experiments are shown. 
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4.1.5. Venom does not interfere with NF-κB transactivation independent from the 
promoter context. 
Since no influence of N. vitripennis venom was apparent on the subcellular localization of 
p65 NF-κB following inflammatory stimuli, the next step was to investigate whether the 
observed inhibition of NF-κB activity (figure 1) could be explained by a nuclear phenomenon. 
To approach this question, it was investigated whether N. vitripennis venom could interfere 
with NF-κB transactivation, independent from the promoter context. Therefore, its effect on 
the transcriptional activation of a Gal4-p65-dependent reporter gene, transactivated by the 
p65 chimera, was analyzed. This Gal4-p65 fusion protein, composed of the DNA-binding 
domain of the yeast nuclear protein Gal4 and the transactivation domain of the NF-κB 
subunit p65, stimulates p(Gal)2-50hu.IL6P-luc+, a luciferase reporter gene, preceded by two 
Gal4-binding DNA sequence elements and the minimal IL-6 promoter. In this particular 
nuclear setup, no direct influence of other responsive element-bound transcription factors, 
which are normally present in the IL-6 promoter context, or interference of cytoplasmic 
events need to be taken into account. When the glucocorticoid receptor (GR), a ligand-
activated transcription factor present in the cytoplasm, binds to its agonist, e.g. the synthetic 
glucocorticoid dexamethasone (DEX), the receptor translocates to the nucleus and interferes 
with the transactivating function of NF-κB, in a process called transrepression. Cells were 
incubated with DEX as a positive control for transrepression of the NF-κB pathway.  
 
In these experiments, HEK293T cells that are devoid of GR, were transiently transfected with 
the expression constructs, and treated with venom, DEX or were left untreated. Finally, 
GAL4-p65 driven expression of luciferase was quantified based on the measurement of its 
activity. Whereas  Gal4 protein on its own cannot activate the reporter, overexpression of 
the nuclear fusion protein Gal4-p65 clearly activated reporter gene expression, as expected 
(figure 5). After adding DEX to the cells, the level of transactivation by the nuclear fusion 
protein Gal4-p65 could be specifically repressed, when sufficient exogenous GR was present. 
However, repression of Gal4-p65-induced transcriptional activation could not be achieved by 
the N. vitripennis venom, indicating that compounds in the venom do not interfere with the 
transactivation potential of the p65 subunit in the nucleus or that they act on specific 
components of the transcriptional machinery that is not involved in this Gal4 assay. 
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Figure 5: Effect of N. vitripennis venom on the Gal4-p65-mediated expression of a reporter gene in a Gal4 
one-hybrid setup. HEK293T cells were transiently transfected by the PEI method with 100 ng of p(Gal)2-
50.huIL6P-luc+ and with various expression plasmids, the total amount of DNA being fixed at 250 ng, i.e., 
pGal4 (10 ng) or pGal4-p65 (10 ng) whether or not with pGR (25 ng). 10-6 M DEX or 5 µg/ml of venom was 
added 24 hours before analysis. Lysates were made and the relative luciferase activity was determined by 
using β-gal values as a basis for normalization. The data are expressed as the mean ± S.D. of three 
biological replicates. * p<0.05, ANOVA with Bonferroni posthoc test. 
 
4.2. Effect of venom on MAPK activation pathways: venom causes 
prolonged JNK-activation. 
It is well established that the phosphorylation and, in turn, activation of MAPKs, i.e. p38, 
ERK1/2 and JNK, are crucial for LPS-induced AP-1 and NF-κB activation and subsequent up-
regulation of pro-inflammatory mediators in macrophages (Kaminska, 2005). p38 MAP 
kinase and/or ERK are required for NF-κB activation in response to LPS and JNK is essential 
for activation of transcription factor AP-1 (Davis, 2000;Xia et al., 1995;Wilkinson & Millar, 
1998). To investigate whether regulation of the activation of these MAPKs is involved in the 
molecular mechanism of action by N. vitripennis venom, phosphorylation of these MAPKs 
was further examined. Hereto, Raw264.7 cells were pre-treated with venom followed by 
addition of LPS for different time points. Whole-cell lysates were prepared and the total 
expression of these different MAP kinases as well as levels of phosphorylated MAPKs were 
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determined by Western blot analysis. The results showed that LPS stimulation activates 
MAPKs in a time-dependent manner. Pre-treatment with venom had no effect on the LPS-
induced phosphorylation of ERK1/2 and p38 (figure 6 and figure S5). However, after 60 
minutes LPS induction, prolonged JNK activation could be observed when N. vitripennis 
venom was added to the cells. 
 
 
Figure 6: Effect of N. vitripennis venom on LPS-induced phosphorylation of MAPKs. Raw264.7 cells were 
either left untreated or treated with venom (5 µg/ml) for 15 minutes followed by stimulation with 1 µg/ml 
LPS for the indicated times. Total cell extracts were assayed by Western blot analysis using the indicated 
antibodies. Tubulin-α  and the respective unphosphorylated proteins were used as loading controls. A 
representative result from three separate experiments is shown. 
 
4.3. Effect of venom on NF-κB regulated secondary anti-inflammatory 
processes. 
Next to the well-studied direct regulation of NF-κB signalling, the regulatory networks that 
control the NF-κB response are extensive. The best studied and well accepted mechanism 
for termination of the NF-κB response involves the resynthesis of IκBα proteins induced by 
activated NF-κB (Pahl, 1999). Newly synthesized IκBα can enter the nucleus, remove NF-κB 
from the DNA, and relocalize it to the cytosol (Hayden & Ghosh, 2004). Another important 
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negative regulator of the NF-κB response is A20, which is up-regulated following NF-κB 
activation. Subsequently, A20 down regulates NF-κB through its dual function as a 
deubiquitinase and ubiquitin ligase (Heyninck & Beyaert, 2005). Furthermore, 
glucocorticoids (GCs) are also negative regulators of NF-κB activation and are widely used as 
anti-inflammatory agents (Auphan et al., 1995). GCs diffuse through the cell membrane and 
bind to their inactive cytosolic receptors (GRs), which then undergo conformational 
modifications that allow for their nuclear translocation. In the nucleus, activated GRs 
modulate transcriptional events by directly associating with DNA elements. In addition, 
activated GRs also act by antagonizing the activity of transcription factors, in particular NF-
κB, by direct and indirect mechanisms (Almawi & Melemedjian, 2002). For these reasons, we 
were interested whether the venom from N. vitripennis causes any differences in these 
secondary regulatory mechanisms of the NF-κB response. We first tackled this question by 
looking at the mRNA expression of two immediate-early genes, IκBα and A20 (figure 7A), and 
of three GR-regulated genes, glucocorticoid inducible leucine zipper (GILZ), mitogen-
activated protein kinase (MAPK) phosphatase-1 (MKP1), and  FK506 binding protein 51 
(FKBP5) (figure 7B). To study the IκBα and A20 mRNA expression, Raw264.7 cells were either 
pre-treated with venom or with insect saline buffer (ISB) as a control and subsequently 
stimulated with LPS for 30 minutes, 1 hour, 3 or 6 hours. Then, RNA was isolated from the 
cells, reverse-transcribed and analyzed by real-time PCR. As shown in figure 7A, mRNA 
expression of IκBα and A20 is up-regulated after 1 hour of LPS induction and remains 
elevated for 6 hours after LPS induction. When venom is applied to the cells, both IκBα and 
A20 expression are significantly suppressed after 1 hour and after 6 hours LPS induction.  
 
Next, the transcriptional response on several GR-regulated genes was investigated. The 
synthetic ligand of GR, dexamethasone (DEX) was used as a positive control and the GR 
antagonist RU38486 was used to monitor whether the ligand-binding domain of GR was 
affected by the venom. Raw264.7 cells were pre-incubated with RU38486 for 1 hour when 
indicated and then stimulated with DEX or with venom for 6 hours. As the results in figure 7B 
show, the transactivation by DEX causes an increase in all three tested genes, while the prior 
addition of the antagonist resulted in a decrease of their expression, as expected. 
Interestingly, when N. vitripennis venom was added to the cells, an increase in GILZ 
expression could also be seen, halfmaximal to the increase caused by DEX. Notably, venom-
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induced MKP1 expression was even higher than the response to DEX. However, no effect of 
venom was apparent on FKBP5 expression. RU38486 addition prior to venom did not affect 
gene expression of these three GC indicator genes. 
 
Figure 7: Effect of N. vitripennis venom on the mRNA expression of secondary anti-inflammatory 
processes. A. Raw264.7 cells were stimulated with LPS (1 µ/ml) alone or with 5 µg/ml venom for 30 
minutes, 1 hour, 3 or 6 hours. Total RNA was isolated and the mRNA expression of IκBα and A20 was 
determined by RT-qPCR. hPRT1 and cyclophilin were used to normalize the data. The data are expressed 
as the mean ± S.D. of three biological replicates. Normality was confirmed by a Shapiro-Wilk test 
(W=0.9131 for IκBα, W= 0.8630 for A20). * p<0.05, ** p<0.01, *** p<0.001 for the venom-treated group 
compared with the vehicle group, ANOVA with Bonferroni posthoc test. B. Raw264.7 cells were pre-
incubated with RU38486 for 1 hour when indicated and then stimulated with 10-6 M DEX or with 5 µg/ml 
venom for 6 hours. Total RNA was isolated and the mRNA expression of GILZ, MKP1 and FKBP5 was 
determined by RT-qPCR. hPRT1 and cyclophilin were used to normalize the data. The data are expressed 
as the mean ± S.D. of three biological replicates. Normality was confirmed by a Shapiro-Wilk test 
(W=0.8952 for GILZ, W=0.8834 for MKP1, W=0.8424 for FKBP5). *** p<0.001, **** p<0.0001 for the DEX 
or venom group compared with the respective vehicle group and for the DEX + RU38486 or venom + 
RU38486 group compared with the respective RU38486 group; ANOVA with Bonferroni posthoc test. 
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Since venom suppressed IκBα and A20 mRNA expression, we were interested whether this 
was concomitant with a suppression at the protein level. Therefore, Raw264.7 cells either or 
not pre-treated with N. vitripennis venom, were treated with LPS for 30 minutes, 1 hour, 2, 3 
or 6 hours (figure 8 and figure S6). Western blot analysis showed that IκBα is almost 
completely degraded after 30 minutes and its resynthesis was detectable after 2 hours of 
LPS induction. When venom was applied on the cells, the resynthesis of IκBα remains 
suppressed even after 6 hours of LPS induction. This probably means that the lowered 
amount of IκBα mRNA caused by the venom (figure 7A) resulted in less translated IκBα 
protein. When looking at the presence of A20, an elevation at the protein level was noticed 
after 2 and 3 hours LPS induction. Venom caused a slight elevation of A20 after 2 hours of 
LPS induction, but a significant suppression could be noted when LPS was applied to the cells 
for 3 hours. This is probably the result of the suppressed A20 mRNA expression (figure 7A). 
 
 
Figure 8: Effect of venom on IκBα and A20 protein levels. Raw264.7 cells were left untreated or were 
pretreated with 5 µg/ml venom for 15 minutes and then stimulated with 1 µg/ml LPS for the indicated 
times. Total cell extracts were assayed by Western blot analysis using antibodies against indicated 
proteins. Tubulin-α was used as a loading control. A representative result from three separate 
experiments is shown. 
 
5. Discussion 
Studies on the immune suppressive effect of N. vitripennis venom have always been directed 
on hemocytes of their hosts (Zhang et al., 2005;Qian et al., 2013) or cultured insect cells 
(Rivers et al., 2002a, 2005;Abt & Rivers, 2007). While investigating the possible function of 
parasitoid venom on mammalian cells may seem unlogic at first, the plethora of available 
research tools in these cell lines, that highly exceeds what is available in insect cell lines, 
convinced us to start working on mammalian cell lines. Secondly, NF-κB transcription factors, 
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the MAPK signal transduction pathways and the glucocorticoid receptor signalling pathway 
that were studied, are evolutionary conserved in metazoan animals (Hatada et al., 
2000;Bolton et al., 2007). Finally, there is an enormous request for anti-inflammatory 
compounds in medicine that represents the high amount of future applications available 
(D'Acquisto et al., 2002). Since so many diseases are driven by chronic inflammatory 
responses, finding good drugs to control this excessive immune response has been the focus 
of much research. The last few decades, venoms have also been added to the growing list of 
anti-inflammatory drugs (Rajendra et al., 2004). The extraordinary finding that the venom of 
a parasitoid wasp is able to suppress the major mammalian immune pathway, intrigued us 
to fully disentangle this interaction. Respectively, we are the first to investigate the 
inhibitory effect of N. vitripennis venom on the NF-κB pathway in mammalian cells and to 
suggest its mode of action.  
 
Previous experiments on natural host organisms have shown that maternally derived venom 
from N. vitripennis disrupts host immune responses almost immediately following 
oviposition (Rivers et al., 2002b). Microarray analysis on parasitized S. crassipalpis pupae by 
N. vitripennis already suggested NF-κB and MAPK pathways in the host as potential 
candidates for the regulation of the immune response to envenomation (Danneels et al., 
2013). The current study was conducted to investigate the potential anti-inflammatory and 
anti-NF-κB responses of N. vitripennis venom on mammalian cells. A proposed model of the 
interactions between the venom and the NF-κB pathway is illustrated in figure 9. Since this 
venom has a high cytotoxicity to certain insect cell types (Zhang et al., 2005), cell viability 
was tested to establish the appropriate concentration ranges of venom for the analysis of 
ongoing experiments. When incubation periods of 6 hours were applied, 5 or 10 µg/ml 
venom appeared to be non-toxic concentrations and were used in further experiments. The 
initial focus was to see whether N. vitripennis venom could inhibit the NF-κB immune 
signalling pathway. This was first studied in murine fibrosarcoma cells stably transfected 
with a recombinant promoter that has an NF-κB-responsive element. Interestingly, when 
these cells were incubated with N. vitripennis venom, a clear dose-related inhibition of 
relative luciferase activity could be noted. Venom-mediated suppression of the NF-κB 
pathway could be confirmed in Raw264.7 macrophages, since the venom dose-dependently 
suppressed IL-6 mRNA and protein expression. This is a remarkable result, since this is the 
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first report that venom from an ectoparasitic wasp is able to suppress NF-κB signalling in 
mammalian cell lines.  
 
The following study focused on localizing the intrusion step by venom compounds. In 2006, 
Gilmore and Herscovitch reported on the identification of more than 785 inhibitors of NF-κB 
signalling (Gilmore & Herscovitch, 2006). They noted that in most cases, inhibition is based 
on a given agent’s ability to block one or more steps of NF-κB signalling in a tissue culture-
based system after stimulation of resting cells with an NF-κB inducer, most commonly either 
TNF or LPS. More than half of those described NF-κB inhibitors block a signal before the NF-
κB dimer is able to bind the DNA in the nucleus. N. vitripennis venom however, did not cause 
an effect on the cytosolic events, nor on the translocation of the NF-κB dimer to the nucleus 
for binding to the DNA, nor did it disturb the transactivation function of p65. These intriguing 
results forced further research activities into the direction of other pathways or regulatory 
mechanisms that could result into this inhibition of NF-κB activity. 
 
The phosphorylation and activation of three major MAPKs – p38, ERK1/2 and JNK – have 
been shown to initiate inflammatory gene expression in LPS-induced macrophages. 
Therefore, the effect of venom on these pathways was also investigated. Interestingly, we 
found that venom prolonged LPS-induced JNK activation in Raw264.7 macrophages. 
Genotoxic stresses, e.g. UV or γ-irradiation, and TNF-induced reactive oxygen species (ROS) 
accumulation induce long-lasting or prolonged MAPK activation, which in turn contributes to 
cell death (Sakon et al., 2003). NF-κB on the other hand, can protect cells against TNF 
cytotoxicity by inhibiting the sustained phase of TNF-induced JNK activation (Wullaert et al., 
2006). Prolonged JNK activation as a result of venom induction could be the result of NF-κB 
inhibition and eventually even lead to cell death. Indeed, N. vitripennis venom induces 
apoptosis of insect cells (Formesyn et al., 2013b), while in murine macrophages, only high 
doses and long induction times were cytotoxic to the cells.  
 
Since aberrant NF-κB activity can directly lead to uncontrolled tissue damage and deleterious 
disease (Staudt, 2010;Lawrence, 2009), the NF-κB driven inflammatory responses need to be 
down-regulated and properly terminated. Therefore, many distinct negative regulatory 
feedback mechanisms have evolved that operate at different molecular levels in the NF-κB 
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signalling pathway (Ruland, 2011). For instance, several proteins among which IκBα and A20, 
are NF-κB target genes, constituting a negative-feedback response. N. vitripennis venom 
was, by causing suppression of inhibitors of NF-κB signalling, indirectly found to give rise to 
an elimination of this negative-feedback response. The abrogation of this negative regulation 
can therefore be seen as the normal consequence of the venom-induced suppression of the 
NF-κB activity.  Another regulation of the NF-κB activation is realized by glucocorticoids 
(Almawi & Melemedjian, 2002). Today, nothing is known about possible steroids or 
corticoid-like substances in N. vitripennis venom. However, besides peptides and proteins, 
venoms are known to contain organic molecules, amines, alkaloids, salts and minerals (Fry et 
al., 2009) and recently, the venom from the toad Bufo bufo gargarizans was found to 
contain steroids that displayed potent inhibitory activities against cancer cells (Tian et al., 
2013). When we looked at genes that are regulated by GR, N. vitripennis venom induction 
caused an up-regulation of GILZ and MKP1. Intriguingly, GILZ and MKP1 are known to inhibit 
NF-κB signalling; GILZ through the interaction with p65 (Riccardi et al., 2001), and MKP1 via 
dephosphorylation and inactivation of members of MAPK family, preferably JNK and p38 
MAPK (Franklin & Kraft, 1997). Studies in T lymphocytes demonstrated that GILZ reduced 
NF-κB transcriptional activity (Ayroldi et al., 2001). Subsequent in vivo studies showed that 
administration of a GILZ peptide inhibits disease development in the experimental 
autoimmune encephalomyelitis model of multiple sclerosis, in part via effects on T cell 
activation (Srinivasan & Janardhanam, 2011). Together, these findings demonstrate a 
suppressive role of GILZ in the regulation of immune cell activation. We speculate GILZ up-
regulation as the most likely candidate for the venom-induced effect, but the precise mode 
of action still needs to be elucidated.  
 
We can conclude that in analogy with inhibition of immune responses in the natural insect 
host, also in mammalian cells anti-inflammatory responses of the venom can be observed. 
However, an interesting difference concerning MAPK pathways was observed. While the 
microarray study on the insect host showed significant down-regulation of a MAPK gene and 
up-regulation of a MAPK-phosphatase, an increase in activation of the JNK pathway was 
seen in the mammalian system. Apparently, the venom has a different mode of action in 
insects than in mammalian cells, which seems interesting to investigate more into detail. 
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Figure 9: Proposed model of venom interference with the NF-κB and glucocorticoid signalling pathways. 
TNF stimulation leads to activation of the canonical NF-κB signal transduction pathway marked by IκBα 
degradation and translocation of the p65-p50 dimer to the nucleus. Subsequent NF-κB DNA binding 
enables transcription of different genes, among which the cytokine IL-6. Venom treatment leads to the 
inhibition of TNF induced IL-6 gene expression. In addition, TNF activates the MAPKs, JNK, ERK1/2 and 
p38, and pretreatment with venom results in prolonged JNK activation. The negative NF-κB regulators A20 
and IκBα are indicated and both were suppressed by the venom. Glucocorticoid binding to the cytosolic 
Glucocorticoid Receptor (GR) results in the dissociation of chaperoning proteins, followed by GR 
translocation to the nucleus, where it can interfere with the activity of NF-κB. Activated GR can also 
directly bind to the DNA, stimulating transcription of FKBP5, MKP1 and GILZ target genes. Only the two 
latter genes are transcriptionally induced by the venom. The red arrows mark the various levels at which 
venom of N. vitripennis interferes with the represented cellular signalling pathways. 
Chapter 4 
131 
In view of the complexity of the NF-κB pathway, the identification of specific inhibitors with 
acceptable side-effects has been challenging, and new molecules are still actively sought 
after. Perhaps, venom from the ectoparasitoid wasp N. vitripennis can meet with these 
conditions by looking at the results presented here, but for sure, future experiments need to 
explore this further. 
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7. Supplementary Materials 
 
Figure S1: Effect of N. vitripennis venom on cell viability in Raw264.7 cells. Viability was measured after 6 
and 24 hours venom incubation in an MTT assay by adding 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) solution (0.5 mg/ml) to the cells. This solution was incubated at 37°C 
until blue deposits were visible. The formazan crystals were then solubilized in SDS/HCl solution and 
incubated for 5 hours at 37°C. The absorbance was determined colorimetrically at 595 nm. White bars 
represent 6 hours venom incubation, black bars represent 24 hours venom incubation. Normality was 
confirmed by a Shapiro-Wilk test (W=0.9677). Statistical analysis on 24 hours compared to 6 hours venom 
incubation, * p-value < 0.05, ANOVA and Dunn’s test. 
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Figure S2: Venom from N. vitripennis inhibits TNF-induced expression of a NF-κB-dependent reporter 
gene: not normalized luciferase and β–galactosidase values. L929sA cells stably transfected with a NF-κB-
dependent reporter gene were pretreated with indicated concentrations of venom for 15 minutes 
followed by stimulation for 6 hours with TNF (2000 IU/ml). A. Luciferase activity. B. β-galactosidase 
expression. The data are expressed as the mean ± S.D. of three biological replicates. Normality was 
confirmed by a Shapiro-Wilk test (W=0.9337 for A, W=0.9662 for B). * p<0.05, **** p<0.0001 versus TNF 
alone, ANOVA with Bonferroni posthoc test. 
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Figure S3: Venom does not inhibit PMA- or dB-cAMP-induced expression of neither an AP-1-dependent 
reporter gene, nor a CRE-dependent reporter gene respectively. On the left, L929sA cells stably 
transfected with an AP-1-dependent reporter gene were pre-treated with indicated concentrations of 
venom for 15 minutes followed by stimulation for 6 hours with phorbol 13-myristate 12-acetate (PMA) 
(10 nM). On the right, L929sA cells stably transfected with a CRE-dependent reporter gene were pre-
treated with indicated concentrations of venom followed by stimulation for 6 hours with N(6),2'-O-
dibutyryladenosine 3':5' cyclic monophosphate (dB-cAMP) (100 µM). A. Luciferase activity. B. β-
galactosidase expression. C. Normalized expression. The data are expressed as the mean ± S.D. of three 
biological replicates. Normality was confirmed by a Shapiro-Wilk test (W=0.8744 and W=0.7985 for A left 
and right respectively, W=0.9124 and W=0.9521 for B left and right respectively, W=0.9195 and W=0.8226 
for C left and right respectively), ANOVA with Bonferroni posthoc test. 
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Figure S4: Histograms of Western blots that show the effect of venom on cytosolic protein activity. 
Raw264.7 cells were left untreated or were pretreated with 5 µg/ml venom for 15 minutes and then 
stimulated with 1 µg/ml LPS for the indicated times. Total cell extracts were assayed by Western blot 
analysis using antibodies against indicated proteins: A. P-IKKα/β normalized with the unphosphorylated 
IKKβ. B. P-p65 normalized with the unphosphorylated p65. Bands of these proteins were quantified and 
data are expressed in histograms as the mean ± S.D. of three biological replicates. Normality was 
confirmed by a Shapiro-Wilk test (W=0.7242 for A, W=0.8585 for B). Statistics were performed by ANOVA 
with Bonferroni posthoc test. Relative amounts of normalized phosphorylated IKKα/β (A) and p65 (B) 
levels between venom-treated and not-induced cells were not significant. 
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Figure S5: Histograms of Western blots that show the effect of venom on phosphorylation of 
MAPKs.Raw264.7 cells were left untreated or were pretreated with 5 µg/ml venom for 15 minutes and 
then stimulated with 1 µg/ml LPS for the indicated times. Total cell extracts were assayed by Western blot 
analysis using antibodies against indicated proteins. A. P-p38 normalized with p38. B. P-ERK normalized 
with ERK. C. P-JNK normalized with JNK. Bands of these proteins were quantified and data are expressed 
in histograms as the mean ± S.D. of three biological replicates. Normality was confirmed by a Shapiro-Wilk 
test (W=0.7085 for A, W=0.8703 for B, W=0.9012 for C). Statistical analysis of venom-treated compared 
with not-induced cells, * p<0.01 versus TNF alone, ANOVA with Bonferroni posthoc test. 
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Figure S6: Histograms of Western blots that show the effect of venom on IκBα and A20 protein levels. 
Raw264.7 cells were left untreated or were pretreated with 5 µg/ml venom for 15 minutes and then 
stimulated with 1 µg/ml LPS for the indicated times. Total cell extracts were assayed by Western blot 
analysis using antibodies against indicated proteins. A. IκBα normalized with Tubulin- α. B. A20 normalized 
with Tubulin-α. Bands of these proteins were quantified and data are expressed in histograms as the 
mean ± S.D. of three biological replicates. Normality was confirmed by a Shapiro-Wilk test (W=0.9253 for 
A, W=0.7062 for B). * p<0.01, ** p<0.001 versus TNF alone, ANOVA with Bonferroni posthoc test. 
 
Table S1: Mouse-specific primer sets developed to amplify transcripts by RT-qPCR of immune specific 
proteins and housekeeping genes.  
Primer name Primer sequence 
IL6_qPCR_FWD 5’-GAGGATACCACTCCCAACAGACC-3’ 
IL6_qPCR_REV 5’-AAGTGCATCATCGTTGTTCATACA-3’ 
IkBa_qPCR_FWD 5’-TGAAGGACGAGGAGTACGAGC-3’ 
IkBa_qPCR_REV 5’-TTCGTGGATGATTGCCAAGTG-3’ 
A20_qPCR_FWD 5’-CCTTGCTTTGAGTCAGGCTGT-3’ 
A20_qPCR_REV 5’-TAAGGAGAAGCACGAAACATCGA-3’ 
FKBP5_qPCR_FWD 5’-TGAGGGCACCAGTAACAATGG-3’ 
FKBP5_qPCR_REV 5’-CAACATCCCTTTGTAGTGGACAT-3’ 
MKP1_qPCR_FWD 5’-GAGCTGTGCAGCAAACAGTC-3’ 
MKP1_qPCR_REV 5’-CTTCCGAGAAGCGTGATAGG-3’ 
GILZ_qPCR_FWD 5’-CCAGTGTGCTCCAGAAAGTGTAAG-3’ 
GILZ_qPCR_REV 5’-AGAAGGCTCATTTGGCTCAATCTC-3’ 
Cyclo_qPCR_FWD 5’-GCATACGGGTCCTGGCATCTTGTCC-3’ 
Cyclo_qPCR_REV 5’-ATGGTGATCTTCTTGCTGGTCCTTGC-3’ 
hPRT1_qPCR_FWD 5’-CCTAAGATGAGCGCAAGTTGAA-3’ 
hPRT1_qPCR_REV 5’-CCACAGGACTAGAACACCTGCTAA-3’ 
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Macrophages treated with venom from N. vitripennis were shown to up-regulate 
transcription of 2 GR-regulated genes, GILZ and MKP1 (see chapter 4, figure 7B). To follow 
up on this result, the effect of venom on the GR signalling cascade was further investigated. 
GR is a ligand-activated transcription factor that must translocate from the cytoplasm to the 
nucleus and interacts with the promoters of GC responsive genes. Transactivation occurs 
when liganded GR binds to glucocorticoid-response elements (GREs), activating transcription 
of GR target genes, like GILZ and MKP1. Possibly, N. vitripennis venom alters the 
transcriptional response elicited by GR, explaining the increase of GR-target genes. 
Therefore, the effect of venom on GR transactivation on a synthetic GRE-containing 
promoter reporter was investigated, while using DEX as positive control. HEK293T cells that 
do not contain functional GR, were used for this experiment. When an increasing amount of 
GR was transfected into the cells, an increase of transactivation by DEX could be seen, while 
the venom had no effect on this process (figure 1A).  
 
Furthermore, in order to examine whether the venom causes a change in nuclear 
localization of GR, fractionation of HEK293T cells was performed followed by western blot 
analysis of nuclear and cytoplasmic fractions (figure 1B). Hereby, DEX caused a 3-fold 
increase of GR nuclear localization, while venom showed the same amount of nuclear GR as 
in un-treated cells. In addition, immunofluorescence staining of GR was performed on 
HEK293T cells to visualize the trafficking of GR (figure 1C). DEX-treatment resulted in 
translocation of GR from the cytoplasm to the nucleus, while venom showed no alteration 
on this process. These results indicate that the venom induced up-regulation of GILZ and 
MKP1 are not caused by an increase in GR signalling, but are possibly mediated via activation 
of other transcriptional responses.  
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Figure 1: Transcriptional efficacy and nuclear localization of GR after DEX or N. vitripennis venom 
treatment. A. HEK293T cells were transiently transfected by the PEI method with 100 ng of p(GRE)2-50-luc 
either or not with two different concentrations of pGR (25 or 50 ng), the total amount of DNA being fixed 
at 200 ng. 10-6 M DEX or 10 µg/ml venom was added 6 hours before analysis. Lysates were made and the 
concentration of luc was determined by using β-gal values as a basis for normalization. *p<0.0001, ANOVA 
with Bonferroni posthoc test. B. Quantification of western blot analysis of nuclear and cytoplasmic 
extracts from HEK293T cells. Cells were incubated for 1 hour with 10-6 M DEX or 10 µg/ml venom. 
Subsequently, nuclear and cytoplasmic extracts were subjected to Western blot analysis to determine GR 
levels. Separation of nuclear and cytoplasmatic fractions was verified using PARP and Tubulin-α as 
respective controls. *p<0.0001, ANOVE with Bonferroni posthoc test. C. HEK293T cells were treated 
similar as in B, but after the inductions, immunofluorescence staining was performed to visualize the 
trafficking of GR.  
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1. Introduction 
N. vitripennis venom is known to contain (at least) 80 different proteins, and possibly much 
more peptides and other bio-molecules. The past century, natural products (NPs) have been 
the source of inspiration for the majority of FDA approved drugs. This is highlighted by the 
fact that nearly 50% of all drugs in clinical use is of natural product origin (Paterson & 
Anderson, 2005). These interesting chemicals are derived from the phenomenon of 
biodiversity in which the interactions among organisms and their environment formulate the 
diverse complex chemical entities within the organisms that enhance their survival and 
competitiveness (Mishra & Tiwari, 2011). The therapeutic areas of infectious diseases and 
oncology have benefited from the complex molecular scaffolds found in NPs of which the 
chemical diversity is unmatched by synthetic molecules. Animal venoms are a rich source of 
NPs that have evolved high affinity and selectivity for a diverse range of biological targets, 
especially membrane proteins such as ion channels, receptors and transporters. Therefore, 
venomics has emerged as an important addition to modern drug discovery efforts (Fry et al., 
2009). Snake venom is a treasure house of toxins that contributed significantly to the 
treatment of many medical conditions and presents a great potential as anti-tumour agent 
(Vyas et al., 2013). The venom and its constituents from honey bees has many therapeutic 
applications ranging from anti-arthritis and pain-releasing to anti-cancer effects (Son et al., 
2007). Venoms from parasitoid wasps contain a staggering amount of toxins, and because 
they can manipulate cell physiology in diverse ways (see chapter 1, 3.2. Mode of actions), 
their therapeutic potential seems interesting to dig into.  
 
In chapter 4, N. vitripennis venom was shown to exert a suppressive action on the NF-ĸB 
pathway in murine macrophages. This important transcription factor regulates a large 
number of target genes involved in multiple cellular processes including inflammation, 
immunity and stress responses. Dysregulation of this signal transduction pathway has been 
associated with inflammatory or autoimmune diseases and cancer. The analysis of the 
expression of nearly hundred key genes responsive to NF-ĸB signal transduction by the NF-
ĸB Signalling Targets PCR Array (SABiosciences, Qiagen) can result in a broader 
understanding of the effects of N. vitripennis venom on the immune response. Next to this, 
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alterations of NF-ĸB signalling target genes with a role in inflammatory diseases and 
oncology could hint at potential therapeutic lead compounds present in the venom.  
 
In 1999, Pahl listed over 150 target genes known to be expressed by the active NF-ĸB 
transcription factor (Pahl, 1999). To date, this list has been extended by more than 250 extra 
investigated NF-ĸB target genes and even more than 300 genes are predicted by computer-
based methods to have composite NF-ĸB regulatory sites (http://www.bu.edu/nf-kb/gene-
resources/target-genes/). The majority of proteins encoded by NF-ĸB target genes 
participate in the host inflammatory and immune responses, which include cytokines and 
chemokines, as well as receptors required for immune recognition, proteins involved in 
antigen presentation, acute phase proteins and cell adhesion molecules. Many of them are 
induced by exposure to a wide variety of bacteria, hosts of viruses and their respective 
products. NF-ĸB, however, is involved in the control of transcription of many genes whose 
functions extend beyond the immune response, but are involved in more general stress 
responses. Various physiological stress conditions such as liver regeneration and 
hemorrhagic shock can activate NF-ĸB. Also physical stress in the form of irradiation as well 
as oxidative stress to cells induce NF-ĸB, that in turn activates a large variety of stress 
response genes. In fact, NF-ĸB relays the information of an imminent stress and at the same 
time enacts a response by promoting the transcription of genes whose products alleviate the 
stress condition. The human body is also exposed to environmental hazards and therapeutic 
drugs, activating NF-ĸB that in turn activates its target genes including many cell surface 
receptors. Several stimuli, among them the cytokine TNFα, can lead to NF-ĸB activation that 
exerts anti-apoptotic activities. On the other hand, there is ample evidence for apoptosis-
promoting functions of NF-ĸB as well (Kaltschmidt et al., 2000;Bednarski et al., 2009). The 
nature of the apoptotic stimulus determines the pro- or anti-apoptotic function of NF-ĸB. 
Activation of NF-ĸB can lead to the transcriptional induction of various transcription factor 
genes, even members of the own Rel/NF-ĸB/IĸB family. The enormous amount of NF-ĸB 
target genes can be categorized in the different groups mentioned above, which has been 
done for the 84 tested genes in the NF-ĸB Signalling Targets PCR Array. 
 
Since it is now known that venom from N. vitripennis suppresses activation of NF-κB 
signalling (see chapter 4), is seems interesting to investigate the consequences of this 
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inhibition on the expression of its signalling targets. Certain pathologies, like cancer or 
inflammatory diseases, can cause great alterations in expression levels of NF-κB target 
genes. If a certain product can specifically interrupt this alteration, it holds great promise as 
therapeutic agent. This was investigated by applying N. vitripennis venom on macrophage 
cells after treatment with LPS, presenting the cells with an immune challenge.  By analysing 
the effects of this venom on NF-κB signalling targets, its possible biomedical application can 
be reveiled.  
 
2. Materials and methods 
2.1. Isolation of crude wasp venom 
See  Materials and methods, Chapter 4. 
 
2.2. Cell culture and treatment 
Mouse macrophage-like Raw264.7 cells were maintained in RPMI 1640 medium at 37°C in 
5% CO2 humidified air. Medium was supplemented with 10% fetal bovine serum, 100 
units/ml penicillin and 0,1 mg/ml streptomycin. Twenty-four hours before induction, cells 
were seeded in multiwell dishes so that they were confluent at the time of the experiment. 
Raw264.7 cells were submitted to the following different treatments: untreated; 6-hour LPS 
induction (1 µg/ml); 6 hours and 15 minutes incubation with 10 µg/ml of N. vitripennis 
venom; 6 hours LPS induction and 6hours and 15 minutes venom incubation. The 4 
treatments were performed in duplicate. 
 
2.3. Total RNA extraction and reverse transcription 
RNA was isolated by using TRIzol Reagent (Invitrogen) as described previously (De Bosscher 
et al., 2005). An on-column DNase digestion was performed and the concentration of RNA in 
all 8 samples was measured. Equal amounts of RNA were reverse-transcribed into cDNA 
using the RT² First Strand Kit (Qiagen) following the manufacturer’s instructions.  
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2.4. Real-time PCR-based array analysis 
The relative expression of NF-ĸB signalling target genes was determined in each of the 8 
samples by RT-qPCR (RT² Profiler Mouse NF-ĸB Signalling Targets PCR Array; SABiosciences 
Corp., Frederick, MD) using the qPCR master mix (RT² SYBR Green; SABiosciences Corp.) 
according to the supplier’s directions. Mixes were pipetted into 384-well PCR array plates to 
evaluate the expression of 84 NF-ĸB signalling target genes. RT-qPCR was performed in 
technical duplicates (Roche LightCycler 480, 384-well block). Raw data from the real-time 
PCR were uploaded using a PCR array data analysis template available at 
http://www.sabiosciences.com/pcr/arrayanalysis.php. Quality controls included within the 
array plates confirmed the lack of DNA contamination and successfully tested for RNA 
quality and PCR performance. The integrated Web-based software package for the PCR array 
system automatically performed all comparative threshold cycle (ΔΔCt)-based fold-change 
calculations from the uploaded data. For these calculations, the average expression of 3 
housekeeping genes (β-actin, glyceraldehydes-3-phosphate dehydrogenase and β2-
microglobulin) was used for normalization of the data. After normalization, the relative 
expression of each gene was averaged for the 2 samples in each condition. Fold regulations 
in average gene expression were expressed as the difference in expression of venom-treated 
compared with untreated cells, or of venom- and LPS-treated compared with only LPS-
treated cells. A fold change ≥ 2.5 with p≤0.05 was considered significant.  
 
3. Results and discussion 
To gain better insight in the NF-ĸB regulating effects of the  N. vitripennis venom, a PCR array 
experiment was set up to evaluate the expression of some NF-ĸB target genes under 
different conditions. Thereto Raw264.7 cells were treated with N. vitripennis venom, with or 
without LPS stimulation. Significant relative expression of 84 genes was evaluated by RT-
qPCR as presented in table S1. The genes that show a significantly differential expression of 
more than 2.5-fold higher or lower in the comparisons of venom-treatment versus no 
treatment and venom- and LPS-treatment versus LPS-treatment alone are summarized in 
table 1 in which the NF-ĸB target genes are classified according to their properties and/or 
functions. 
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The LPS stimulation increased transcription of 36 NF-ĸB target genes and down-regulated 
the expression level of 1. The highest up-regulated genes can be found in the groups of the 
cytokines/chemokines, stress response genes and growth factors. Several transcription 
factors show an elevated transcription level, among them TFs that belong to the own NF-ĸB 
cascade. In chapter 4, RT-qPCR on Raw264.7 cells stimulated with N. vitripennis venom 
showed no significant effect in mRNA levels of IĸBα and A20, that are both early response 
genes. The NF-ĸB Signalling Targets PCR Array resulted in 1 NF-ĸB target gene that showed 
down-regulated expression, and 9 that were up-regulated after venom treatment. 
Remarkable is the up-regulation of Relb expression by venom treatment, which could 
possibly lead to further elevation in expression of other NF-ĸB target genes. On the other 
hand, Reporter Array performed after venom treatment on human embryonal kidney cells 
(HEK293T) resulted in the induction of several transcription factors, like ATF2/3/4, C/EBP, 
AP-1 and MEF2 (figure S1; Formesyn, 2013c) potentially attributing to the up-regulated 
expression levels shown here.  
 
Before cells are stimulated with LPS, NF-κB subunits like p50 and p52 can already be bound 
to NF-κB binding sites in the promoters of a number of genes, exhibiting a certain range of 
expression levels (Schreiber et al., 2006). After cellular stimulation with LPS, other NF-κB 
family members enter the nucleus and bind to those genes and to other genes, leading to 
enhanced gene transcription. N. vitripennis venom could influence this process before cells 
are stimulated with LPS resulting in the down-regulated expression level of NF-κB target 
gene, cyclin D1.  
 
Transcription of the stress response gene NAD(P)H dehydrogenase quinone 1 (Nqo1) is 
almost 25 times up-regulated after venom treatment. This gene has been demonstrated to 
play an important role in protecting cells against oxidative stress (Dinkova-Kostova & Talalay, 
2000). Venoms of several animals, including the parasitoid wasp Aphidius ervi, are known to 
cause oxidative stress in their host organism (Falabella et al., 2007;Katkar et al., 2014). The 
elevation of the Nqo1 gene expression after venom treatment in macrophage cells could 
therefore suggest a protective function. Remarkably, the venom induced transcription of 2 
growth factors, colony stimulating factor 1 and 3 (Csf1 and Csf3) that stimulate the bone 
marrow progenitor cells to differentiate into macrophages or granulocytes respectively. 
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These proteins have an important role in innate immunity and inflammation (Takahashi et 
al., 1996). Especially transcription of Csf1 is highly up-regulated (nearly 56 times), which 
even doubles when the cells are immune challenged with LPS.  
 
However, most differentially expressed genes could be observed when venom was added to 
the macrophage cells, combined with an immune challenge of LPS. Transcription of two of 
the NF-ĸB target genes tested by the NF-κB Signalling Target PCR Array were previously 
tested by RT-qPCR: IĸBα and IL-6 (see chapter 4). Although the suppression of IĸBα 
transcription (see figure 7A in chapter 4) could not be validated in this experiment, the 2-fold 
inhibition of IL-6 transcription on the other hand (see figure 2B in chapter 4) could be 
confirmed by a 1.5-fold down-regulation in the PCR Array. Transcription of the cytokine IL-
1β, produced by activated macrophages and an important mediator of inflammatory 
response, shows a nearly 6-fold up-regulation after venom-treatment, while being 4.3 times 
down-regulated after co-treatment of venom and LPS. Apparently, the cells need to be 
immune challenged, in this case by LPS, in order for the venom to be able to suppress the 
inflammatory response.  
 
In the previous chapter, we focussed on the inhibitory effect of venom on the canonical NF-
κB pathway, in which IKKβ phosphorylates IκBs at N-terminal sites to trigger their ubiquitin-
dependent degradation and induce nuclear entry of RelA:p50 dimers (Karin & Ben-Neriah, 
2000). The remark has to be made that next to this classical NF-κB signalling pathway, an 
alternative non-canonical signalling cascade has been identified that activates NF-κB 
signalling based on processing of the NFκB2:p100 precursor protein by IKKα (Xiao et al., 
2001, figure 1). In this alternative NF-κB pathway, the stimulation by LPS (among others) 
results in the nuclear translocation of the dimer RelB:p52 (Mordmuller et al., 2003). While 
many target genes are shared between the canonical and the non-canonical pathways, some 
promoters of NF-κB target genes are only recognized by RelB:p52 dimers and not by 
RelA:p50 dimers (Bonizzi et al., 2004;Schreiber et al., 2006). Several NF-κB target genes can 
bind multiple members of the NF-κB family, suggesting that they can be activated by both 
the canonical and the non-canonical pathways. For instance, Icam1 and Gadd45b can bind all 
5 members of the NF-κB family (p52, p50, Rela, Relb and c-Rel) in U937 cells after LPS 
stimulation (Schreiber et al., 2006). When Raw264.7 cells were treated with N. vitripennis 
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venom, transcription of Icam1 and Gadd45b were up-regulated respectively 17.63 and 10.99 
times.  Therefore, it can be suggested that N. vitripennis venom potentially has an inhibitory 
effect on the canonical pathway (see chapter 4), but a stimulatory effect on the alternative 
NF-κB signalling pathway explaining the up-regulation of some inflammatory genes. This 
hypothesis however needs to be further investigated. Interestingly, N. vitripennis venom up-
regulated transcription of 4 different NF-κB subunits when cells were co-treated with LPS, of 
which Nfkb2 (p52) and Relb, that take part in the non-canonical NF-κB pathway, show the 
highest elevations.  
 
 
Figure 1: The canonical NF-κB pathway (left) induced by signals including antigens, TLR ligands and 
cytokines such as TNF uses a wide variety of signalling adaptors to engage and activate the IKKβ subunit of 
the IKK complex. IKKβ phosphorylation of classical IκB proteins bound to NF-κB dimers such as p50-p65 
results in ubiquitination (Ub) of IκB and proteasome-induced degradation. This allows NF-κB to enter the 
nucleus where it binds specific DNA sequences (κB sites). The noncanonical pathway (right) engaged by 
members of the TNF-like family of cytokines requires NIK to activate IKKα, which then phosphorylates 
p100 (NF-κB2), triggering its proteosomal processing needed for the activation of p52-RelB dimers. (figure 
from Gerondakis et al., 2014) 
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Table 1: Differentially expressed NF-ĸB signalling target genes in Raw264.7 cells after treatment with N. 
vitripennis venom, either induced with LPS or not. Gene fold regulations for the comparison of venom- 
and LPS-treatment versus LPS-treatment alone are presented in the third column (Venom+LPS/LPS). The 
last column contains differentially expressed genes for the comparison of venom-treatment versus no 
treatment(Venom/veh). When no number is inserted, the fold regulation was not significant (p≤0.05 
or/and FR≥-2.5 or ≤2.5). (Abb = abbreviation; FR = fold regulation)  
Differentially expressed NF-ĸB target genes Abb 
FR  
(Venom+ 
LPS/LPS) 
FR  
(Venom/ 
veh) 
Cytokines, chemokines and their modulators       
Interleukin 15 Il15 13.41 
 
Interleukin 1 beta Il1b -4.39 5.88 
Immunoreceptors       
CD40 antigen Cd40 
 
9.93 
CD83 antigen Cd83 29.40 
 
Cell adhesion molecules       
Intercellular adhesion molecule 1 Icam1 17.63 
 Vascular cell adhesion molecule 1 Vcam1 3.48 
 Stress response genes       
NAD(P)H dehydrogenase, quinone 1 Nqo1 
 
24.64 
Regulators of apoptosis       
B-cell leukemia/lymphoma 2 related protein A1a Bcl2a1a 
 
5.03 
Baculoviral IAP repeat-containing 2 Birc2 6.29 
 Baculoviral IAP repeat-containing 3 Birc3 3.60 
 Fas (TNF receptor superfamily member 6) Fas 6.86 3.26 
Tnf receptor-associated factor 2 Traf2 5.11 
 Growth factors, ligands and their modulators       
Colony stimulating factor 1 (macrophage) Csf1 117.79 55.85 
Colony stimulating factor 3 (granulocyte) Csf3 -31.72 5.49 
Transcription factors and their modulators       
Interferon regulatory factor 1 Irf1 13.95 
 Microphthalmia-associated transcription factor Mitf 7.25 
 Myelocytomatosis oncogene Myc 
 
17.90 
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105 Nfkb1 3.40 
 
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p52/p100 Nfkb2 10.25 
 
Reticuloendotheliosis oncogene Rel 3.86 
 
Avian reticuloendotheliosis viral (v-rel) oncogene related B Relb 8.68 3.59 
Miscellaneous       
Cyclin D1 Ccnd1 -7.44 -2.67 
Growth arrest and DNA-damage-inducible 45 beta Gadd45b 10.99 
 Matrix metallopeptidase 9 Mmp9 -5.80 
  
 
The potential of N. vitripennis venom as therapeutic agent 
150 
Interesting is the number of up-regulated NF-ĸB target genes involved in apoptosis 
regulation after venom and LPS co-treatment. Formesyn and colleagues have previously 
proven that serine proteases and metalloproteases in N. vitripennis venom cause apoptosis 
in non-host insect cells and suggested their possible role in immune related processes 
(Formesyn et al., 2013b). In this PCR Array on murine macrophages, pro- as well as anti-
apoptotic mediators were differentially expressed: Fas activation induces apoptosis (Huang 
et al., 1999), while Birc2, Birc3 and Traf2 are known for their anti-apoptotic effects (Wang et 
al., 2012;Lin et al., 2003).  
 
An acute stimulation, for instance by LPS, is known to create two distinct waves of NF-ĸB 
recruitment to target promoters: a fast recruitment to immediately accessible promoters 
and a late recruitment to promoters requiring stimulus-dependent modifications in 
chromatin structure to make NF-ĸB sites accessible (Saccani et al., 2001). A relatively long (6 
hours) LPS-treatment was chosen in the PCR Array experiment, so the data are in relation to 
the results presented in chapter 4. Unfortunately, possible transient effects caused by N. 
vitripennis venom, due to the short mRNA half life of many of the early response genes, 
cannot be observed by this experiment and time kinetics would need to be performed in 
order to have a glimpse on the complete venom profile.  
 
Besides an NF-ĸB binding site, the promoter of the genes tested by this PCR Array may also 
contain binding sites for other transcription factors (TFs). Instead of an up-regulated 
transcription by NF-ĸB binding to the promoter, expression of these genes can also be 
targeted by other TFs. When performing a TFSEARCH, the promoter sequence of a gene of 
interest can be screened for possible TF binding sites by correlating this sequence against 
the TRANSFAC MATRIX database. The upstream gene sequence 2000 nucleotides before and 
50 nucleotides after the start of the gene (where the promoter sequence is assumed to be 
located) is inserted into the TFSEARCH program and a 85.0 threshold is used. This was done 
for 5 genes that showed the highest significant up-regulated fold regulation (FR) after 
venom-and LPS-treatment, and for 4 genes that had a negative FR after venom- and LPS-
treatment. All 9 genes obviously contained the NF-ĸB TF binding site, as the genes included 
in the array were previously demonstated to be NF-ĸB target genes. The TF binding sites that 
were predicted by the program to be present in all 5 up-regulated genes were listed in table 
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2. This means that the up-regulated transcription of these genes, next to NF-ĸB binding to 
their promoter, could also be the result of binding of these other TFs to their promoters. 
When looking at these TF binding sites in the promoters of the 4 down-regulated genes, 
cAMP response element-binding protein (CRE-BP) can be a possible candidate for causing 
the synthesis of several of the tested genes while at the same time not having an increasing 
effect in transcription of Csf3, Mmp9 and Ccnd1, since these genes do not contain a binding 
site for CRE-BP. On the other hand, a role of CCAAT-enhancer-binding proteins (C/EBPs) in 
the activation of NF-ĸB target genes can also be proposed. C/EBP binding sites can be found 
in promoter regions of several tested genes with an up-regulated transcription, while being 
absent in the promoters of some of the down-regulated genes (see table 2). Additionally, 
C/EBPs can interact with p50 homodimers activating NF-ĸB target genes, even in the 
absence of canonical NF-ĸB activation (Dooher et al., 2011). Interestingly, the reporter array 
performed on HEK293T cells treated with N. vitripennis venom, also showed significant up-
regulation of the C/EBP reporter (figure S1). The presence (or absence) of many other TF 
binding sites in specific gene promoters could possibly aid to explaining the apparent 
contradiction between the up-regulation of several inflammatory genes by N. vitripennis 
venom, but at the same time the anti-inflammatory activity of the venom on the other hand 
(see chapter 4). Other mechanisms can play a role in the change of gene expression: 
microRNAs can post-transcriptionally bind to the 3’-UTR (untranslated region) of their target 
mRNAs and repress protein production (Cannell et al., 2008), or epigenetic phenomena like 
DNA methylation or histone modification can cause differential gene expression (Jaenisch & 
Bird, 2003). Untill now, none of these processes have been investigated for the gene 
alterations caused by parasitoid venoms. 
 
The remark has to be made that venom from N. vitripennis is a complex mixture of at least 
80 different proteins. Maybe even more other venom compounds like peptides or other bio-
molecules could be present, all having their own effects on gene regulation. Regarding to 
venomous effects on the complex apoptosis process, it would be interesting to see how the 
separate venom compounds, especially the serine proteases and metalloproteases as tested 
in insect cells (Formesyn et al., 2013b), would affect the mammalian cell death process. But 
it would also be interesting to investigate what the effects of individual venom compounds 
would be on mammalian cells, concerning gene regulation.  
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Table 2: Transcription factor binding sites that are commonly present in the promoters of 5 up-regulated 
genes tested by the NF-ĸB Signalling Targets PCR Array, predicted by TFSEARCH (threshold 85.0). The 
presence of these TF binding sites is shown for 4 down-regulated genes when cells were treated with 
venom and LPS. ‘x’ represents the presence of the respective TF site in the promoter region of that 
particular gene. At the bottom are the fold regulations presented of the selected genes. 
NF-κB signalling target genes Cd83 Csf1 IL15 Irf1 Icam1 Il1b Csf3 Mmp9 Ccnd1 
TF binding site 
   
 
     
NF-Kap x x x x x x x x x 
C/EBP x x x x x x x x 
 
C/EBPa x x x  x 
 
x x 
 
AML-1a x x x x x x x x x 
CdxA x x x x x x x x x 
CRE-BP x x x x x x 
   
deltaE x x x x x x x x x 
GATA-1 x x x x x x x x x 
GATA-2 x x x x x x x x x 
GATA-3 x x x x x 
 
x x x 
GATA-X x x x x x x x 
 
x 
HSF2 x x x x x x  x  
MZF1 x x x x x x x x x 
Nkx-2. x x x x x x x x x 
Oct-1 x x x x x x x x 
 
SRY x x x x x x x x x 
TATA x x x x x x 
 
x x 
Fold regulation 
   
 
     
venom- and LPS- vs LPS-treated 29.4 117.8 13.4 14.0 17.6 -4.4 -31.7 -5.8 -7.4 
venom-treated vs untreated 3.0 55.9 2.5 2.0 1.2 5.9 5.5 1.6 -2.7 
 
Many of the target genes of NF-ĸB signalling are involved in multiple inflammatory or 
autoimmune diseases. Some of them are promising targets in certain therapies (Dziadziuszko 
& Jassem, 2012;Lawlor et al., 2004), while others can themselves be used as agents in 
processes involved in human diseases (Murray, 1994;Bouker et al., 2005). Interestingly, N. 
vitripennis venom significantly altered the expression of some of these possible drug targets, 
presenting the venom with an exciting potential as therapeutic in several diseases (table 3). 
The second highest up-regulated NF-ĸB target gene transcription tested after the addition of 
solely venom on the cells, was NAD(P)H:quinone oxidoreductase 1 (Nqo1). This enzyme 
detoxifies quinones and reduces oxidative stress. Low activity of this enzyme is associated 
with increased risk of acute leukemia in adults (Smith et al., 2001). Inducing this 
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detoxification enzyme in certain mammalian cell types could potentially benefit patients 
suffering from acute leukemia.  
 
For the other venom targets with potential therapeutic application, the cells needed to be 
immune challenged with LPS, offering a possible use in diseases characterized by 
constitutive activity of NF-ĸB, like autoimmune diseases (Ellrichmann et al., 2012) or many 
cancers (Voboril & Weberova-Voborilova, 2006). With regard to anti-inflammatory drugs, 
colony stimulating factor 3 (Csf3) with a nearly 32-fold decrease in transcription after venom 
and LPS incubation compared to LPS induction, seems the most interesting to further 
investigate. This regulator of granulopoiesis has a critical role in driving joint inflammatory 
diseases, like rheumatoid arthritis (RA), and its antagonists may be of therapeutical value 
(Lawlor et al., 2004). Anti-IL-1β is a commonly used drug with the name canakinumab used 
in several auto inflammatory diseases (Dinarello, 2010). Previously mentioned inhibition of 
IL-1β transcription by venom- and LPS-treatment may therefore hint at a therapeutic role of 
N. vitripennis venom.  
 
Intriguingly, the possible anti-cancer role of N. vitripennis venom is displayed by the 
regulation of different NF-ĸB targets. Transcription of Cyclin D1, involved in the G1-S phase 
transition of cells, is significantly suppressed by N. vitripennis venom, with and without LPS-
treatment. Since pharmacological inhibition of cyclin D1/CDK4 complexes is suggested to be 
a useful strategy to inhibit the growth of tumours, the potential of N. vitripennis venom in 
cancer treatments is worthwhile to further investigate. In contrast, the expression of Irf1 is 
significantly up-regulated after the co-treatment of venom and LPS. A functional role of Irf1 
was established in the growth suppression of breast cancer cells and it was implicated to act 
as a tumor suppressor gene in breast cancer by controlling apoptosis (Bouker et al., 2005). 
The potential of N. vitripennis venom as therapeutic agent in several oncogenetic diseases is 
therefore interesting to dig into.  
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Table 3: NF-ĸB target genes that were differentially transcribed and can be a possible drug target of N. vitripennis venom. Three different comparisons are 
presented: venom-treated versus no treatment, venom- and LPS-treatment versus LPS-treated cells and LPS-treatment versus no treatment. In bold is the fold 
regulation that lead to the assumption of the venom being a possible drug target. (Abb = abbreviation; FR = fold regulation) Fold regulations are only mentioned 
when p≤0,05 and FR≥2,5 and FR≤2,5 
Possible drug targets of venom Abb 
FR venom 
(untreated  
control) 
FR venom+LPS 
(LPS control) 
FR LPS  
(untreated control) 
Potential targeted diseases Reference 
NAD(P)H dehydrogenase, quinone 1 Nqo1 24.64   acute leukemia (Smith et al., 2001) 
Cyclin D1 Ccnd1 -2.67 -7.44 -5.05 breast cancer (Grillo et al., 2006) 
Interferon regulatory factor 1 Irf1  13.95 2.95 breast cancer (Bouker et al., 2005) 
Matrix metallopeptidase 9 Mmp9  -5.80 17.82 cancer (Hua et al., 2011) 
Colony stimulating factor 3 (granulocyte) Csf3 5.49 -31.72 15821.68 inflammatory arthritis (Lawlor et al., 2004) 
Interleukin 1 beta Il1b 5.88 -4.39 15647.33 autoinflammatory diseases (Dinarello, 2010) 
Complement factor B Cfb 
 
-4.20 14.68 
complement mediated  
inflammatory diseases 
(Ruiz-Gomez et al., 2009) 
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4. Conclusion 
The NF-ĸB Signalling Target PCR Array performed on Raw264.7 macrophages treated with N. 
vitripennis venom and/or LPS uncovered several new ideas on how the venom exerts its 
complex effects. The inhibition of the canonical NF-ĸB pathway by the venom described in 
chapter 4 is however not that obvious when looking at the expression of a large number of 
NF-ĸB target genes. Several aspects encourage us to be cautious in interpreting the results. 
The complexity of the venom mixture applied on the cells creates multiple crosstalk effects, 
that could be circumvented when working with separate venom compounds. The fact that 
one time-point was used, only gives a glimpse of the complete picture. Additionally, changes 
in transcription expression do not always translate into the same changes in protein level, 
since alterations in translation efficiency and post-translational modifications can lead to a 
different end-result. Possible effects on the non-canonical NF-ĸB pathway next to the 
canonical pathway, in addition to the presence of multiple TF sites in the promoter of NF-ĸB 
target genes, makes the puzzle extra hard to solve. However, keeping all these remarks in 
mind, still several interesting hints for future research could be noted, which was the original 
intent of this experiment. Some NF-ĸB target genes that were differentially expressed by the 
addition of N. vitripennis venom, with or without LPS-treatment, are drug targets of major 
diseases, hinting to possible future biomedical application as therapeutic agent in several 
human diseases. Performing time kinetics and dose-responses by the separated venom 
compounds seems the logical next step.  
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5. Supplementary materials 
Table S1: Effect of N. vitripennis venom in Raw264.7 cells, either induced with LPS or not, on NF-ĸB 
signalling targets. Fold regulation of all tested NF-ĸB signalling target genes are presented in the different 
comparisons with either LPS-treated or untreated cells as control. When no fold regulation is inserted, 
p>0,05 (Abb = abbreviation; FR = fold regulation)  
NF-ĸB signalling target genes Abb 
FR 
(LPS versus 
untreated 
control) 
FR 
(venom 
versus 
untreated 
control) 
FR 
(LPS- and 
venom 
versus LPS 
control) 
Cytokines/chemokines and their modulators         
Chemokine (C-C motif) ligand 22 Ccl22 917.635   
Chemokine (C-C motif) ligand 5 Ccl5 1254.881   
Chemokine (C-C motif) receptor 5 Ccr5 1.625   
Chemokine (C-X-C motif) ligand 10 Cxcl10 483.835   
Chemokine (C-X-C motif) ligand 3 Cxcl3 111.806   
Interleukin 15 Il15   13.408 
Interleukin 1 alpha Il1a 1273.082  
 Interleukin 1 beta Il1b 15647.327 5.885 -4.392 
Interleukin 1 receptor antagonist Il1rn 26.052   
Interleukin 6 Il6 525.452  -1.472 
Lymphotoxin A Lta 25.056   
Tumor necrosis factor Tnf 36.399  -1.193 
Immunoreceptors         
CD40 antigen Cd40 68.505 9.933  
CD80 antigen Cd80 3.113   
CD83 antigen Cd83   29.395 
Tumor necrosis factor receptor superfamily, member 1b Tnfrsf1b 22.445   
Proteins involved in antigen presentation         
Complement component 3 C3 3.651  
 Complement factor B Cfb 14.677  -4.199 
Cell adhesion molecules         
Intercellular adhesion molecule 1 Icam1   17.631 
Vascular cell adhesion molecule 1 Vcam1   3.481 
Acute phase proteins         
Coagulation factor III F3 41.407   
Stress response genes         
NAD(P)H dehydrogenase, quinone 1 Nqo1 
 
24.637  
Prostaglandin-endoperoxide synthase 2 Ptgs2 698.790 
 
 
Superoxide dismutase 2, mitochondrial Sod2 4.919 -1.052  
Regulators of apoptosis         
B-cell leukemia/lymphoma 2 related protein A1a Bcl2a1a 33.896 5.027  
Bcl2-like 1 Bcl2l1 2.677   
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Baculoviral IAP repeat-containing 2 Birc2 
 
 6.288 
Baculoviral IAP repeat-containing 3 Birc3 1.874  3.599 
Fas (TNF receptor superfamily member 6) Fas 11.621 3.261 6.857 
Tnf receptor-associated factor 2 Traf2  1.983 5.107 
Growth factors, ligands and their modulators         
Colony stimulating factor 1 (macrophage) Csf1 35.675 55.854 117.792 
Colony stimulating factor 2 (granulocyte-macrophage) Csf2 530.000 
  Colony stimulating factor 3 (granulocyte) Csf3 15821.676 5.486 -31.724 
Platelet derived growth factor, B polypeptide Pdgfb 3.395 
  Transcription factors and regulators         
Interferon regulatory factor 1 Irf1 2.945  13.953 
Microphthalmia-associated transcription factor Mitf 
 
 7.247 
Myelocytomatosis oncogene Myc 25.814 17.898 
 Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 1, p105 Nfkb1 4.526  3.399 
Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 2, p49/p100 Nfkb2 
 
 10.255 
Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor, alpha Nfkbia 7.963   
Reticuloendotheliosis oncogene Rel 2.664  3.864 
Avian reticuloendotheliosis viral (v-rel) oncogene related B Relb  3.591 8.675 
Signal transducer and activator of transcription 1 Stat1 2.855 -1.257 
 Signal transducer and activator of transcription 3 Stat3 1.517 -1.104 -1.444 
Miscellaneous         
Cyclin D1 Ccnd1 -5.051 -2.667 -7.439 
Growth arrest and DNA-damage-inducible 45 beta Gadd45b 8.330 
 
10.985 
Matrix metallopeptidase 9 Mmp9 17.819 
 
-5.805 
The potential of N. vitripennis venom as therapeutic agent 
158 
 
Figure S1: Selective up- and down-regulation of several pathways after N. vitripennis venom treatment in HEK293T cells tested by Cignal FinderTM 45-Pathway 
Reporter Array. Normalized values of both test and control samples were used to calculate the mean fold change of pathway (in)activation. A fold change of 1 
indicates no differences in pathway activation between test and control samples. A fold change < 1 indicates a pathway down regulation in venom treated cells, up-
regulation of pathways upon venom treatment is indicated by a fold change > 1. Asterisks indicate the significant up- and down-regulation of pathways when 
comparing relative luciferase units of venom-treated samples with untreated samples, ANOVA with Bonferroni posthoc test, * p<0.05. 
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1. Molecular traits of the parasitoid-host interaction 
Attack and oviposition by parasitic wasps induce vigorous physiological alterations in the 
host insect. Although endo- and ectoparasitoids differ in venom composition and mode of 
egg-laying, successful parasitization by both results in alterations of host development, 
immunity and metabolism (Asgari & Rivers, 2011;Danneels et al., 2010). In the end, hosts are 
completely consumed by the developing wasp larvae, but the different strategies used by 
female wasps varies extensively. Since endoparasitoids lay their eggs inside the host body 
tissues, effective ways to evade host defence responses are crucial. Asobara tabida for 
instance, an endoparasitoid of D. melanogaster, lays eggs that adhere to the fat body and 
other internal organs of the host. This results in incomplete formation of a capsule, which 
allows the parasitoid eggs to hatch and escape encapsulation (Wertheim et al., 2005). 
Because ectoparasitoids lay their eggs on the outside of hosts, less extensive suppression of 
host immune systems can be expected. On contrary, Nasonia vitripennis lays its eggs on the 
outside of the host outer integument, and was proven to affect host hemocytes mediating 
cellular and humoral immune responses (Rivers et al., 2002b;Qian et al., 2013). To offer the 
best possible environment for the offspring, parasitoids use an extensive arsenal of virulence 
factors: polydnaviruses, virus-like particles, venom, teratocytes and proteins secreted from 
larvae (Beckage & Gelman, 2004). Interestingly, N. vitripennis only has venom and larval 
secretions at its disposal to ensure successful parasitization. This means that before the eggs 
hatch and larvae actively start feeding, host physiology can only be channelled by maternally 
derived venom. Aiming at understanding this fascinating interaction, we performed a 
transcriptomic study on parasitized flesh fly pupae targeting the early stages of host 
response to envenomation (chapter 3). Since N. vitripennis larvae start host feeding 24 hours 
after egg-laying, time-points explicitly before that stage were chosen. The study revealed 
that only 1 transcript was differentially expressed in S. crassipalpis pupae 3 hours post-
parasitization by N. vitripennis. This is in contrast with results from a transcriptome study on 
hemocytes from Musca domestica treated with extracted venom from N. vitripennis. One 
hour after venom treatment, differentially expressed transcripts revealed effects related to 
immune and stress response, apoptosis, metabolism, transport and transcription/translation 
regulation (Qian et al., 2013). Furthermore, other studies using host hemocytes of S. bullata 
or specific tissues such as the fat body and brains, showed that envenomation by N. 
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vitripennis induces alterations in cell behaviour and toxicity, which were already visible after 
1 hour (Rivers et al., 2002b). Since whole bodies of parasitized flesh fly pupae were used for 
the transcriptome study, transcripts with various regulation in different cell types or tissues 
could be ruled out. All tissues and cell types are included in the RNA sample, possibly 
resulting in the absence of specific transcripts. Nonetheless, this approach in which 
unnecessary manipulations of tissue dissections are avoided, was still found favourable, 
ensuring unharmed samples. With this scope in mind, successful parasitization by N. 
vitripennis in the flesh fly host also must be verified without opening the pupae in an 
attempt to search for parasitoid eggs. Therefore, a screening tool was developed that targets 
Nos mRNA in parasitoid eggs by the use of RT-qPCR.  
 
Twenty-five hours after envenomation, a lot more genes were differentially expressed 
compared to 3 hours post parasitization. In total, 19 genes were significantly down-regulated 
and 109 up-regulated. By clustering these genes in groups relating to their possible function, 
3 major host processes appeared to be changed by parasitization: the immune system, host 
development and metabolism. Concerning host immunity, several suggestions can now be 
made of potential interactions between venom and host pathways. Imbalance in Ca2+ 
homeostasis in the mitochondria caused by N. vitripennis venom appears to facilitate 
immune modulation by promoting apoptosis in hemocytes. Next to this, Rho signalling 
pathway members were found to be differentially expressed. Activation of this pathway 
promotes blebbing by actin cytoskeleton reorganisation, hereby reducing hemocytes to 
produce pseudopodial projections critical for spreading responses. MAPK signalling seems a 
promising candidate for regulating both cellular immune response to envenomation as well 
as hemocyte apoptosis. Since envenomation by N. vitripennis has long been associated with 
decreased melanisation of Sarcophaga host hemolymph (Rivers et al., 2002b;Abt & Rivers, 
2007), it was not surprising to find up-regulated transcripts that potentially impede with pro-
phenoloxidase activity and host melanisation response. Interestingly, not a single 
antimicrobial peptide transcript was found to be differentially expressed, which is consistent 
with another study on host-endoparasitoid interaction that shows minimal AMP up-
regulated expression (Wertheim et al., 2005). We have to remark however, that these 
transcriptomic studies cannot disentangle the host defence response from the 
manipulations caused by the parasitoid. Therefore, further studies investigating specific 
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immune responses of the host to different threats (antimicrobial, parasites, viruses), 
compared to the additional infection with parasitoids, could aid to filter out the exact 
manipulations caused solely by the parasitoid.  
 
Molecular techniques in science are constantly evolving. When this transcriptomic study was 
planned in 2008, microarray was widely-used and had proven to be successful in reaching 
publishable results. Next generation sequencing had only recently made its entrance and 
was a lot more expensive at that time. Nowadays, this technique became increasingly 
affordable and would probably now be the preferred approach, since only an EST database is 
available for the host S. crassipalpis. The group of John Werren at the University of 
Rochester has recently performed an elaborate transcriptomic study on S. bullata pupae 
parasitized by N. vitripennis at different time points by RNA sequencing (unpublished data). 
It would be interesting to see whether their results can confirm current data and maybe new 
interactions have come to light.  
 
Following on the transcriptomic study, the obvious next quest is to unravel what venom 
compounds are causing the effects. The combination of bioinformatic and proteomic studies 
has revealed 80 proteins in the venom of N. vitripennis (de Graaf et al., 2010;Ye et al., 2010). 
Twenty-three of these proteins showed no homology to any known protein. Computational 
tools failed to designate a function to these proteins based on sequence and structural 
homology of proteins with known functions. Since a vast majority of proteins interacts with 
others for proper biological activation, the function of the novel protein may be extrapolated 
by knowing the function of its binding partners (Phizicky & Fields, 1995). Investigating the 
interacting partner of N. vitripennis venom compounds would therefore be one approach. 
Another method that has already been used for parasitoid wasps to assign functions to 
venom proteins, is the injection of recombinant expressed venom protein into the host 
(Price et al., 2009;Wang et al., 2013;Colinet et al., 2011). Yet, a completely different 
approach to tackle this functionality research, is silencing one (or more) venom protein(s) in 
the female N. vitripennis wasp. After both injection of recombinant expressed venom 
compounds and silencing the compound in the wasp, specific bio-assays need to be 
performed in order to investigate the effect of this compound (or the lacking of this 
compound) on the host physiology. Mostly, general effects caused by natural parasitization 
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are known, presenting several possibilities of processes that the single compound could be 
involved in. For the interaction of N. vitripennis with its host, several bio-assays are 
extensively described and already performed on naturally parasitized hosts concerning 
developmental arrest (Rivers & Denlinger, 1994a), apoptosis (Rivers et al., 2009), 
melanisation (Abt & Rivers, 2007), encapsulation (Rivers et al., 2002b) and hemocyte 
spreading (Rivers et al., 2010). Both approaches to unravel functionalities of N. vitripennis 
venom compounds were tested. Unfortunately, due to practical difficulties, both techniques 
could not have been followed through successfully. The preliminary studies that have been 
executed and possible solutions for the road blocks we ran into, are suggested in the 
addendum to chapter 3.  
 
2. Biomedical application of N. vitripennis venom 
Working with N. vitripennis in the laboratory has many practical advantages: short 
generation time, availability during the whole year, large amount of offspring and many 
more. One unfortunate disadvantage however, is the small size of these wasps together with 
the low quantity of venom they produce. When performing experiments to investigate the 
mode of action of this venom, dissecting the venom glands out of the female wasps is 
inevitable. Luckily, extracted N. vitripennis venom samples can be stored for a period of time 
in -20°C remaining its biological activity, making it possible to perform the dissections several 
weeks before the planned assays. All experiments to investigate the biomedical application 
of N. vitripennis venom were performed with manually dissected extracts. The discovery of 
the exact venom compound that is causing the anti-inflammatory effects on mammalian 
cells, would imply that laborious dissections can be replaced by use of the recombinantly 
expressed protein or synthesised peptide, depending on the nature of the specific 
compound. 
 
The fact that venom of parasitoid wasps suppresses the immune system of the host, is no 
secrete for several decades now. Even the fact that these parasitoids can interfere with the 
insect NF-κB signalling cascade by injecting virulence factors into the host, is known. In 
endoparasitoids, polydnaviruses injected along with the wasp eggs into the host are 
responsible for this specific immune suppression (Thoetkiattikul et al., 2005;Kroemer & 
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Webb, 2005;Bae & Kim, 2009;Gundersen-Rindal & Pedroni, 2006;Gueguen et al., 2013). 
Instead of replicating in the host, these viruses interfere with the immune system. 
Polydnaviruses can code for proteins that destroy hemocytes (Kumar & Kim, 2014) or can 
interfere with the production of phenoloxidase, suppressing host melanisation (Lu et al., 
2010). Finally, polydnaviruses can encode a family of genes with homology to IκB proteins 
from insects and mammals. These IκB proteins have posterior ankyrin repeats that act as 
irreversible inhibitors to NF-κB signalling in the host, hereby suppressing the insect immune 
response. Surprisingly, ectoparasitoids that only possess venom as virulence factor are also 
able to effectively suppress host immunity without the use of polydnaviruses. An 
endogenous venom compound must therefore be the responsible agent in the inhibition of 
host defence system by the ectoparasitoid wasp N. vitripennis.  
 
Targeting immune pathways of enemies by immune-suppressive molecules is a general 
strategy for success among Hymenopteran insects (Jang et al., 2006). Components in 
honeybee venom protect bees against arthropod and vertebrate predators. Unintentionally, 
however, bee venom also has an anti-inflammatory mode of action and is an ancient therapy 
for chronic inflammation and pain relief (Cherniack, 2010). Viral ankyrins (vankyrins) in 
endoparasitoids were reported to inhibit NF-ĸB signalling, presenting one possible 
mechanism by which anti-inflammatory effects of Hymenopteran products may be realized 
(Gueguen et al., 2013). Since inhibition of NF-ĸB signalling continues to be a significant area 
of research for strategic development of drug targets for human diseases (Gilmore & 
Garbati, 2011), possible other mechanisms of anti-inflammation used by ectoparasitoids may 
provide potential for the treatment of inflammation-based human diseases from arthritis to 
cancer. Therefore, extracted N. vitripennis venom was applied on different types of 
mammalian cells in order to further investigate how this immune suppressive action in 
insects translates to higher evolved metazoans.  
 
When cytotoxicity towards N. vitripennis venom was estimated by MTT assay, the insect cell 
line Sf21 showed first cytotoxic effects 6 hours after treatment that became more distinct 
after 24 hours induction (Formesyn et al., 2013b), while in the human cell line HEK293T, it 
took at least 48 hours until venom resulted into first signs of cytotoxicity (Formesyn, 2013c). 
Even though low toxicity appeared in HEK293T cells after venom treatment, several studies 
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revealed that the cells suffered from an increase in stress responses affected by the venom. 
The highest up-regulated reporter tested by the Cignal FinderTM 45-Pathway Reporter Arrays 
on HEK293T cells after N. vitripennis treatment, was the amino acid response element 
(AARE) reporter, which is known to be an early response upon amino acid deprivation of ER 
stress (chapter 5, figure S1;Formesyn, 2013c;Chen et al., 2005). AARE contains a C/EBP-ATF 
composite site that is composed of a half-site for the C/EBP family of TFs and a half-site for 
the ATF family of TFs (Schneider et al., 2012). ATF4 is an important regulator of several ER 
stress target genes, amino acid transporters and antioxidants (Saito et al., 2011). By binding 
to the C/EBP-ATF composite site within the AARE, ATF4 transactivates C/EBP protein-
homologous protein (CHOP). CHOP is a multifunctional TF in the ER stress response, involved 
in apoptosis and inflammation (Nishitoh, 2012). Interestingly, the C/EBP reporter was also 
significantly up-regulated in the performed Reporter Array after venom treatment, 
suggesting the likely activation of ER stress by venom. In addition, possible involvement of 
C/EBP in transcriptional regulation by N. vitripennis venom has also been proposed in 
chapter 5 when Raw264.7 macrophages were co-treated with LPS and venom, as analysed 
by PCR Array. The presence of C/EBP binding sites in promoter regions of several venom up-
regulated genes, together with its absence in promoters of some down-regulated genes, 
suggested its role in the seemingly contradictory up-regulation of inflammatory genes. In 
addition, ER stress also induces the IRE1-TRAF2-ASK1-JNK pathway that contributes to CHOP-
mediated macrophage cell death (Sano & Reed, 2013). Both TRAF2 transcription and JNK 
phosphorylation were found to be enhanced by co-treatment of N. vitripennis venom and 
LPS on macrophages, respectively detected by PCR Array (chapter 5, table 1) and western 
blotting (chapter 4, figure 6). Based on the results of current experimental data, we 
hypothesize that N. vitripennis venom possibly causes ER stress, characterized by alterations 
in the AARE and C/EBP reporters, together with enhanced TRAF2 transcription and 
prolonged JNK activation after co-treatment with LPS, eventually leading to cell death.  
 
Multiple experiments undoubtedly have proven that N. vitripennis venom suppresses 
mammalian NF-ĸB activity. TNF-stimulated NF-ĸB activation was significantly suppressed in 
L929sA fibrosarcoma cells, while LPS-stimulated Raw264.7 macrophages showed a decrease 
in protein secretion and gene transcription of the NF-ĸB regulated cytokine IL-6. In addition, 
transcription and translation of 2 negative feedback regulators that prevent excessive NF-ĸB 
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activation, IĸBα and A20, were both significantly down-regulated, probably as a direct result 
of inhibition of NF-ĸB activity by the venom. Prolonged JNK activation, seen after co-
treatment with N. vitripennis venom and LPS in macrophages, could potentially lead to cell 
death and is probably a secondary effect indirectly caused by suppression of NF-ĸB 
activation. The canonical cascade in the cytoplasm and nuclear translocation of the p65 
subunit appeared to be unaffected by the venom.  
 
The assembly of these results only leave few options open for venom intervention on the 
NF-ĸB pathway. One of them is an alteration in the general transcriptional machinery, 
preventing effective transcription of NF-ĸB target genes. The complete transcription 
regulation in eukaryotes is a very complex process that is composed out of several processes 
(Bhatt & Ghosh, 2014). First, the core promoter serves as a platform for the assembly of 
different transcription factors, RNA polymerase II and other general TFs. Next to that, co-
factors can transmit regulatory signals between gene-specific activators and the general 
transcription machinery. As for other transcription factors, NF-ĸB activity can be drastically 
altered by affecting the general transcription machinery and this might be a possible place of 
intervention by N. vitripennis venom. Also interference with other TFs is a well-known event 
for transcriptional regulation. The probably most studied mechanism of repression of NF-ĸB 
activity is via glucocorticoids. Through binding with glucocorticoids, GRs act strongly anti-
inflammatory and thereby GCs are widely used in the clinic to treat both chronic 
inflammation and cancer. GRs can modulate their anti-inflammatory activity via multiple 
mechanisms (Ratman et al., 2013). Possible mechanisms of GCs/GR interfering with NF-ĸB 
signalling, is via protein-protein interaction, of which several different models have been 
proposed (Almawi & Melemedjian, 2002). In the composite as well as the competition 
model, NF-ĸB binds with its DNA binding site, but transactivation of NF-ĸB is inhibited: in the 
composite model, GR associates with the trans-activating domain of p65, while in the 
competition model, GR competes with NF-ĸB for nuclear coactivators. However, in the  Gal4-
p65 assay (see chapter 4, figure 5), where the (Gal)2-50hu.IL6P-luc+ plasmid was transiently 
transfected in HEK293T cells, no effect of N. vitripennis venom on GAL4-p65 activity involving 
the general transcription machinery could be observed. Thereby, both models of GR activity 
cannot explain the possible suppression of NF-ĸB activity by N. vitripennis venom. 
Furthermore, venom did not inhibit PMA- and dB-cAMP-induced luciferase expression of 
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respectively the AP-1-dependent reporter gene, nor the CRE-dependent reporter gene (see 
chapter 4, figure S3), making the option that venom affects NF-ĸB dependent gene 
regulation via targeting of the general transcription machinery including RNA polymerase II 
and its co-actors rather unlikely. Furthermore the latter data underline the specificity of 
venom activity. 
 
Based on these observations, the most plausible scenario for venom activity implies the 
prevention of NF-ĸB binding to its DNA binding site. A large group of NF-ĸB inhibitors 
specifically blocks the binding between NF-ĸB and its cognate DNA binding site in the 
nucleus (Gilmore & Herscovitch, 2006). This specific process was not investigated by the 
Gal4-p65 assay, since the binding between DNA and the Gal4-p65 fusion protein takes place 
between the DNA-binding domain of the yeast nuclear protein Gal4 and the two Gal4-
binding DNA sequence elements that precede the luciferase reporter gene. Therefore, the 
lacking effect of venom on the transactivation process of p65 independent from the 
promoter context, analysed by this experiment, does not exclude the fact that venom 
potentially interrupts direct binding between p65 and its DNA-binding site. Interestingly, 
incubation of Raw264.7 cells with N. vitripennis venom for 6 hours showed significant up-
regulation of GILZ transcription (see chapter 4, figure 7B). GILZ was previously demonstrated 
to physically bind the p65-subunit and thereby prevent the NF-ĸB-mediated activation of 
transcription (Riccardi et al., 1999;Cheng et al., 2013b). Indeed exogenous GILZ in 
endothelial cells inhibited TNF-induced p65 DNA binding, which occurred in the absence of 
an effect on p65 nuclear translocation (Cheng et al., 2013b). Similarly, N. vitripennis venom 
could inhibit NF-ĸB activation in Raw264.7 macrophages by the up-regulation of GILZ 
expression, followed by the prevention of NF-ĸB binding to its DNA binding site. A possible 
scenario for the up-regulation of GILZ can be found in the transcription activating action of 
glucocorticoid receptor (GR) signalling. Investigating the crosstalk between TNF and GR 
signalling pathways, many possible mechanisms of interference of GCs/GR in TNF signalling 
were revealed (Van Bogaert et al., 2010), among which the up-regulation of GILZ. 
Unfortunately, the venom showed no change in GR transactivation on a glucocorticoid 
responsive element (GRE)-containing promoter reporter (see addendum to chapter 4, figure 
1A) and no alteration on translocation of GR from the cytoplasm to the nucleus was caused 
by N. vitripennis venom, which did occur when dexamethasone was added (see addendum 
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to chapter 4, figure 1B and C). Therefore, we would assume that this up-regulation of GILZ 
expression is possibly mediated via activation of other transcriptional responses. Indeed also 
the b/HLH/Z TF upstream stimulatory factors, USF1 and USF2, as well as the 
mineralocorticoid receptor have previously been demonstrated to regulate GILZ expression 
(Koberle et al., 2012;Ueda et al., 2014). So, in order to understand what N. vitripennis venom 
is eliciting with regard to the GILZ signalling pathway, further investigation of transcriptional 
regulation of GILZ by the venom is required. However, in a similar manner as for NF-ĸB also 
AP-1 activity could be repressed by GILZ (Mittelstadt & Ashwell, 2001), which could not be 
observed for the N. vitripennis venom in the L929sA reporter assay system. Therefore, knock 
down studies for GILZ should reveal its contribution to the NF-ĸB repressing effects of the 
venom. 
 
In another GR anti-inflammatory action model, called the simple model, hormone-activated 
GR does not affect the availability or translocation of NF-ĸB nor its function, but rather binds 
to NF-ĸB in the nucleus and/or cytosol, thereby forming a complex which fails to bind to 
DNA. This scenario could fit with the results of N. vitripennis venom effects in mammalian 
cells mentioned in chapter 4 and would imply that venom binds to NF-ĸB, still allows NF-ĸB 
to translocate to the nucleus, but prevents NF-ĸB from binding its DNA binding site. Since 
hormone-activated GR binds to NF-ĸB, forming a GR-NF-ĸB-complex that does not bind DNA, 
transactivation through GRE-binding is interrupted (see addendum to chapter 4, figure 1A). 
It would however not explain the unaffected translocation of GR to the nucleus (see 
addendum to chapter 4, figure 1B and C). In addition, for this scenario to persist, N. 
vitripennis venom needs to contain a possible ligand of GR, in order to activate its binding to 
NF-ĸB. Since no steroid hormones have been found in venoms in general, this train of 
thoughts seems highly unlikely. Alternatively, the possibility that a compound in the venom 
from N. vitripennis directly binds to NF-ĸB, preventing it from binding DNA, still remains and 
requires further investigation. First results investigating possible interaction of N. vitripennis 
venom on p65-DNA binding by electrophoretic mobility shift assay (EMSA) using a non-
radioactive p65 probe on cell-lysates of HEK293T cells overexpressing p65, seem promising. 
However, optimisation of this EMSA is required. 
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Besides general effects on NF-ĸB DNA binding, the effects of N. vitripennis venom might be 
more gene specifically regulated, as suggested by the results from the PCR array performed 
on venom treated Raw264.7 cells (chapter 5). Chromatin can be remodelled by histone 
modifications like lysine acetylation and methylation as well as genomic DNA methylation, in 
order to make binding sites accessible to their cognate DNA-binding proteins. For instance, 
in case of NF-ĸB transcriptional regulation, differences in promoter accessibility have been 
demonstrated to create 2 waves of NF-ĸB recruitment to target promoters resulting in 
immediate early responses and late NF-ĸB responses (Saccani et al., 2001). Therefore, 
Chromatin Immunoprecipitation (ChIP) to determine what specific regions in the promoter 
associated with p65 are affected by the venom, need to be performed to fully disentangle 
the effect of N. vitripennis venom on the NF-ĸB pathway.  
 
Described results seem promising to use N. vitripennis venom as anti-inflammatory agent for 
chronic inflammatory conditions, auto-immune diseases and cancer. In order to reach that 
goal, first the exact mode of action of venom needs to be fully unravelled and the venom 
compound responsible for this activity needs to be identified. Fractionation of the venom by 
HPLC followed by identification and production of the compound performing anti-
inflammatory action is therefore the strategy for the coming years.  
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